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Abstract 
The pathogen Streptococcus pneumoniae encounters different levels of oxygen 
during the infection cycle including colonisation, pneumonia, bateraemia and 
meningitis. These different anatomical niches require high levels of genome 
changes to sense and respond to those external environmental stimuli. The 
bacterial gene expression is known to be affected by oxygen, and it must react 
properly for survival and for developing invasive pneumococcal desiseases (IPDs).  
Microarray techniques have allowed scanning the whole pneumococcal genome 
during growth in different tensions of oxygen mimicking in vivo conditions. It 
was found that oxygenated growth conditions have significantly elevated several 
key virulence genes. This was further confirmed with qRT-PCR for a selection of 
genes implicated in pathogenicity. Moreover, post-transcriptional stages have 
been also investigated such as protein production, biofilm formation, biological 
activities and adherence assays for several virulence factors performed under 
the effect of presence or absence of oxygen. 
The data illustrate that 420 out of 2,236 genes (17 % of the entire TIGR4 
genome) were differentially expressed in the presence of oxygen compared to its 
absence. 262 genes (11 %) were over-expressed when pneumococci were grown 
in oxygenated conditions relative to transcriptional profile in anaerobic growth 
conditions, indicating the magnitude of roles played by oxygen on pneumococcal 
gene expression. Anaerobic growth of TIGR4 showed down-regulation of 158 
genes (7 %). Oxygen modulates induction of ply, pspC and other seven genes 
involved in pili structuring subunits (rlrA, rrgA, rrgB and rrgC) and assembling 
enzymes (srtB, srtC and srtD). This may suggest that the pneumococcal 
population grown under atmospheric environment is equipped with greater 
capability to progress IPDs compared to anaerobically grown bacteria. In 
addition to this, pneumococcal adhesion in vitro for TIGR4 grown in oxygenated 
or anaerobic growth conditions revealed a significant increase in those grown in 
oxygenated growth conditions, indicating that oxygen may play a key role in 
bacterial-host attachment. Interestingly, ablation of pspC has resulted in similar 
adhesion percentages of TIGR4 grown under both conditions, oxygenated and 
anaerobic.  
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Furthermore, several genes involved in metabolism were up-regulated in 
oxygenated environment, particularly transporters, which are considered highly 
important for a bacterium that lacks an electron transport chain, catalase and 
tricarboxylic acid. Additionally, the results showed phenotypic characterisation 
and changes in cells morphology from pneumococcal growth curves for several 
strainswith different genome backgrounds grown under different levels of 
oxygen concentrations. Further investigation of the pathogen biology revealed 
differences in pneumolysin production and activity.   
These findings highlight that virulence genes expression is induced once the 
micro-organism is exposed to oxygenated environment, and data analysis has 
demonstrated potential links between pneumococcal metabolism and their 
ability to cause diseases. 
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1. Introduction 
1.1 Streptococcus pneumoniae 
Streptococcus pneumoniae, also known as pneumococcus, is an extracellular 
pathogen considered to be one of the most serious life-threatening causes of 
infectious disease in the world (Hammerschmidt 2006; Martner et al., 2008). The 
bacterium is a facultative anaerobe microorganism enveloped within a 
polysaccharide capsule, which plays an essential role in the bacterial 
pathogenicity. Currently, there are 93 recognised variant capsular 
polysaccharide (CPS) structures, called serotypes, which have mostly been 
identified microscopically as a swelling, resulting from a specific reaction of 
antibodies, known as Quellung reaction, against the pneumococcal capsule. 
However, its high technical cost has led to different typing systems such as PCR-
based serotyping (Jin et al., 2009; Park et al., 2007; Song et al., 2012).  
The pneumococcus is implicated as the most common cause of respiratory 
infection in the United Kingdom, and the situation is worse in developing 
countries (Kadioglu et al., 2008). Despite the availability of antibiotics and the 
successful introduction of vaccines (Azzari et al., 2008), the pneumococcus is 
responsible for mortality of an estimated 2 million people per year, and the 
majority have been reported principally in developing countries (Trappetti et 
al., 2011a; Williams et al., 2012). It is possible that inadequate diagnosis 
probably results in underestimating the true pneumococcal disease burden 
(Paterson et al., 2006). Furthermore, the pneumococcus has been reported to 
cause significant morbidity and mortality in developed countries. For instance, 
in the United States, there were 50,000 pneumonia cases, 7 million cases of 
otitis media and 3,000 cases of meningitis per year (Paterson et al., 2006). 
Additionally, in 2012, an updated electronic source presented by the health 
protection agency (HPA) showed 40,000 GP consultations of pneumonia resulted 
in hospitalisations due to S. pneumoniae; and similarly in England and Wales 
63,000 cases of acute otitis media (AOM) were caused by the pathogen S. 
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pneumoniae 
(http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/120300886402). 
1.2 Characteristics and genotyping of S. pneumoniae 
S. pneumoniae can be identified using several specific tests which include bile 
solubility of broth culture, α-haemolytic activity on a blood agar plate, 
sensitivity to discs soaked with 5mg ethyl hydrocupereine (optochin), catalase 
negativity (Greiner et al., 2001; Hendley et al., 1975; Taniai et al., 2008; 
Wessels et al., 2012), and the technique “swelling reaction” (Park et al., 2007). 
Moreover, genotypic means that microarray, genome sequencing and Multi Locus 
Sequence Typing (MLST) can accurately differentiate pneumococcus from other 
closely related microbes (Hanage et al., 2005).   
1.2.1 Multi Locus Sequence Typing (MLST) 
In 1998, Enright and Spratt developed the Multi Locus Sequence Typing (MLST) 
technique for genotyping using a sequence of seven highly conserved 
housekeeping genes (aroE, gdh, gki, recP, spi, xpt, ddI), with allelic variants of 
each gene allocated a number (Enright et al., 1998). This has facilitated access 
and comparison between laboratories through the available website (MLST.com) 
for worldwide studies (Obert et al., 2007). The high sensitivity of this technique 
can detect bacterial genotype variations through DNA sequencing. For example, 
in S. pneumoniae, Streptococcus pyogenes, Neisseria meningitidis, 
Staphylococcus aureus, Enterococcus faecium and Salmonella enterica (Lemee 
et al., 2004). 
There are over 4,000 MLSTs reflecting the high genome plasticity among 
pneumococci in responding to the environmental conditions. The organism is 
highly transformable representing a massive level of genomic variation (Leung et 
al., 2011). For example, examination of the pneumococcal genome by 
microarray has revealed 8-10% of genes are absent/divergent in any of the 
medical strains in comparison to TIGR4 as a reference strain (Silva et al., 2006). 
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Unlike serotyping, MLST is performed using unencapsulated pnaumococci, and 
also the technique is beneficial after PCR of an extracted DNA from non-viable 
or clinically isolated viable pneumococcal pathogens (Hanage et al., 2005). 
Aplications of clinical MLST are reviewed with reporting their advantages and 
disadvantages (Sullivan et al., 2005).   
 
1.2.2 Microarray  
Microarrays are utilised in studies to investigate the whole bacterial genome 
(Conway et al., 2003) either by looking at presence/absence gene using 
Comparative Genome Hybridisation (CGH) for bacterial comparison including 
Escherichia coli, Salmonella and Shigella (Chizhikov et al., 2001), or with the 
use of fluorescently labelled cDNA to study levels of gene expression as 
generally explaned in Figure 1-1. 
Bacterial RNA extraction 
Reverse transcription 
Pneumococci 
Labeled cDNA using 
Cy3 and Cy5  
Hybridisation on slide Scanning  and data analysis 
 
Figure  1-1 Basic microarray procedure 
 
Four steps reflecting the main procedure to perform microarray. After RNA extraction from 
bacteria, reverse transcription is achieved in order to prepare cDNA before labelling the DNA 
with the dyes (Cy3 and Cy5). Labelled cDNA then is hybridised on a prepared slide before 
scanning to obtain expression data. 
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An example of this can be seen in a study that dissected Haemophilus gene 
expression under different in vitro host-mimicking environments (Melnikow et 
al., 2005).  
In the CGH technique, genes are assessed and analysed only for their presence 
or absence which are practically performed after labelling and hybridising DNA 
samples against an array glass slide on which the bacterial genome has been 
prepared (Chizhikov et al., 2001). However, it does not detect levels of 
expression. Microarray experiments using cDNA have solved this. cDNA is 
prepared to be hybridised onto the slide to study levels of gene expression that 
represent the amount of RNA expressed under a specific condition (Bryant et 
al., 2004).    
The microarray technique has been used in several aspects of pneumococcal 
biology including examination of pneumococcal stress responses to an antibiotic, 
vancomycin (Haas et al., 2005), studying effects of variant host-mimicking 
temperatures on gene expression (Pandya et al., 2005) and an in vivo 
investigation of the entire pneumococcal genome collected from different 
anatomical niches in animal models (Orihuela et al., 2004a).     
1.3 Pneumococci and carriage 
Streptococcus pneumoniae is carried in the upper respiratory tract (URT) in 
healthy individuals (Hammerschmidt et al., 2005; Nelson et al., 2007; Price et 
al., 2012). Mehr and Wood (2012) reported that the carriage percentage of 
pneumococcal serotypes is 40-60% in young children (Mehr et al., 2012). 
Interestingly, pneumococcal carriage seemed to be serotype-dependent. Studies 
with Australian communities have shown that serotype 1 has been rarely isolated 
from healthy people (Harvey et al., 2011b). However, other similar studies in 
Kenya undertook culturing several interval swabs from children during months 
and revealed that type 1 pneumococci were detected for almost 9 days after 
which the pathogens could not be found again from same childeren (Abdullahi et 
al., 2012). In fact, pneumococcal colonisation of human nasopharynx is a key 
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step as it might progress to cause both invasive and non-invasive pneumococcal 
diseases.  
Some individuals are considered to be at high-risk from pneumococcal diseases 
and predisposed to pneumococcal infections, e.g., patients who have developed 
viral infections such as influenza (Diavatopoulos et al., 2010), human 
immunodeficiency virus (HIV), immuno-compromised people and elderly people 
(Anthony et al., 2012; Li et al., 2012). In addition to these, there are a number 
of risk factors that can contribute to paving the way for bacterial colonisation, 
such as smoking (Bakhshaee et al., 2012). 
Once the pathogens colonise the host mucosal surfaces and tissues, there will be 
competition between pneumococci and other organisms for the same ecological 
niche and nutrients. These bacteria include Moraxella catarrhalis, Haemophilus 
influenzae and N. meningitidis (Kais et al., 2006). Therefore, S. pneumoniae has 
to compete using several competition factors. An example includes production 
of hydrogen peroxide (H2O2) that is released as a by-product of the pathogen´s 
aerobic metabolism during growth. The peroxide carries out a number of 
biological functions such as inhibition of growth of other bacteria (Pericone et 
al., 2000; Regev-Yochay et al., 2007; Selva et al., 2009), interrupts the ciliary 
beating system leading to epithelial cells damage (Feldman et al., 2002; Hirst et 
al., 2000a; Regev-Yochay et al., 2007) and mediates pneumococcal-induced 
apoptosis (Regev-Yochay et al., 2007). Moreover, sialidase, which can modify 
surfaces of other competitors in the same environmental niche, exposes some 
competitors to the host’s immune system (Burnaugh et al., 2008; Shakhnovich et 
al., 2002). In addition, pneumolysin, which will be explained in more detail 
later, is another multi-functional pneumococcal protein which is known to form 
pores in host cells allowing fragments from nearby H. influenzae to enter 
epithelial cells that consequently trigger the host immune response against this 
competitor; therefore, Ply in this case indirectly promotes the immune system 
toward others (Ratner et al., 2007). Further, the pneumococcus produces 
bacteriocins to kill other competing bacteria (Dawid et al., 2007; Dawid et al., 
2009). However, under certain circumstances, pneumococci can cause serious 
diseases as they may propagate from the upper respiratory tract (URT) to the 
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sterile parts of the LRT, resulting in invasive pneumococcal disease (IPD) 
including pneumonia, septicaemia, meningitis (Cartwright 2002; O'Brien et al., 
2009), and N-IPDs such as AOM, sinusitis and bronchitis (Bogaert et al., 2004). 
1.4 Diseases caused by S. pneumoniae 
1.4.1 Acute Otitis Media (AOM) 
Pneumococcal infiltration and replication within the Eustachian tube results in a 
host inflammatory immune response determined as a middle ear infection 
(Mahadevan et al., 2012; Monasta et al., 2012). In comparison to adults, 
children are more predisposed to AOM (Corbeel 2007), and up to 80% will 
develop AOM at least once in the first three years of childhood (Monasta et al., 
2012). The progress of the infection can lead to fluid accumulation filling the 
infection site. Consequently, blocking of the Eustachian tube may cause severe 
pain and potential deafness if it is not cured. This could affect the education 
skills or language skills of the child (Allegrucci et al., 2006).  
It was reported that in one year only, there were 24 million cases of middle ear 
infection in the United States (McEwen et al., 2003). Zhou and colleagues stated 
that over 15 million antibiotic prescriptions were issued for medical treatment 
because of AOM infection cases (Zhou et al., 2008). 
1.4.2 Pneumonia 
There were 19,000 deaths out of 866,000 cases of pneumoniae in the United 
States (Huang et al., 2011). However, in African children, there are up to 4 
million cases of deaths per year attributed to pneumococcal pneumonia (Scott 
2007).  
Although the pneumococcal pathogens have been shown to colonise a large 
proportion of the human population without causing diseases, the mechanism by 
which they may transmit to the LRS is poorly understood (Frolet et al., 2010). 
Once in the alveoli the pathogens can replicate extracellularly, leading to the 
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release of toxic molecules and causing an inflammatory reaction (Kadioglu et 
al., 2008). This fluid-microorganism mixture in the alveoli might prevent 
optimum gaseous exchanges that may alter the infection site from an aerobic to 
an anaerobic environment. This bacterial assembly will possibly facilitate 
pneumococcal transition to the adjacent areas (Cano et al., 1986) such as the 
blood circulation system, possibly causing bacteraemia.  
There are several different host micro-ecological conditions, which may have an 
effect on the bacterial pathogenicity. For example, a study has investigated the 
possible effect of both the nasopharyngeal surface temperature (33ºC) and the 
body temperature (37ºC) on pneumococcal gene expression (Pandya et al., 
2005). They found an induction in a number of genes encoding adhesive proteins 
at 33ºC, but not 37ºC, indicating that the nasopharyngeal temperature 
contributed to S. pneumonia colonisation. Nevertheless, oxygen concentration 
also varies in these two host niches.   
1.4.3  Bacteraemia 
Pneumonia may result in bacteraemia and this outcome is believed to cause 
death (Laterre et al., 2005; Myers et al., 2007). Myer and Gervaix also showed 
that in Switzerland, 50% of the IPD cases developed pneumococcal bacteraemia 
in children below 3 years old and they stated similar episodes in the United 
States (Myers et al., 2007). Higher rates were recently reported in a hospital-
based study among adult patients who had developed pneumococcal infection 
from 2000 to 2008 in Denmark, where 81% of S. pneumoniae bacteraemia (SPB) 
was reported (Christensen et al., 2012).  
Despite the increase in bacterial resistance to antibiotics, particularly 
pneumococci due to their known classical evolution ability, penicillin is still the 
first choice in treating SPB (Christensen et al., 2012).  
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1.4.4  Meningitis 
Pneumococcal meningitis is characterised as an inflammation of the protective 
membranes of the central narvous system (CNS) (Mook-Kanamori et al., 2011). 
This follows a pneumococcal infection such as pneumococcal pneumonia, 
bacteraemia and AOM (Ostergaard et al., 2005). However, the microorganisms 
can also invade directly to the CSF via the olfactory neurons to the central 
nervous system (CNS) (van Ginkel et al., 2003). 
A study published last year spanning over 19 years has revealed that 45% of 
adults who have been identified with S. pneumoniae in their blood had positive 
cultures of meningitis (Choi et al., 2012). Another recent investigation in Turkey 
showed an approximately similar percentage of meningitis in newborn infants 
and found 42.1% of pneumococcal meningitis among 10,186 hospitalised 
neonates (Bas et al., 2011).   
Symptoms of bacterial meningitis are recognised with a number of 
manifestations including neck stiffening, headaches, seizures and even coma 
that consequently may cause death or a serious disability (Menaker et al., 2005). 
To medically treat the disease, available antibiotics are efficacious, especially 
those which do not cause bacterial lysis that avoid the release of pneumococcal 
antigens and pneumolysin into the CSF (Mook-Kanamori et al., 2009). 
 
1.5 Virulence Factors 
The number of pneumococcal virulence factors that have been studied has 
increased gradually in the last two decades (Kadioglu et al., 2008; Watson et 
al., 1995), with techniques such as signature-tagged mutagenesis (Hava et al., 
2002; Lau et al., 2001; Mitchell 2000) and genome sequencing for a number of 
highly conserved genes including those encode pneumolysin, neumaminidase A 
and capsular polysacharide (Hu et al., 2012; Williams et al., 2012). These 
determinants allow the bacterium to interact, colonise and cause a disease. 
Although sequencing of the whole pneumococcal genome has largely contributed 
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to understanding the pathogenicity (Tettelin et al., 2001), biological gene 
functions are still not completely understood. A set of 29 virulence-related 
genes have been identified to be responsible for S. pneumoniae pathogenicity 
(Oggioni et al., 2006). The majority of the pneumococcal virulence factors and 
their biological functions in pathogenicity are outlined in Table 1-1. 
Table  1-1 Pneumococcal virulence factors and their contribution in pathogenicity 
 
Virulence factors Biological functions 
Pneumococcal 
surface protein A 
(PspA) 
Contributing to colonisation, pneumonia and bacteraemia 
(Ogunniyi et al., 2007) 
 
Binds the key iron transporter protein lactoferrin 
(Hammerschmidt 2006) 
IgA protease 
Leads to evasion of the immune system by degrading IgA 
and then facilitates colonisation (Poulsen et al., 1996) 
Hyaluronidase (Hyl) 
Hydrolysing hyaluronic acid situated in connective tissues 
promoting bacterial spread in the host (Paton et al., 1993) 
Pyruvate oxidase 
(SpxB) 
Decarboxylates pyruvate to H2O2 and CO2 during 
pneumococcal aerobic metabolism (Pesakhov et al., 2007; 
Spellerberg et al., 1996) 
 
In vivo gene expression has shown to be up-regulated in 
the nose when compared to its expression in host lung and 
blood (Mahdi et al., 2008) 
 
 
 
 
Hydrogen peroxide 
(H2O2) 
 
Induced under aerobic incubation conditions (Spellerberg 
et al., 1996). 
 
Plays an essential role against other species in the same 
niche (Pericone et al., 2000; Regev-Yochay et al., 2007) 
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Interrupts the ciliary beating system causing host 
epithelial damage and cell injury (Feldman et al., 2002) 
(Hirst et al., 2000a; Regev-Yochay et al., 2007) 
 
 
 
Mediates pneumococcal-induced apoptosis (Regev-Yochay 
et al., 2007) 
Pneumococcal 
surface adhesion A 
(PsaA) 
Fundamental for colonisation and psaA mutants were 
significantly less virulent in vivo (Berry et al., 1996) 
 
Responsible for transporting manganese (Johnston et al., 
2004) and is assumed to transfer iron and zinc across the 
pneumococcal cytoplasmic membrane (Tseng et al., 2002) 
 
Loss of psaA resulting in hypersensitivity to the oxidative 
stress (Johnston et al., 2004) 
Zinc 
metalloprotease 
(Zmp) 
Stimulates TNF-α after triggering an inflammatory 
response in the lower respiratory system in infected mice 
(Blue et al., 2003b) 
 
Caseinolytic 
protease C (ClpC) 
 
 
ClpP 
 
 
Clp protease 
 
 
Required for LytA and Ply release (Ibrahim et al., 2005) 
 
 
 
Responds to oxidative stress and involved in virulence 
(Ibrahim et al., 2005) 
 
Implicated in degrading damaged proteins by ROS 
(Gottesman 1996; Gottesman et al., 1998) 
Pneumococcal iron 
acquisition protein 
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A (PiaA) Genetically conserved in S. pneumoniae (Whalan et al., 
2006) 
 
Iron ABC transporter and required for full pneumococcal 
virulence in animal murine (Whalan et al., 2006) 
Pneumococcal 
Hisitidine Triad 
(Pht) 
 
Essential for pathogenicity and binds to Factor H 
(Ogunniyi et al., 2009) 
 
Animal experiments have demonstrated protection against 
most prevalent pneumococci (Adamou et al., 2001) 
 
1.5.1  Capsule 
The pneumococcal capsular polysaccharide (CPS) is believed to be a key 
virulence determinant for the capability of the bacterium to cause disease. It 
contains several repeats of multiple sugar structuring (Bentley et al., 2006). The 
CPS gene expression changes during the pneumococcal infection cycle according 
to the surrounding environmental conditions (Ogunniyi et al., 2002). In the 
primary stage of colonisation, the bacterial capsule seems to prevent efficient 
adherence to host epithelial surfaces (Moscoso et al., 2006), as it entirely covers 
the pneumococcal cell wall (Kadioglu et al., 2008).  
The majority of bacterial isolates display phase variation; i) Expression of a thick 
CPS when they are collected from the blood stream, to avoid opsonisation that 
results in bacterial engulfment by phagocytes, ii) Expression of a thinner capsule 
in the URT to allow binding of epithelial cells (Hammerschmidt et al., 2005; 
Vannapraseuth 2004; Weinberger et al., 2009). 
Interestingly, it has been reported that oxygen availability is responsible for 
down-regulating CPS in S. pneumoniae (Weiser et al., 2001), which will be 
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discussed in greater detail later, as well as opaque/transparent phenotypes and 
the role of oxygen in phase variation (Section 1.12).  
1.5.2 Choline-binding proteins 
There are up to 16 choline-binding proteins (CBPs) placed on the bacterial cell 
surface (Bergmann et al., 2006). Choline is vital for the pneumococcal growth, 
cell separation, autolysis and pathogenicity (Rock et al., 2001). Examples of CBP 
are listed in Table 1-2. 
Table  1-2 List of some of the choline-binding proteins 
 
According to (Bergmann et al., 2006; Gosink et al., 2000).  
 
 
 
 
 
 
 
 
Pneumococcal cell wall is structured with peptidoglycan to which teichoic acid 
is covalently linked (Eberhardt et al., 2009), whereas lipoteichoic acid is known 
to attach to the bacterial cell membrane (Dave et al., 2004a; Fischer et al., 
1993). CBPs are non-covalently bound to phosphorylcholine (P-Cho) on the cell 
wall (Bergmann et al., 2006; Dave et al., 2004a; Kwak et al., 2002) exposing 
them on the bacterial cell surface (Attali et al., 2008; Hammerschmidt 2006; 
Rock et al., 2001).  
Choline-binding proteins Abbreviation 
Pneumococcal surface protein A PspA 
Choline-binding protein A 
Pneumococcal surface protein C 
Secretory pneumococcal surface proteins A 
CbpA 
PspC 
SspA 
Choline-binding protein D CbpD 
Choline-binding protein F CbpF 
Choline-binding protein J CbpJ 
Choline-binding protein G CbpG 
Choline-binding protein E CbpE 
Autolysin A LytA 
Autolysin B LytB 
Autolysin C LytC 
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PspC (SP-2190) is a major pneumococcal adhesin factor that mediates  
attachment to host epithelial cells (Ma et al., 2007), binds immunoglobulin A 
(IgA) (Lu et al., 2003), is able to bind complement 3, Factor H (FH) (Dave et al., 
2004b; Quin et al., 2007) and stimulates interleukin 8 (IL-8) (Madsen et al., 
2000). It was found to be regulated by TCS06 as deletion of rr06 completely 
abolished pspC expression and resulted in loss of bacterial adhesion (Standish et 
al., 2005). In an in vivo study, a pspC-deficient mutant has shown a reduction of 
more than 50% in adhering to its known ligands on eukaryotic cells. The carriage 
of this mutant in animal experiments reduced 100-fold, whereas this high 
difference disappeared with sepsis model when mice were infected via the 
intraperitoneal route using the same mutant as compared to parent strains 
(Rosenow et al., 1997). Mice infected with pspC mutant showed significantly 
longer survival times compared to parent strains (Iannelli et al., 2004). 
Similarly, in vitro findings have revealed statistical significance, up to 85%, 
lower (p<0.001) adherence of PspC mutant to the human A549 lung cells 
(Standish et al., 2005). 
However, these effects were documented to be strain specific as researchers 
used a number of serotypes including 2, 3, 4 and 19F, and only TIGR4 pspC 
mutants showed a significant reduction in virulence in animal models in 
comparison to the TIGR4 parental wild-type (Kerr et al., 2006). 
CbpD (SP-2190) was reported to be involved in competence-induced cell lysis 
(Hakenbeck et al., 2009) and plays a role in colonization as well as CbpE 
(Bergmann et al., 2006). CbpF (SP-0391) inhibits LytC activity (Molina et al., 
2009) and CbpG has shown to contribute to sepsis and increased nasopharyngeal 
adhesion (Gosink et al., 2000). Furthermore, CbpJ (SP-0378) has been illustrated 
to be able to bind C-reactive proteins (CRP) (Frolet et al., 2010).  
To my knowledge, there are no studies in the literature demonstrating the 
relationship between these key CBPs and oxygen or describing the role of oxygen 
in controlling the expression of CBPs.   
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1.5.3 Autolysin 
S. pneumoniae undergoes a peculiar spontaneous tendency to carry out a 
specific covalent bond cleavage in cell wall, resulting in autolysis once the 
pathogen reaches the stationary growth phase or when it is exposed to 
antibiotics (Dagkessamanskaia et al., 2004; Ibrahim et al., 2005; Martner et al., 
2008; Ramos-Sevillano et al., 2011). 
This property is mediated with autolysin and the function of the molecule is to 
break down the peptide cross-linking of the peptidoglycan in the cell wall which 
then leads to bacterial lysis (Martner et al., 2008). Moreover, autolysin can be 
activated under stress conditions such as penicillin treatment or nutritional 
starvation (Mitchell 2000). Mitchell has also been pointed out that the autolysis 
process performed with Lyt activity may enable the bacterium to release the 
key virulence determinant Ply, as well as discharging vast amounts of 
pneumococcal cell wall fragments. As a result, the larger the number of these 
fragments, the higher the inflammatory response (Martner et al., 2008; 
Vannapraseuth 2004). Experiments in mice revealed that these bacterial 
components strongly stimulated the immune response resulting in pneumonia, 
otitis media and meningitis (Hoffmann et al., 2007; Moscoso et al., 2005; 
Tuomanen 1986; Tuomanen 1987).  
LytA is a member of a family of proteins that have been shown to be involved in 
host colonisation and in causing pneumococcal diseases (Ramos-Sevillano et al., 
2011). It has been documented that the autolytic enzyme LytA is implicated in 
pneumococcal virulence (Berry et al., 1989), LytB contributes to daughter cell 
separation following the bacterial cell division (Martner et al., 2008), LytC leads 
to the organism’s attachment to the nasophyrengeal cells indicating its role in 
colonisation, the first pneumococcal step prior to invasive disease (Ramos-
Sevillano et al., 2011). Additionally, LytC is actevited at 30ºC, which is similar to 
URT temperature, and the enzyme was shown to promote pneumococcal 
adhesion to host nasopharynx  (Moscoso et al., 2005). It has been highlighted 
that its role is synergistic with LytB resulting in an increase in the bacterial 
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biofilm formation, indicating their cooperative role in pneumococcal biofilm and 
adhesion (Ramos-Sevillano et al., 2011).  
It was found that autolysin-negative mutants cleared rapidly from host lungs, 
showed no pneumococcal pneumonia with an absence of inflammatory response 
in the lungs of infected animals (Mitchell 2000).  
1.5.4  Pneumolysin (Ply) 
Pneumolysin is a multifunctional protein (Feldman et al., 2002; Mitchell et al., 
1997). The toxin Ply is known as a major virulence factor in S. pneumoniae and 
is conserved virtually in all pneumococci (Berry et al., 1992; Feldman et al., 
2002; Mitchell et al., 1997; Price et al., 2012; Yoo et al., 2010). Although some 
serotypes showed non-haemolytic activities, antibodies generated against wild 
type pneumolysin were able to cross-react with those dysfunctional toxins 
(Kirkham et al., 2006).   
Tilley and colleagues showed that the protein Ply forms a large ring-shape in the 
human cell membranes after binding to cholesterol situated on host membrane 
(Tilley et al., 2005). This creates pores measured as ~400 Å (Price et al., 2012), 
and the process is thought to be responsible for several biological activities of 
the toxin (Mitchell et al., 1997).  
The protein is produced intracellularly and was shown to be released under the 
autolysin effect (Berry et al., 1989; Martner et al., 2008; Steinfort et al., 1989). 
However, it has been suggested that secretion of the protein in WU2 
pneumococci is not dependent on pneumococcal autolysis (Balachandran et al., 
2001). Moreover, recent studies documented that before cell lysis occurred, Ply 
could be detected on the pneumococcal cell wall with Western blot in 18 
different serotypes to be localised, and it was biologically active (Price et al., 
2009).  
The cytolytic Ply has been shown to cause a wide range of immunomodulatory 
effects including stimulation of nitric oxide production in phagocytes (Braun et 
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al., 1999), induction of inflammatory responses with cytokine production such as 
tumor necrosis factor α (TNF-α) (Malley et al., 2003), interleukin 1β (IL-1β) 
(Houldsworth et al., 1994) and complement activation (Paton et al., 1984). It 
can inhibit non-specific defences like the respiratory cilial-beating in epithelial 
cell lining in the URT (Braun et al., 1999; Harvey et al., 2011a; Malley et al., 
2003; Martner et al., 2008; Steinfort et al., 1989; Yoo et al., 2010). Therefore, 
pneumolysin protein has a wide range of activities in the pneumococcal 
pathogenicity.  
Interestingly, recent studies have detected some strains isolated from patients 
to express non-haemolytic pneumolysin, and these strains showed greater 
virulence capability relative to pneumococci in which the toxin was deleted, 
indicating that pneumolysin possesses a further unknown function (Harvey et al., 
2011a; Kadioglu et al., 2008).  
Pneumolysin is not the only cytolytic factor in pneumococci; hydrogen peroxide 
(H2O2) produced by S. pneumoniae lacking Ply was shown to cause haemolytic 
activity to human ciliated epithelium cells in vitro (Feldman et al., 2002; Hirst 
et al., 2000b). H2O2 is mostly produced during the aerobic pneumococcal 
metabolism (Section 1.7). However, available data reflecting how this major 
pneumococcal virulence factor can be affected by the presence or absence of 
oxygen are extremely limited.        
1.5.5  Neuraminidase 
The colonization of the nasopharynx is an important stage in the development of 
pneumococcal disease, and S. pneumoniae expresses many factors to colonise 
epithelial surfaces. The enzyme neuraminidase (NA), also called sialidase, is one 
of them (Uchiyama et al., 2009). It was reported that the function of this 
virulence determinant is to cleave a terminal sialic acid (N-Acetylneuraminic 
acid) from glycoconjugates situated on mucosal surfaces, at the cell membrane 
of epithelial cells, leading to exposing “unmasked” cell receptors for bacterial 
adherence (Kadioglu et al., 2008; King et al., 2004).  
32 
Studies have shown that pneumococci encode up to three NAs proteins: NanA, 
NanB and NanC (Manco et al., 2006). It was also demonstrated that both NanA 
and NanB are implicated in cleaving sialic acid, but these two enzymes have two 
variant pH optima (NanA at ph 6.5 and NanB at pH 4.5), suggesting different 
roles for these proteins in vivo (Manco et al., 2006).  
NanA was reported to contribute in colonising the nasopharyngx and the 
development of otitis media in a chinchilla as well as being involved in 
pneumococcal biofilm formation (Parker et al., 2009). Both NanA and NanB 
mutants were unable to cause sepsis in mice (Manco et al., 2006). In addition, 
Oggioni and colleagues stated that gene expression during host blood infection 
was characterized by a decrease in these neuraminidases, A and B, relative to 
their expression in the lungs (Oggioni et al., 2006).  
Further work on S. pneumoniae NanA shows its capacity to modify the surface of 
other organisms competing with pneumococci in the same environmental niche 
(Burnaugh et al., 2008). For example, a study has pointed out that the enzyme 
which breaks down sialic acid from both N. meningitidis and H. influenzae cell 
surface (Shakhnovich et al., 2002). They also suggested that this cleaving 
exposes the competitor to be attacked by the host’s immune defences, resulting 
in pneumococcal exploitation of the microenvironment. Furthermore, a recent 
investigation described that an attachment to the endothelial barrier was 
mediated with NanA both in in vivo animal models and ex vitro human brain 
endothelial cultures (Uchiyama et al., 2009). Additionally, NanA was recently 
shown to be involved in virulence by promoting pneumococcal biofilm formation 
(Parker et al., 2009). 
1.5.6 Pili 
Bacterial pili have been identified first in Gram-negative micro-organisms, and 
recently in Gram-positive bacteria. They were documented to fulfil multiple 
bacteriological functions during the microbial life cycle including colonisation, 
cell aggregation, biofilm formation, twitching motility, and DNA uptake 
(Hilleringmann et al., 2009; Proft et al., 2009).  
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To date, two types of pneumococcal islets encoding pili have been identified, 
pilus islet 1 (PI-1) and pilus islet 2 (PI-2) (Bagnoli et al., 2008). Type 1 (Figure 1-
2, A) is expressed by S. pneumoniae TIGR4 (Bagnoli et al., 2008; El Mortaji et 
al., 2012a; El Mortaji et al., 2012b; LeMieux et al., 2006). Pneumococcal PI-1 is 
a flexible and filament-like measured as 1µm in length, surface-exposed 
virulence factor (Hilleringmann et al., 2009). Its expression was shown to result 
in an increase in the adhesion ability in vitro to lung epithelial cells (Barocchi et 
al., 2006; El Mortaji et al., 2010). The contribution of attachment by palliated 
pneumococci was significantly increased in vivo, and similarly in streptococci 
such as S. pyogenes and S. agalactiae (Lauer et al., 2005; LeMieux et al., 2006; 
Nelson et al., 2007). Nelson and co-researchers have found that S. pneumoniae 
mutants without RrgA, one of the pneumococcal pilins, showed significantly less 
attachment to respiratory cells compared to the wild-type bacteria (Nelson et 
al., 2007).  
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Figure  1-2 Pilus genes and structure in TIGR4 pneumococci  
 
Schematic illustration of PI-1 genes (A) and structure (B). In (A), the brown arrow shows the 
transcriptional regulator, blue arrows are the structural pilus genes, green indicates the 
assembling enzymes, and the orange arrows show the flanking sequences, adapted from 
(Bagnoli et al., 2008). (B) the brown circle represents RrgC protein attached to the gray 
curve showing the pneumococcal cell wall, blue boxes are RrgB building up the pilus 
backbone, and RrgA black spikes, modified from (El Mortaji et al., 2012a). 
RrgA was reported later in attaching (Bagnoli et al., 2008). Furthermore, studies 
have illustrated that RrgA and RrgB in TIGR4 PI-1 were shown to bind TLR2, and 
consequently stimulate an inflammatory response in mice that was associated 
with the release of TNF-α from macrophages as compared to nonpiliated 
isogenic mutants (Barocchi et al., 2006; Basset et al., 2013). 
Genetically, the pilus 1 proteins have been shown to be expressed by the 
pneumococcal rlrA pathogenicity islet in S. pneumoniae TIGR4 (Nelson et al., 
2007; Song et al., 2008). Its expression is based on three genes, one major rrgB 
rlrA rrgA rrgB rrgC srtB srtC srtD IS1167 IS1167 
A 
B 
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for the pilus formation and two minor subunits rrgA and rrgC situated at the 
pilus proximal shaft anchoring it to the bacterium cell wall (El Mortaji et al., 
2012a). All of these are responsible for structuring the bacterial pili, as well as 
the other three major pilus enzymes (SrtB, C and D) which are responsible for 
the pilus assembly as shown in Figure 1-1, B (Hilleringmann et al., 2009; LeMieux 
et al., 2006).  
It is worth mentioning that genes responsible for coding rlrA islet in S. 
pneumoniae were found to be carried in 27% of clinically isolated pneumococci, 
which was reported in Portugal from invasive pneumococcal infections (Aguiar et 
al., 2008). It has been shown that pilus genes are serotype-specific as they were 
detected in different pneumococcal serotypes. For example, 4, 6A and 35B have 
pili, whereas types 1, 3, 14, 15A, 5, 7F, and 18C do not possess rlrA operon 
encoding PI-1 proteins (El Mortaji et al., 2012a; Moschioni et al., 2008). 
However, genome sequencing has recently shown type 2 pilus (PI-2) in the strain 
INV104 that represents serotype 1 (Bagnoli et al., 2008). It was also revealed 
that PI-2 contains five genes, pitA, pitB, sipA, srtG1 and srtG2 (Figure  1-3).  
 
 
Figure  1-3 Pneumococcal genes of pilus islet 2 
 
Blue arrows are the genes structure coding for pilus proteins, green indicates the genes 
coding for assembling enzymes, and the grey arrow is a signal peptidase. Stars on pitA and 
srtG2 indicate that genes contain a frameshift in all for some pneumococcal strains, 
modified from (Bagnoli et al., 2008).   
Analysis of 305 pneumococcal strains showed that PI-2 exists in almost 16% of 
the strains, and has been associated with pneumococci lacking PI-1 (Serruto et 
al., 2009). Deficiency of PI-2 has been tested in vitro to assess its contribution 
in adherence. It was found that the PI-2 mutant showed a reduction in its 
capability to attach different cell lines (Bagnoli et al., 2008).  
There is a possibility that in vivo oxygen variation controls the expression and 
synthesis of pilus proteins, but this is yet to be elucidated.  
pita* sipA pitB srtG1 srtG2* 
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1.5.7 Two-component system (TCS) 
It is well known that bacteria are able to sense and respond to the surrounding 
environmental conditions such as pH and temperature, and accordingly regulate 
a number of genes. These responses are mediated via the Two-Component 
Systems (TCS) comprising of two proteins: a histidine kinase (HK) and a response 
regulator (RR) (Blue et al., 2003a). The HK is anchored to the pneumococcal cell 
membrane and is involved in sensing external environmental stimuli leading to 
its phosphorylation (Dutta et al., 1999). The phosphate group is then transferred 
to the RR, which is situated in the cytoplasm, and possesses a highly conserved 
DNA binding domain, consequently affecting the protein transcription (Blue et 
al., 2003a). As a result, a particular bacterial gene expression is displayed in 
response to external stimuli.  
This signalling system has been demonstrated to be involved in a large number 
of cellular activities including regulating bacterial pathogenicity, 
osmoregulation, sporulation, photosynthesis, and has been shown to play a 
major role in the bacterial viability (Lange et al., 1999).  
There are 13 HK and RR pairs and an orphan unpaired RR that have been studied 
in pneumococci. Their roles in gene expression were studied (Lange et al., 1999; 
Paterson et al., 2006; Throup et al., 2000).  
All of these known TCSs are listed in Table 1-3, illustrating their alternative 
names and their roles in pneumococcal pathogenicity. 
Table  1-3 Pneumococcal Two-component systems and their contribution in virulence.  
 
quoted and modified from (Paterson et al., 2006). 
TCS Alternative names Role in virulence 
01 480 Yes 
02 Vic, MicAB, YycFG and 492 Yes 
03 474 No 
04 PnpRS and 481 Yes 
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The majority of these signalling systems are implicated in the pneumococcal 
virulence and the inactivation of some has revealed variation in the ability to 
cause diseases in experimental models of infection (Blue et al., 2003a).  
The infection site was shown to have an impact on TCSs contribution of 
virulence as well as the strain background, which all adds to the complexity of 
analysing and studying such systems (Paterson et al., 2006). An example of this 
difference has been seen in TCS09 as loss of its function in D39 caused a loss of 
virulence in animal models. On the other hand, the same defective gene was 
constructed in another strain 0100993, but in this strain the mutation did not 
result in attenuation in virulence (Blue et al., 2003a).  
In 2004, McCluskey and colleagues reported that mutation of rr04 in S. 
pneumoniae TIGR4 resulted in attenuation in virulence in comparison to its 
parent strain. Additionally, McCluskey et al also showed that when TCS04 was 
inactivated in TIGR4, the psa operon that is responsible for encoding the 
manganese ABC transporter system was down-regulated. Furthermore, the 
operon has been shown to contribute to the pneumococcal virulence and 
oxidative stress resistance. rr04 deficiency leads to hypersensitive to hydrogen 
peroxide killing (McCluskey et al., 2004a).  
Additionally, TCS03, 05 and 11 have been reported to be involved in bacterial 
stress response (Haas et al., 2005), while TCS02 (also called MicAb, VicRK, 
492hkrr and YycFG) is essential for pneumococcal survival (Lange et al., 1999). 
05 CiaRH and 494 Yes 
06 478 Yes 
07 539 Yes 
08 484 Yes 
09 ZmpSR and 488 Yes 
10 VncRS and 491 No 
11 479 No 
12 ComDE and 498 Yes 
13 BlbRH and 486 Yes 
Orphan RR RitR and 489 Yes 
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TCS02 is involved in regulating bacterial cell wall, biosynthesis of fatty acid and 
expression of the virulence factor PspA (Ma et al., 2007; Mohedano et al., 2005; 
Ng et al., 2005). Studies have shown that hk02 mutants were less virulent in 
causing pneumococcal pneumonia (Kadioglu et al., 2003). Moreover, TCS02 
deficiency in S. mutans has affected several important processes including 
growth, adhesion, biofilm formation, and competence (Senadheera et al., 
2005). 
TCS05 (also called CiaRH) has been documented to affect virulence (Ibrahim et 
al., 2004a), contribute to nasophryngeal colonisation, biofilm formation and 
adhesion to host epithelial cells (Trappetti et al., 2011a). It was also shown to 
play a role in antibiotic resistance, sugar metabolism, competence and 
regulating the high-temperature requirement A protein (HtrA) (Halfmann et al., 
2007; Ibrahim et al., 2004b), HtrA is a key virulence factor, and an oxygen stress 
responder. HtrA was down-regulated when TCS05 was absent, and the 
relationship between TCS05 and oxygen has been studied (Echenique et al., 
2000).  
Furthermore, S. pneumoniae expresses TCS13 (486rr) which has been implicated 
in virulence (Throup et al., 2000), quorum-sensing regulon and is known as a 
bacteriocins-like peptide (Blp) (de Saizieu et al., 2000). Bacteriocins (Blps) are 
bacterial products that have been shown to inhibit or kill those related 
competing microorganisms using immunity proteins to protect themselves from 
their own toxin (Dawid et al., 2007). Dawid and co-researchers also reported 
that the bacteriocin mutants in 6A serotype background revealed an inability to 
compete with its parent and serotype 4 pneumococci during nasopharyngeal 
colonisation.   
The orphan regulator RitR (repressor of iron transport, RR489) which also has a 
role in virulence in animal models (Throup et al., 2000), and was required for 
lung infection as its deletion led to reduction in pathogenicity (Ulijasz et al., 
2004). Furthermore, RitR was described to be involved in iron transportation, a 
key bacterial growth factor. Most importantly its transcription was associated 
with oxidative stress response and loss of its function has resulted in an increase 
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in bacterial H2O2 susceptibility (Ulijasz et al., 2004). In addition, ritR has been 
shown recently to be phosphorylated by a serine/threonine protein kinase (StkP) 
that increases the response regulators affinity to its target DNA (Ulijasz et al., 
2009).   
Although oxygen availability was shown to control TCS05 (Echenique et al., 
2000), how all other TCSs react to oxygen is largely unknown.   
1.6 Pneumococcal growth 
It is well known that a typical pneumococcal growth curve fallows four main 
stages: lag, logarithmic (log/exponential), stationary and decline/death phases. 
Once the pneumococcus is allowed to grow in optimal bacteriological growth 
conditions or in its host, it will adapt itself enzymatically from the incubation 
environment that it was grown in previously (Perry et al., 1997). This important 
adjustment in preparation for the bacterial growth occurs in a new environment, 
and cells will continue to grow until they synthesise the necessary metabolites 
and proteins to balance both growth and division to start entering the lag phase 
(Perry et al., 1997; Swinnen et al., 2004). Additionally, the length of the lag 
phase was shown to be significantly associated with serotypes; strain with long 
lag phases are associated with greater invasiveness such as 1, 4, 5, 7F and 14, 
whereas the ones with short lag phases were linked to carriage, including  6A, 
6B, 8, 9V, 15, 18C, 19F, 23F, 33 and 38 (Baettig et al., 2006). 
During the logarithmic phase, the number of pneumococcal cells increases 
exponentially allowing for generation time (GT) calculation. GT was found to be 
21 min for serotype 3 in broth cultures (Tauber et al., 1984a). This doubling 
time, using the same bacteria, rose to 67 min in vivo in rabbit tissues (Tauber et 
al., 1984b). Another study investigating growth curve characteristics in ideal 
growth conditions for a range of clinically isolated bacteria (11 pneumococci) 
and showed generation times between 24 to 36 min (Mazzola et al., 2003).  The 
log phase continues until the pathogen faces a number of deleterious factors 
either in the broth culture or from the host that they grow in. For instance, this 
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linearised growth phase will be affected by lack of nutrition, pH changes, 
accumulation of the bacterial waste, and effective responses from the host 
immune system. All these factors play an essential role in decreasing the 
pneumococcal population size until they reach the stationary phase (Perry et 
al., 1997).  
In the stationary phase, pneumococcal death rates will be equal to the growth 
(division), therefore there is no increase in the bacterial population. This is 
attributed to several effectors such as high metabolite levels (particularly at the 
end of the phase), accumulation of organic acids and encountering starvation 
because of nutritional exhaustion. It is worth mentioning that there are several 
genes known to be expressed only at this phase such as secondary metabolite 
genes and others involved in survival (sur) that are essential for growth during 
the stationary phase when faced with stress factors (Perry et al., 1997). 
Bacterial cells will finally enter the decline phase represented by a logarithmic 
decrease in the death rates.  
Pneumococcal growth has been shown to be regulated with several factors such 
as calcium (Trombe et al., 1992), capsule gene expression (Baettig et al., 2007), 
different temperatures (Pandya et al., 2005) and variant broth media (Baettig et 
al., 2006; Slotved et al., 2005). Moreover, pneumococcal growth in the absence 
of oxygen was reported to be elevated (Baettig et al., 2006). A recent work on 
S. mutans found an impaired streptococcal growth in aerated conditions (Ahn et 
al., 2007). However, the effect of oxygenic and anaerobic incubation 
environments has not been investigated in a wide range of pneumococci, and it 
is well known that bacterial growth under specific conditions may show how 
they behave biologically. 
1.7 Fermentation in S. pneumoniae and oxidative stress 
resistance   
S. pneumoniae is known as an aero tolerant anaerobic bacterium and obtains its 
metabolic energy sufficient to support its growth and cell division from 
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carbohydrate fermentation. Pneumococcal genome is considered to encode 
enzymes for converting (oxidation) of carbohydrates to pyruvate via glycolysis 
(Spellerberg et al., 1996) and the pathways detaies are available on line:  
http://www.streppneumoniae.com/carbohydrate_utilization.asp , viewed 2013).  
The microorganism is believed to frequently encounter variant levels of oxygen 
during the process of infection (Yesilkaya et al., 2013); for example, oxygen 
availability have been reported to be 21% in nasopharynx, 10-15% in the alveoli, 
5% in the tissues (Burghout et al., 2010) and 1.4% to 1.9% in the human 
bloodstream (The Clinician’s Ultimate Reference, 
http://www.globalrph.com/martin_4_most2.htm#Oxygen%20Content%20Equatio
n, accessed in March 2013).  
However, S. pneumoniae has been shown to lack several of the defence 
mechanisms that other bacteria possess for surviving in an oxidative 
environment (Hajaj et al., 2012; Pesakhov et al., 2007). Sequencing of the 
whole pneumococcal genome revealed that the bacterium lacks genes for 
catalase, which is able to break down hydrogen peroxide into oxygen and water 
(Taniai et al., 2008), and does not express a large number of genes for aerobic 
oxidative pathways. For example, S. pneumoniae has no genetic material 
required for haem biosynthesis and even lacks alternative requirements such as 
cytochromes, and the cytoplasmic proteins involved in aerobic respiration 
(Auzat et al., 1999; Taniai et al., 2008). Additionally, genes required for a 
complete electron transport chain (ETC) were not found and none of the known 
18 Tricarboxylic acid cycle (TCA) genes considered to play a role in catabolising 
organic molecules in the presence of oxygen to gather energy for the bacteria to 
survival (Hoskins et al., 2001) 
http://www.streppneumoniae.com/carbohydrate_utilization.asp, viewed 2013). 
S. pneumoniae is known to obtain the energy needed for growth from 
metabolising glucose (Carvalho et al., 2013). Under aerobic growth conditions, 
pneumococci convert glucose into pyruvate (Spellerberg et al., 1996). They also 
express the pneumococcal enzyme pyruvate oxidase (SpxB), encoded by spxB 
gene, that in turn decarboxylates pyruvate to H2O2, carbon dioxide (CO2) and 
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acetyl-phosphate (AP) as can be seen in (Figure  1-4, A), this metabolism 
pathway is also found in other streptococci (Zheng et al., 2011). In addition, 
activity of SpxB or exogenous supplementation of H2O2 was reported to largely 
elevate mutation rates (Pericone et al., 2002) and decrease pneumococcal 
growth (Regev-Yochay et al., 2007), indicating less bacterial survival in aerated 
growth conditions relative to anaerobically grown cells. Battig and colleagues 
stated that anaerobic growth increased pneumococcal growth (Baettig et al., 
2006). Similarly, this was reported with S. mutans (Ahn et al., 2007).  
Furthermore, under the same oxygen environment, the bacterium expresses 
NADH oxidase (Nox) which can convert oxygen to water (Auzat et al., 1999). The 
pneumococcal Nox enzyme is also able to reduce O2 into H2O, facilitating 
pathogen survival in aerobic oxidative stress environments (Pericone et al., 
2003).  
Pneumococci are known to produce H2O2 in aerated incubation conditions during 
exponential growth phase and the highest levels have been detected at the 
stationary phase (Taniai et al., 2008). This toxic production was documented to 
be responsible for the bacterial spontaneous death during the TIGR4 stationary 
growth phase (Regev-Yochay et al., 2007). It was reported that the elimination 
of H2O2 from the bacterial growth cultures, either with addition of catalase, or 
growing the pneumococci under anaerobic condition or by deletion of spxB, has 
resulted in significant increase of the pneumococcal stationary phase (Regev-
Yochay et al., 2007). 
Under anaerobic conditions, carbohydrates will be oxidised into pyruvate which 
in turn is converted to lactic acid by the enzyme lactate dehydrogenise (LDH) 
(Figure  1-4). However, group A streptococci (GAS) carry out fermentative growth 
irrespective of the oxygen availability (McIver et al., 1995), and spxB expression 
was recently detected with Western blot in S. gordonii grown aerobically and 
anaerobically (Zheng et al., 2011).  
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Figure  1-4 Metabolism of pyruvate in pneumococci  
 
Proposed aerobic metabolic pathway (A) and anaerobic (B). Acetyl-P is acetyl phosphate, 
Lox: lactate oxidase, PFL: pyruvate formate layes, Pta: phosphotransacetylase, AcKA: 
acetate kinase, LDH: lactate dehydrogenase. Based on (Carvalho et al., 2013; Spellerberg et 
al., 1996).  
Reduction of pyruvic acid to lactic acid anaerobically results in regenerating 
most of the NADH (Spellerberg et al., 1996). Moreover, these investigators have 
also documented that a loss of SpxB function in S. pneumoniae mutants has 
shown pneumococcal disability to grow in a Chemically Defined Medium (CDM) 
without supplementation with acetate in micro-aerophillic growth conditions. A 
few years later, Hoskins et al and others confirmed this aerobic metabolism 
pathway and illustrated the acetate outcome from pyruvate (Hoskins et al., 
2001; Pericone et al., 2003). Furthermore, the spxB mutant was unable to grow 
with the addition of sub lethal concentrations of H2O2 (Regev-Yochay et al., 
2007), suggesting that SpxB protects the cells from the effect of H2O2. In 
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addition, in spxB mutant, the production of ATP levels was reduced compared to 
the wild type pneumococci, and SpxB was responsible for producing more than 
99% of H2O2 when compared with its inactivated pneumococci (Pericone et al., 
2000). 
It was stated that levels of acetyl-phosphate generated by SpxB activity was 
induced up to 85% in some of the aerobically grown pneumococci (Pericone et 
al., 2003). Acetyl-phosphate is considered to have critical biological functions 
when carbohydrates are aerobically metabolised. For instance, AP is a precursor 
to acetyl-CoA which is involved as a metabolic constituent for the pneumococcal 
cell wall, amino acid and biosynthesis of fatty acid (Ramos-Montanez et al., 
2010). It would be expected then that any conditions that are able to negatively 
affect the production of the global intracellular messenger acetyl-phosphate 
may largely lead to a defect in the bacterial gene expression profiles. 
1.8 Sources and effects of oxidative stress molecules 
Pneumococci are exposed to two main sources of oxidative stresses; endogenous 
and exogenous. For the endogenous, the aerobic growth conditions are 
continuously exposed to reactive oxygen species (ROS), which are known to be 
deleterious to biomolecules. These reactive intermediates are formed from an 
incomplete reduction of oxygen to water through respiration as shown in the 
following chemical reaction according to Fridovich (1998) and Imlay 2003 
(Fridovich 1998; Imlay 2003), quoted from Imlay 2003. 
 
  
These species include hydroxyl radical, superoxide anion and H2O2 generate from 
the metabolic pathways (Zheng et al., 2011), and recently reviewed (Yesilkaya 
et al., 2013). The effects of these reactive species are well studied as they can 
damage DNA, proteins and the bacterial cell membrane leading to bacterial 
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growth inhibition (Imlay 2003; Mostertz et al., 2003; Regev-Yochay et al., 2007). 
Additionally, pneumococcal organisms have been shown to produce a hydroxyl 
radical because of Fenton reaction from endogenously produced H2O2 (Pericone 
et al., 2003) Fenton reaction chemically is known to be responsible for 
generating hydroxyl radical when metal ions are present, iron is a good example. 
The only ROS that can highly and negativily affect cell contents is hydroxyl radical, 
particularly DNA resulting in genetic mutation and lipid oxidation leading to plasma 
membrane damages, whereas superoxide anaion and hydrogen peroxide damage 
proteins through oxidation (Imlay 2003). This oxidation is known to result in 
damaging biomolecules through two main mannars; I. oxidation of the plasma 
membrane, which affects its permeability, nutrient transport through the plasma 
mebrane and osmosis impalance, and II. Oxidation of nitrogenous bases and then 
destroying DNA (Imlay 2003).  
Exogenous sources of ROS are a further burden for S. pneumoniae. Barbuti et al 
have highlighted the ability of the human immune system to carry out a 
respiratory burst as a key innate immune defence against bacterial infections 
(Barbuti et al., 2010). Respiratory burst generates superoxide anion during a 
phagocytosis process where phagocytes transport extra oxygen to the cell. This 
transported oxygen is then converted into a superoxide anion followed by 
diffusion H2O2 into the phagosome in order to kill the engulfed bacterium 
(Martner et al., 2008). An early study has shown that the lack of H2O2 production 
by the immune system affects the infection rates (Klebanoff 1980). He was also 
stated that this could be noted in patients with chronic granulomatous disease 
where H2O2 is not produced. People diagnosed with this genetic disease are not 
able to mount the crucial respiratory burst process (Klebanoff 1980). Therefore, 
although pathogens are phagocytosed, the absence of H2O2 leads to insufficient 
phagositic willing. Nevertheless, pneumococci cannot survive in these patients 
due to the fact that S. pneumoniae cells are known as H2O2 producers and this 
might provide the phagocytes with what they need to perform the 
pneumococcal killing after engulfment (Klebanoff 1980).         
Furthermore, the host neutrophils are able to produce nitric oxide. The reactive 
nitric oxide also acts as an oxidising antibacterial agent for destroying 
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microorganisms (Braun et al., 1999). The neutrophils perform the production of 
nitric oxide in the presence of H2O2, which is secreted by the neutrophil itself. 
Another exogenous source, used as a herbicide, is called paraquat. It is largely 
known in microbiological laboratories for generating an oxidative stress in 
bacterial cultures and oxidative assays (Ahn et al., 2007). 
1.9 Bacterial defences against oxidative stress 
In other bacteria that have developed defences against oxidative stress, there 
are several bacterial strategies to defeat ROS molecules by detoxification 
mechanisms. For instance, catalase along with alkyl hydroperoxidase have been 
reported to play a fundamental role in cooperation to protect E. coli against 
both exogenous and endogenous sources of H2O2 (Seaver et al., 2001), while 
superoxide dismutases (SodA and SodB) react against superoxide anion and have 
been shown to be crucial survival factors in aerobic growth (Carlioz et al., 
1986). 
Both of the Gram-negative microbes Streptococcus typhimurium and E. coli 
express up to 40 genes controlled by some regulators such as SoxRS and OxyR in 
response to H2O2, and another 40 to paraquat (Demple 1999). Therefore, E. coli 
is believed to be well equipped with a firm global network against oxidative 
stress (Greenberg et al., 1989).   
In addition, E. coli possesses two differentially localised types of catalase, 
periplasmic and cytoplasmic catalases (Heimberger et al., 1988). These are 
capable of transforming two H2O2 molecules to O2 and H2O, protecting the 
organism from exogenous and endogenous sources of H2O2 (Fridovich 1998).  
Furthermore, the bacterium produces RecA protein which can repair the 
damaged DNA resulting from oxidative stress (Farr et al., 1991).  
Gram-positive bacteria have been illustrated to have different mechanisms in 
their response to oxidative stress as SoxRS and OxyR are not involved in the 
regulation process. They express the peroxide response regulator (PerR) that is 
known to be expressed in the soil bacterium Bacillus subtilis, but is not present 
47 
in pneumococci (Mostertz et al., 2003; Tettelin et al., 2002). PerR was also 
shown to regulate catalase (kat) and alkyle hydroperixidase (ahp) in 
Staphylococcus aureus (Horsburgh et al., 2001), which is well known as a 
catalase positive organism. Additionally, the regulator PerR was reported to be 
highly important for stress response in group A streptococcus (GAS) as 76 genes 
were PerR dependent (Grifantini et al., 2011). Furthermore, an investigation has 
revealed that NADH defective S. pyogenes grown in oxygen showed enhanced 
sensitivity to oxidative stress, and the bacterium was unable to resist its 
endogenous production of H2O2 (Gibson et al., 2000). However, a recent 
genomic comparison between TIGR4 genome and other streptococci revealed 
that other streptococci lack some genes known to be involved in oxidative stress 
response (Yesilkaya et al., 2013). For example, they cited that alkyl 
hydroperoxidase has not been found genetically in a number of streptococci 
including S. pyogenes, S. aglactiae, S. gordonii, Streptococcus suis and 
Streptococcus sanguinis, but is present in pneumococci, indicating that 
pneumococci have developed a specific strategy to react to an oxidative 
lifestyle compared to other streptococcal pathogens (Yesilkaya et al., 2013).  
1.10 Pneumococcal adaptation to oxidative stress 
Oxidative stress can be defined as an imbalance occurs between oxygen or its 
derivatives and the biological systems ability to eliminate toxicity and repairing 
biomolecules damages. The mechanisms that pneumococci follow to survive in 
oxidative stress are not completely understood. Pneumococci have to some 
extent adapted to the stress conditions. An example is some of the 
pneumococcal genes that have been investigated for their particular responses 
to stress environments. These putative genes include nox codes NADH, tpx codes 
thiol peroxidase, spxB codes streptococcus pyruvate oxidase, sodA codes 
superoxide dismutase A, htrA codes high-temperature requirement, ahp codes 
alkyl hydroperoxidase and rgg codes a regulator (Bortoni et al., 2009; Hajaj et 
al., 2012; Ibrahim et al., 2004b). In addition to these, a deletion in a 
pneumococcal operon which was recently found to contain ccdA (putative 
cytochrome), tlpA (thioredoxin-like protein) and msrAB (methionine sulfoxide 
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reductase) has resulted in at least 10-fold greater pneumococcal susceptibility 
to H2O2 (Andisi et al., 2012).    
SpxB is one of the well known defence mechanisms against ROS. As explained 
earlier in section 1.7, under aerobic incubation conditions, SpxB reduces O2 to 
H2O2, which also produces CO2 and acetyl phosphate. Acetate kinase then 
transforms this acetyl phosphate into acetate with concomitant ATP production 
(Auzat et al., 1999). Consequently, the pathogen generates greater amounts of 
ATP compared to pyruvate conversion to lactate. Pericone and colleagues (2003) 
have constructed spxB mutant and grew them in the presence of oxygen. They 
detected less ATP production in the spxB mutant, which led them to hypothesise 
that this would affect the DNA repair system resulting in the observed bacterial 
death. spxB mutant was documented to express <1% H2O2 production in 
comparison with the wild-type strain, and the mutants showed an increase in 
their susceptibility to be killed by H2O2 (Pericone et al., 2000). It is worth to 
mention here that pneumococci have been found to be able to generate more 
than 2.0 mM of H2O2 (Pericone et al., 2002).  
Nox is another tool used by pneumococci to face ROS. It reduces oxygen to 
water; performing four-electron reduction of O2 to H2O. A study has constructed 
nox-mutant pneumococci and showed a pleiotropic effects of the bacteria, 
altering their transformability, pathogenicity, and persistence in murine models 
of pneumococcal infection and even led to less resistance to oxidative stress 
compared to the wild type (Auzat et al., 1999; Echenique et al., 2000). Further 
investigations have demonstrated that nox defective pneumococci were 
attenuated in causing respiratory tract infection (Yu et al., 2001). Recently, 
ablation of nox gene has been reported to result in significantly less 
pneumococcal adhesion to A549 cells and the mutants pathogenicity was 
similarly attenuated in vivo (Muchnik et al., 2013), indicating possible 
relationships between S. pneumoniae physiology and virulence. 
Moreover, psaD (also called tpx) gene is a part of psa operon, and is known to be 
part of a manganese transporting system. It was shown in a recent study to 
encode the vital pneumococcal antioxidant, thiol peroxidase (Hajaj et al., 
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2012). It was also revealed by Hajaj et al that gene expression of tpx in vitro 
was significantly increased in pneumococci grown aerobically relative to their 
anoxic growth (Hajaj et al., 2012). They also cited that as Tpx is situated on the 
bacterial cell wall and therefore plays an important role against exogenous 
peroxides not endogenous.  
Yesilkaya and colleagues have also found that when sodA was absent in the 
pneumococcus, the aerobic bacterial growth showed a reduction in virulence 
after intranasal, but not intravenous infection (Yesilkaya et al., 2000). As 
mentioned earlier, Sod is known to play a role against superoxide anion and was 
shown as a crucial survival factor in aerobic growth conditions due to its ability 
to convert superoxide anion to O2 and H2O2 (Carlioz et al., 1986). Ahp is counted 
against ROS as well because of the capability of the protein to cleave hydrogen 
peroxide to alcohol and water (Paterson et al., 2006). In addition to these, 
NmIR, MerR (Potter et al., 2010) and cysteine desulphurase subfamily protein 
SufS (Ramos-Montanez et al., 2008) were shown to participate in the 
pneumococcal defence against hydrogen peroxides.   
Furthermore, as mentioned before, S. pneumoniae is not only unable to express 
catalases, but also lacks some of the proteins that are known to be involved in 
oxidative stress response regulation which are present in other bacteria such as 
SoxRS, OxyR, NADH peroxidase and PerR (Demple 1999; Pericone et al., 2003), 
(Section 1.9). However, a study came out during our work reported for the first 
time a genetic response to oxygen in serotype 2 pneumococci (Bortoni et al., 
2009). 
Additionally, recent studies on pneumococcal oxidative stress response showed 
genes (ccdA, tlpA and msrAB) involved in H2O2 responses (Andisi et al., 2012). 
Investigation of Tpx which is coded by SP-1651 in TIGR4 (Hajaj et al., 2012) have 
contributed in increasing our knowledge about relationships between 
pneumococci and ROS. However, the roles of other enzymes such as glutathione 
peroxidase (Gpo, SP-1279), which is homologous to Dpr (DNA-binding ferritin-like 
protein), and glutathione reductase (SP-0784) are still unknown. Potter et al 
have recently reported for the first time that glutathione reductase is utilised by 
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D39 to resist oxidative stress (Potter et al., 2012), and this is believed to be an 
orphan study investigating glutathione reductase in S. pneumoniae. Therefore, 
how S. pneumoniae responds and survives in an atmospheric condition, which is 
considered its normal habitat, is still to some extent ambiguous.  
1.11 Pneumococcal biofilm formation 
Biofilms are developed when pneumococci attach to both biotic and abiotic 
surfaces (Allegrucci et al., 2006). They can then extrude several extracellular 
matrixes in which they embed themselves, proliferate and match to each other 
(Hall-Stoodley et al., 2008). The following definition was described and 
considered one of the best explanations for biofilm as it generally covers the 
whole process:  
‘‘A microbially derived sessile community characterized by cells 
that are irreversibly attached to a substratum or interface or to 
each other, are embedded in a matrix of extracellular polymeric 
substances that they have produced, and exhibit an altered 
phenotype with respect to growth rate and gene transcription’’. 
            (Donlan et al., 2002) 
Moscoso and co-workers have stated that this attachment ability is responsible 
for more than 60% of bacterial infections (Moscoso et al., 2006). There are a 
large number of pathogenic bacteria which can adhere to host cells in the upper 
respiratory airways, an initial key step to progress to an infection before causing 
pneumococcal diseases including otitis media (Hall-Stoodley et al., 2008) and 
sepsis (Tapiainen et al., 2010). There was little available literature on the for 
biofilm formation by S. pneumoniae until recently (del Prado et al., 2010; 
Moscoso et al., 2006; Tapiainen et al., 2010). It has been documented that 
pneumococcal biofilms were detected in the middle ear infection, 
nasopharyngeal colonisation, on the adenoid surface, biopsied mucosal 
epithelial tissues and among children who have had a tympanostomy tube or 
implanted medical devices (Allegrucci et al., 2006; del Prado et al., 2010; 
Tapiainen et al., 2010).   
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Pneumococcal communities in biofilms are highly structured and they have 
shown resistance to antibacterial agents, host immune attack and surrounding 
environmental challenges (del Prado et al., 2010; Tapiainen et al., 2010). It has 
been reported that there are many phenotypic differences that occur inside this 
tied pool of microorganisms. For example, large number of genes have found in 
S. pneumoniae to be responsible for both biofilm formation and nasopharyngeal 
colonisation in mice (Munoz-Elias et al., 2008).  
Moreover, several key virulence genes including CBPs are expressed 
differentially during pneumococcal growth in biofilm relative to other 
environments (brain, lung and blood) (Oggioni et al., 2006). It was also shown 
that competence-stimulating peptide (CSP) is required for biofilms and a CSP 
receptor mutant inhibited the formation of pneumococcal biofilms, and was less 
virulent to develop pneumonia. Similarly, biofilm formation by S. mutans 
increased 85% in the presence of CSP (Petersen et al., 2004). Furthermore, an 
investigation of genes involved in the pneumococcal biofilm has shown a 
decrease in biofilm formation with CBPs deficient mutants in comparison to its 
parent strain provided (Moscoso et al., 2006).  
Trappetti and colleagues have further recent support to these results as they 
constructed a deletion in both lic operon and TCS05. Lic is involved in choline 
uptake. They found that the mutants showed a reduction in forming biofilms, 
were not able to translocate from nasopharyngeal colonisation to the lungs, and 
poorly attached to human alveolar pneumocytes (Trappetti et al., 2011b). The 
operon lic is also present in other respiratory pathogens including H. influenzae, 
N. meningitidis and Pseudomonas aeruginosa, and known to encode genes 
responsible for choline uptake and metabolism (Kwak et al., 2002; Rock et al., 
2001).  
In addition, NanA has been also reported recently to contribute to 
pneumococcal biofilm formation (Parker et al., 2009). Another study examined 
the biofilm composition formed by pneumococcal clinical isolates and detected 
that DNA was present extracellularly in the biofilms (Hall-Stoodley et al., 2008). 
They confirmed this result by treating the pneumococcal biofilms with DNase 
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and found there was a significant dose responsive reduction in the biomass of 
the pneumococcal biofilms. The release of free DNA into the biofilm matrix has 
been suggested to play an essential role in S. mutans biofilms as it was required 
as a major molecule for initially establishing biofilm formation (Petersen et al., 
2004). It is well known that S. pneumoniae is a highly transformable bacterium 
and spontaneously releases DNA under the effect of CSP (Hall-Stoodley et al., 
2008; Moscoso et al., 2006). Furthermore, biofilms have been shown to be 
induced with CSP in several other bacteria including S. gordonii, S. mutans and 
Streptococcus intermedius (Oggioni et al., 2006).  
Other pneumococcal virulence factors have been shown to affect the bacterial 
biofilms. Moscoso et al undertook a microscopy examination for the bacterial 
capsule and found that an up-regulation in CPS had a key role against the 
formation of the biofilm (Moscoso et al., 2006). Moreover, they studied the 
influence of CPS in pneumococcal biofilms, which revealed that the presence of 
the capsule has negatively affected the development of the biofilm by more 
than 60%. A recent work reported that cpsA, the first CPS gene in the S. 
pneumoniae capsule operon, was down-regulated during biofilm formation in 
comparison with the planktonic grown pneumococci (Hall-Stoodley et al., 2008). 
However, although there is accumulating evidence linking biofilms to virulence, 
recent studies revealed that biofilms are not essential for virulence, and no 
correlation was detected between pneumococci collected from PID and N-PID in 
biofilm formation (Lizcano et al., 2010).  
In terms of the oxygen´s effect on biofilm formation, Ahn and co-researchers 
illustrated that O2 is involved in regulating S. mutans biofilm formation (Ahn et 
al., 2007), but its role in pneumococcal aggregation and biofilms remains to be 
investigated. In 2009, a relationship between oxygen and biofilms by S. 
pneumoniae was discovered. Pneumococcal rgg, a transcriptional regulator, has 
been shown to involve in both the bacterial biofilm formation and oxidative 
stress response (Bortoni et al., 2009). 
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1.12 Effect of environment on bacterial gene expression 
The ability of bacteria to adapt, grow and survive in varied environments and 
mammalian host anatomical sites requires flexible global gene expression. 
Therefore, bacterial gene expression, particularly virulence factors, has been 
shown in various studies to be affected by various environmental conditions. 
Some examples which are highly related to our topic will be highlighted herein; 
a high temperature (39ºC) was reported to elevate gene expression of the 
adhesion factor SspB in S. gordonii, an important organism causing dental plaque 
and endocarditis, whereas changes in osmolarity and high pH decreased sspB 
expression (El-Sabaeny et al., 2000). Recently, environmental influences have 
resulted in different production of hydrogen peroxide in S. gordonii (Zheng et 
al., 2011). In addition to the above genetic variation, phenotypic differences 
were also studied in four different bacteria; Shigella flexneria, Bordetella 
pertussis, Yersenia pestis and Borrelia burgdorferi, and most of their virulence 
genes have shown to involve in responding to temperature variations (Konkel et 
al., 2000). 
 It has been recently documented that environmental acidification led to an 
increase in pilus synthesis and biofilm formation in S. pyogenes (Manetti et al., 
2010). A selection of in vitro growth conditions such as biofilm and planktonic 
states had an effect on global gene expression of Moraxella catarrhails, which is 
a causative of otitis media and pulmonary diseases (Wang et al., 2007). Sulphide 
has an effect on gene expression and bacterial growth physiology of 
Desulfovibrio vulgaris (Caffrey et al., 2010). All these have obviously prove that 
how surrounding environmental changes affect the microbial gene expression. 
1.12.1 Environmental factors effecting pneumococcal gene 
expression 
Although there are a large number of studies in the literature focusing on 
pneumococcal virulence-related genes, regulators and competence 
(Dagkessamanskaia et al., 2004; Echenique et al., 2001; Hava et al., 2003; 
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Iannelli et al., 2004; Iannelli et al., 2002; Iannelli et al., 1999; King et al., 2004; 
Lau et al., 2001; Oggioni et al., 2003), there has been relatively little 
investigation on the pneumococcal physiology during disease and its behaviour in 
different environmental conditions. Additionally, several issues remain unclear 
such as the translocation mechanisms from colonising the host upper respiratory 
system to the lungs through the blood-brain barrier (Oggioni et al., 2006). 
Different in vivo environmental conditions have been reported to modulate the 
pneumococcal pathogenicity. For instance, a scan of the whole genome showed 
that key virulence genes were regulated differentially based on the body sites 
that pneumococci collected from including nasopharynx, lungs, blood stream 
and CSF (Orihuela et al., 2004a). An excellent example of how an in vivo niche 
can affect the bacterial virulence is seen when 10-fold greater adhesion on 
human epithelial cells was reported with S. pneumoniae gathered from 
peritoneal murine cavities in comparison to those grown in in vitro cultures 
(Orihuela et al., 2000).   
Pandya and colleagues have investigated the effect of different host 
temperatures, such as 21ºC, 29ºC, (representing the environmental 
temperature) 33ºC (reflecting temperature of nasopharyngeal surface), 37ºC 
(the body temperature) and 40ºC (as a fever during infection), on the 
pneumococcal gene expression (Pandya et al., 2005). They have reported 
phenotypic differences in S. pneumoniae and found an induction in genes 
encoding adhesion proteins at 33ºC that might contribute to nasopharyngeal 
colonisation. Similar studies have investigated the effect of temperature and pH 
changes on pneumococci (Mazzola et al., 2003). Furthermore, host-derived 
compounds have an influence on pneumococcal gene expression. For instance, 
providing S. pneumoniae with mucin in Sicard’s defined medium induced nanA 
gene expression (Yesilkaya et al., 2008), and pneumococcal growth in blood 
cultures affecting production of key proteins (Bae et al., 2006).  
Moreover, microarray data, which was validated with qRT-PCR, found that 386 
genes were involved in responding to penicillin (Rogers et al., 2007). Host-
derived compounds also have been shown to affect mRNA levels of capsular 
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polysaccharide, pneumolysin and PspC. All these three proteins were elevated in 
pneumococci exposed to host fluids in vitro versus those grown in TYH broth 
medium (Ogunniyi et al., 2002). Furthermore, growing S. pneumoniae (serotypes 
6B, 9V, 14 and 23F) in the sugar xylitol  has significantly lowered the expression 
of cpsB (Kurola et al., 2009). Streptococci may be able to take and metabolise 
xylitol through phosphotransferase system (PTS) (Palchaudhuri et al., 2011).  
The pneumococcal capsule was also found to be up-regulated in the blood 
stream in vivo versus in vitro growth cultures (Ogunniyi et al., 2002), and 
expression of nanA has been changed according to opaque and transparent 
phase variation (King et al., 2004). They stated that nanA had a greater 
expression and activity in transparent pneumococci than the opaque cells. 
Transparent variants showed an increase in the nasopharyngeal adhesion ability, 
and therefore are more efficient in colonisation, while opaque phenotypes have 
been correlated to resist opsonisation and were linked to causing pneumococcal 
sepsis (King et al., 2004; Weiser et al., 1994a; Weiser et al., 1994b). In addition, 
Oggionoi and coinvestigators showed that based on the infected site of the 
animal models, virulence genes expression showed variation (Oggioni et al., 
2006). 
All these recent studies have documented the bacterial sensing of external 
stimuli and accordingly responded by changing its gene expression.  
1.12.2 Oxygen availability and pathogenicity    
Molecular oxygen can act as a growth substrate, toxic factor, regulator for 
bacterial gene expression and it is mainly considered as a major regulatory 
signal of metabolism in facultative anaerobic microorganisms (Unden et al., 
1991). Bacterial exposure to stress conditions has been shown to result in 
switching the expression of the virulence genes, which may lead to increasing 
the bacterial pathogenicity. For example, it was recently reported that diffusion 
of oxygen to the villi in the host intestinal tract was associated with virulence in 
the Shigella strain M90T (Marteyn et al., 2010). Moreover, oxygen molecules are 
required to control the global regulator FNR in Klebsiella pneumoniae (Grabbe 
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et al., 2001; Grabbe et al., 2003). Other bacteria are with FNR O2-dependence 
include E. coli and Salmonella (Unden et al., 1991). Early work has shown that 
abscess formation by S. aureus is enhanced with aeration (Schmidt et al., 1967). 
Furthermore, growth of S. mutans in oxygen resulted in changes virulence gene 
expression and markedly affected surface protein profiles (Ahn et al., 2007).  
Oxygen has been shown in regulating certain bacterial traits such as adhesion 
factors. For example, invasion assays of the human cell lines (A549) and 
neuroepithelial cells (PFSK-1) validated with electron micrograph experiments, 
revealed that there was significantly increase in bacterial counts of intracellular 
Group B streptococci (GBS) when the pathogen was grown in the presence of 
oxygen, indicating that oxygen is involved in elevating the bacterial adhesins 
(Johri et al., 2003). The study also showed that neonatal mice inoculated with 
GBS grown in oxygen had significantly less survival (p=0.0007) than GBS grown 
anaerobically. This demonstrates that the availability of oxygen is a key 
environmental stimulus leading to an increase in the bacterial virulence level, 
and that microbial exposure to oxygenic growth conditions might be a powerful 
induction for GBS pathogenicity (Johri et al., 2003). 
In S. pneumoniae, a study shown the first evidence that oxygen can contribute 
in regulating both pneumococcal transformability and ability to cause disease 
(Auzat et al., 1999). In addition, the availability of oxygen has been implicated 
in down-regulation of the pneumococcal CPS (Weiser et al., 2001). A few years 
later, this important oxygen relationship to phenotypic phase variation was 
further supported after modulating oxygen concentration during pneumococcal 
growth in the mid-log phase. The authors’ conclusion was as follows: 
‘‘The variation from anaerobic to aerobic atmosphere during the 
stationary phase of S. pneumoniae cultivation in the bioreactor 
increased the percentage of the total CPS recovered from the 
supernatant’’. 
                (Goncalves et al., 2006) 
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This capsular variation may facilitate the bacterium-host interaction during 
colonisation, where their adhesins may need to be uncoated, while up-
regulation of the capsule genes might be required in the absence of oxygen to 
avoid the immune response during bacteraemia (Ogunniyi et al., 2002; 
Weinberger et al., 2009). This phase variation might be also involved in the 
bacterial transition from being coloniser in the upper airways to invasiveness 
(Hammerschmidt et al., 2005). It is noteworthy that transparent phenotypes 
have shown an increased ability to cross the blood-brain barrier (Ring et al., 
1998).  
During this project, a study has shown global gene expression changes in            
S. pneumoniae in response to air (Bortoni et al., 2009). They reveal that 
pneumococcal resistance to oxidative stress is associated with virulence, and 
exposure of S. pneumoniae to air was responsible for changes in expression of 69 
genes, 54 of which were up-regulated (almost 2.3% of the whole pneumococcal 
genome); whereas the remaining 15 genes were shown to be down-regulated 
under the same conditions. Furthermore, interestingly they reported up to an 
11-fold transcriptional increase in the regulatory gene rgg during growth in 
aerobic environment. This is the only available published study that scans the 
whole pneumococcal genome in the presence/absence of oxygen using serotype 
2 pneumococci. Hence, there is a need to expand this investigation in order to 
increase our understanding of how the pneumococcal gene expression is 
affected by oxygen and responds to different levels of oxygen. 
1.13 Genomic variation in S. pneumoniae 
Several bacterial species show different levels of genomic variation such as 
Campylobacter jejuni (Dorrell et al., 2001) and Helicobacter pylori (Bjorkholm 
et al., 2001), but genomic of Mycobacterium tuberculosis seems to be highly 
conserved (Behr et al., 1999). Pneumococci are historically known as naturally 
transformable bacteria exhibiting genetic exchange resulting in environmental 
adaptation. For example, S. pneumoniae R6 representing serotype 2 has been 
fully genome sequenced in 2001 (Hoskins et al., 2001), and similarly the strain 
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TIGR4 representing serotype 4 in 2001 which was isolated from a patient´s blood  
(a man aged 30 year) in Norway 1990s (Tettelin et al., 2001). A genomic 
comparison between these two pneumococcal strains (R6 and TIGR4) revealed 
that there are 10% variation (Bruckner et al., 2004). Further investigation has 
been carried out in R6 and TIGR4 pneumococci to explain any genes requirement 
for invasive disease or carriage (Obert et al., 2006).  
Invasive pneumococcal diseases and carriage have been geogrifically associated 
with some serotypes, for example, common pneumococcal diseases have been 
reported to be serotype-specific such as type 14, 6B, 5, 6A and 19A in the Middle 
East, wheras in Europe and the USA, type 1, 19F and 23F cause more IPDs than 
other serotypes (Mehr et al., 2012). Additionally, some pneumococcal genetic 
variations have been linked to carriage rather than causing IPDs, an example of 
this is seen in serotype 3 strains which are usually found in host’s nasopharynx 
with carrying prophages in their genomes (Loeffler et al., 2006). In contrast, 
type 1 pneumococci are known to be hyper-virulent bacteria that rarely 
detected in the nasopharyngeal niches (Harvey et al., 2011b; Williams et al., 
2012). 
Differences in pneumococcal ability to cause a disease are attributed to their 
genome content. For instance, capsular switching and penicillin resistance are 
believed to occur as a consecuence of horizontal gene transfere leading to the 
pneumococcal survival after escaping from a vaccine and acquisition penicillin 
resistance gene, respectevily (Coffey et al., 1991; Coffey et al., 1998). 
Furthermore, Weiser et al and other pneumococcal laboratories reported phase 
variation of pneumococci showing two different phunotypes (transparent and 
opaque). This was explained earlier in section 1.12.1, and can be considered 
here as another good example reflecting pneumoccal ability for genomic 
variation, which can be linked to the bacterial transformatiom capability as 
pneumococci are know to be naturally competent and equipped with several 
genes accounted for the pneumococcal competence including coma, comb, 
comC, comD and comE (Pericone et al., 2002). They also showed that oxygen 
was able to control competence in S. pneumoniae, and the spontaneous 
mutation rates were reduced 10-fold during growth in an anaerobic growth 
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condition or with addition of catalase where hydrogen peroxide was not 
detectable. This suggests that oxidative stress occurs in host nasopharyngeal 
environment due to the presence of oxygen might facilitate gene exchanging 
interspecies and intraspecies resulting in greater virulence (Pericone et al., 
2002).  
1.14  Aims of the study 
In spite of a number of studies showing the contribution of pneumococcal 
virulence factors to its pathogenicity, the effects of environmental factors on 
pneumococcal growth characteristics, gene expression and the bacterial 
physiology require further investigation. Studying the impact of different 
environmental conditions might be highly useful and contribute to an 
understanding of the interaction between the pathogen and the host. 
The aims of this study are: 
1. To study the effects of O2 on pneumococcal growth characteristics.  
2. Investigate the bacterial gene expression during O2 exposure.  
3. Study possible roles of virulence factors in various levels of oxygen.  
4. Evaluate the pneumococcal physiology during both conditions. 
This identification could allow us to gain a molecular insight into phenotypic 
changes during the pneumococcal growth in the presence of oxygen as compared 
to its absence. To assess these aims, pneumococcal growth characteristics, 
biofilm formation, and pneumococcal gene expression using microarray, in the 
precence of oxygen was determined. These were further confirmed with 
immunoblot for a number of key virulence proteins, adhesion assays and several 
other experiments including haemolytic assays, peroxide assays and pH assays 
during pneumococcal growth in the presence/absence of oxygen.  
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Data from these experiments aim to improve our understanding of how S. 
pneumoniae regulates its virulence determinants in response to oxygen. 
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Chapter 2 – Materials and Methods 
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2 Materials and Methods  
2.1 Pneumococcal growth 
2.1.1 Preparation of media and glycerol stock 
Pneumococcal strains used in this study are listed in Table 2-1, and all have 
been genome sequenced as a collaborative project between our group and the 
Sanger institute. After preparing ten liters of BHI (Brain-Heart infusion, Oxoid, 
United Kingdom), each S. pneumoniae was streaked on a prepared BAB (Blood 
Agar Base, Oxoid, United Kingdom) supplemented with 5% horse blood (E&O 
Laboratories, Scotland, United Kingdom). Plates were then anaerobically 
incubated overnight in a candle jar at 37ºC to confirm purity using an optochin 
disc (Mast Diagnostics, United Kingdom); this was prior to a single colony being 
inoculated in the liquid culture BHI at 37ºC until the bacterial growth reached 
almost an optical density ~ 0.6 of OD600nm. Each pneumococcal culture has been 
aliquoted into sterile vials. 
Approximately six hundred aliquots were prepared aseptically for each strain so 
that the same microbial stock can be used in this study and possibly beyond. All 
were stored, after mixing (bacterial culture and glycerol) properly with a pre-
warmed 15% sterile glycerol (Riedel-de Häen, Germany), at –80ºC. For the 
pathogen P. aeruginosa, which was used as a positive control in biofilm assays, 
the medium Luria-Bertani (LB), (Sigma, United Kingdom) broth was used. 
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Table  2-1  Pneumococcal strains used in this study 
 
* S. pneumoniae isolated from different sites (Cerepro-Spinal Fluid (CSF) and Blood) but same 
patient profile. TIGR refers to The Institute of Genomic Research now part of the JCVI – J. Craig 
Venter Institute, Glasgow refers to the Polyomics Facility, University of Glasgow, and Sanger 
refers to the The Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge. UP = 
unpublished data and NS = not sequenced. 
 
For counting pneumococcal population, serial dilution from 10-1 to 10-7 in a 
round-bottomed 96-well plate Costar, United (Kingdom) was carried out and 
viable counts were determined colony forming unit (CFU) by plating out three 
spots of each dilution on BAB plates. All these spots were allowed to dry at room 
temperature (20-22ºC) for 10-15 min. 
Accession 
Number 
Strain 
name/ ID 
Genome 
Sequen-
cing facility 
Reference 
Sero-
type 
NC_003028 TIGR4 
TIGR4 
(JCVI) 
(Tettelin et al., 2001) 4 
UP TIGR4-403 Glasgow 
Unpublished data – due for 
publication A.M.Mitchell et al 
4 
NC_021004 03-3038 
Glasgow 
/Sanger 
(Donati et al., 2010); Mitchell 
et al., in preparation 
1 
NZ_CACF01000000 NCTC7465 
Glasgow 
/Sanger 
(Donati et al., 2010); Mitchell 
et al., in preparation 
1 
NZ_CACE01000000 P1041 
Glasgow 
/Sanger 
(Donati et al., 2010); Mitchell 
et al., in preparation 
1 
NC_017591 INV104B 
Glasgow 
/Sanger 
(Donati et al., 2010); Mitchell 
et al., in preparation 
1 
NC_021005 99-4039 * 
Glasgow 
/Sanger 
(Donati et al., 2010); Mitchell 
et al., in preparation 
3 
NC_021026 99-4038 * 
Glasgow 
/Sanger 
(Donati et al., 2010); Mitchell 
et al., in preparation 
3 
NC_017592 OXC141 
Glasgow 
/Sanger 
(Donati et al., 2010); Mitchell 
et al., in preparation 
3 
NC_018594 A45 
Glasgow 
/Sanger 
(Donati et al., 2010); Mitchell 
et al., in preparation 
3 
ND ATCC6308 NS ___ 8 
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BA plates were then incubated overnight anaerobically in a candle jar at 37ºC. In 
order to calculate the CFU/ml, colonies grown between 10-70 per spot were 
counted for each pneumococcal strain according to the following equation:  
Equation 1-2 for bacterial CFU/ml calculation after serial dilution: 
1st spot + 2nd spot + 3rd spot ÷ 3 = average  
Average × 50 × dilution factor = average CFU / ml 
 
There were some mutants used in this study for different purposes. These strains 
and their descriptions are shown in Table 2-2. 
  Table  2-2 Charecteristics of pneumococcal mutants and P. aeruginosa used in this study 
 
 
 
2.1.2 Growth conditions 
From the above prepared stock, every vial was thawed rapidly before vortexing; 
and the start inoculation was ~105 CFU/ml, while the incubation temperature 
was 37ºC. In some experiments, pneumococci were grown in three different 
levels of oxygen; oxygenated (aerated), anoxygenated (anaerobic) and aerobic 
(static semi-aerobic) environments. Oxygenated and anoxygenated growth 
conditions were mainly generated for most experiments.   
NO. Strain Description 
1 D39`ply 
A positive control used in haemolytic assays, a stop 
mutant generated by Dr Calum Johnston, a PhD 
student in our group, 2006. 
2 TIGR4`cps 
Used in adhesion assays for comparison with the 
parent isolate. 
3 P. aeruginosa 
Positive control in biofilm formation assays, kindly 
provided by Dr Dan Walker’s group. 
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Experiments were performed in triplicates; the pneumococcal broth tubes had 
their lids released to allow oxygen exchange and pre-warmed for 24-48 hr before 
starting an experiment. This pre-warming can also confirm that there was no 
contamination in the media, which possibly may happen from different sources 
during preparation.    
In the aerobic conditions, 20ml of BHI in 50ml Falcon tubes were incubated 
routinely in a water bath at 37ºC. After pneumococcal inoculation, optical 
density (OD600nm) and VC represented as CFU/ml were measured after being 
vortexed and serially diluted, respectively, at several time intervals. When 
taking these readings at different time-points, the bacterial culture was mixed 
properly prior to transferring 1ml into a cuvette (Bio, Rad, United Kingdom) for 
measuring ODs.  
For the anaerobic procedure, bacteria were inoculated similarly into liquid 
cultures of BHI that had been placed in an anaerobic station to be pre-warmed, 
removing any unwanted oxygen for 48 hr before an experiment with released 
lids (miniMACS, Anaerobic Workstation).  
Oxygenated conditions were performed by mixing 50ml Falcon tubes containing 
20ml BHI medium under shaking at 180 rounds per minute (rpm) for 24 hr.  
A related study has performed the three different conditions similarly: 
“streptococci were cultured under low-O2 conditions in 10-ml 
broth cultures tightly sealed in 15-ml conical tubes or on agar 
plates incubated in an anaerobicgas chamber (GasPak; catalogue 
no. 70304; BBL). High-O2 conditions were produced when strains 
were grown in 30-ml broth cultures with vigorous agitation”. 
 
       (Gibson et al., 2000) 
 
Other studies used bubbling to generate oxygen in the broth media (Bortoni et 
al., 2009). Oxygen concentration when providing pneumococcal cultures with a 
stream of filtered bubbles was measured and found to be 20% until mid-log 
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phase, wheras 0% at the same growth phase was detected in anaerobic growth 
conditions (Bortoni et al., 2009).  
Generation times were calculated according to Cappuccino et al., (2002). 
Equation 2-2 for calculation of the bacterial generation time: 
GT= t(OD 0.4) – t(OD 0.2). 
GT: Generation Time. 
t: time in minutes between two points in the log phase. 
 
2.2 Hydrogen peroxide assay 
S. pneumoniae TIGR4 was grown under the oxygenated and anaerobic 
conditions. Their growth rates were taken into account to reach OD600nm ~ 0.6 at 
the same time. Once the OD in each growth condition was similar, 180µl of 
culture was placed in triplicate onto a round bottom 96-well plate (Costar, 
United Kingdom). To this 180µl, 20µl of 3mg/ml ABTS [2,2 azinobis (3-
ethylbenzthiazolinesulfonic acid)], and 0.2mg of horseradish peroxide/ml in 0.1 
M of sodium phosphate buffer were added and adjusted to pH 7.0. 
The reaction then was allowed to develop for 1 hr at room temperature, 
followed by spinning the 96-well plate for 30 min at 2,000 rpm. One hundred 
micro-litres then from each well was transformed to a flat 96-well plate (Costar, 
United Kingdom). To analyse the samples, FLUOstar Optima plate reader (BMG 
Labtech, United Kingdom) was used at 544nm as described in the literature 
(Pericone et al., 2003). 
Additionally, for comparison with known concentrations, standards of hydrogen 
peroxide (H2O2) were assayed by serially diluting 30% of H2O2 in the BHI used for 
growing the pneumococcus. The broth culture BHI without adding TIGR4 was 
considered as a negative control. 
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2.3 pH drop assay 
Six universal tubes with 20ml BHI in were pre-warmed overnight. The strain 
TIGR4 was inoculated in the prepared media and grown under the three 
conditions: aerobic, anaerobic and oxygenated. From these growth 
environments, 1ml of bacterial culture was taken for pH measurements hourly in 
duplicate until pneumococci reached the stationary phase.  
All of the statistical analysis for pneumococcal growth curves, hydrogen 
peroxide assays and pH assays were performed using Graph Pad prism (GraphPad 
Prism 5, USA 2007). 
2.4 Gram staining and microscopic examination 
Likewise, the clinical isolate TIGR4 was grown aerobically and anaerobically 
until approximately the mid-logarithmic phase before smearing 10µl of bacterial 
culture, grown in each condition, on a clean microscope slide. These films of 
cultures were exposed to a Bunsen flame for heat-fixing. Each slide was merged 
for 1 min with crystal violet, rinsed with sterile distilled water after which the 
slide was flooded for 30 seconds with iodine solution. Crystal violet with iodine 
is known to form a combination in the bacterial cell wall giving the purple 
colour. Slides were washed with water followed by gently dropping a few drops 
of alcohol on before flushing with water again. Safranin was used then to merge 
the fixed bacterial films for 1 min before washing with water for the final time. 
Then, slides were examined under a Zeiss M1 Axioskopp microscope at x40 
magnification using Volocity software (PerkinElmer, United Kingdom) for image 
capturing.   
2.5 Screening TIGR4 whole genome 
2.5.1 DNA extraction 
A single colony of TIGR4 was grown in a normal water bath at 37ºC overnight in 
20ml BHI and in order to check its purity, a blood agar (BA) plate was streaked 
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under aseptic bacteriological conditions; optochin resistance has been confirmed 
using an optochin disc. The remaining micro-organisms were then centrifuged at 
4,000 rpm for 15 mins before discarding the supernatant. The obtained pellet 
was re-suspended in 1ml of a lysis buffer in an Eppendorf tube (Eppendorf 
centrifuge 5417C, USA) containing 10µl Tris, 200ml EDTA (from Ambion/Applied 
Biosystems, United Kingdom), and 50µl SDS (Sodium Dodecyl Sulphate) 
(Ambion/Applied Biosystems, United Kingdom) prior to incubating at 37ºC for 
1hr in a digital dry bath (Accublock™ Digital Dry Bath, Labnet International, 
United Kingdom). 
Five micro-litres of proteinase K, from 20mg/ml stock, (Invitrogen, Scotland) 
were added to the tube followed by incubation at 50ºC for 3hr. After this, 2µl of 
RNase A from 10mg/ml stock (Invitrogen, Scotland) was added to the sample. 
This was incubated at 37ºC for 30 min, and then split into two 1.5 ml Eppendorf 
tubes (Eppendorf centrifuge 5417C, USA) in order to add an equal volume of 
phenol: chloroform: isoamyl alcohol (Sigma-Aldich, United Kingdom). Both tubes 
were inverted several times to mix the samples after which they were 
centrifuged at 13,000 rpm for 3 min. One-half of a millilitre of the solution 
upper phase from both tubes was transferred to two fresh 1.5 ml tubes 
(Eppendorf centrifuge 5417C, USA) before 100µl of 10M ammonium acetate 
(Sigma-Aldich, United Kingdom) and ~600µl absolute ethanol (Fisher Scientific, 
United Kingdom, analytical reagent grade) was added to each. The samples were 
then gently inverted and spun at 13,000 rpm for 30 min in order to pellet the 
DNA. The supernatant was then carefully removed. Both tubes were opened to 
air-dry for 15 min, then pellets were re-suspended in 200µl of a TE buffer and 
incubated at 65ºC for 10 min before storing at -20ºC until required. 
The DNA samples were quantified on a Nanodrop ND-1000 spectrophotometer 
(Agilent Technologies, United Kingdom). To check for quality of the extracted 
chromosomal DNA, the pneumolysin gene (ply) was amplified with primers 52Q 
(forward) and 52R (reverse) using GoTaq DNA polymerase (Promega, USA), giving 
a PCR product of 350 bp as expected. 
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2.5.2 RNA extraction 
From the prepared glycerol stock that has been counted and tested for its 
purity, 30 ml of BHI medium was inoculated with ~105 CFU/ml of the strain 
TIGR4. Pneumococci were growon under the three different levels of oxygen 
(aerobic, anaerobic and oxygenated) in triplicates until their optical density 
reached approximately 0.35 OD600nm. Liquid cultures from bacteria grown in each 
condition were exposed to optochin discs during an overnight incubation at 37ºC 
on 5% blood agar plates for purity confirmation.  
These broth cultures were centrifuged at room temperature for 5 min at 5,000 
rpm. Pellets were directly frozen in liquid nitrogen after discarding supernatants 
from the growth tubes. All samples were stored at -80ºC for RNA extraction.  
Before the RNA extraction, a fresh lysozyme TE buffer was prepared, and to 
make 1 ml of this lysozyme, 10µl 1M Tris HCl at pH 8.0 was made 
(Ambion/Applied Biosystems, United Kingdom). To this, 2µl of 0.5M EDTA pH 8.0 
(Ambion/Applied Biosystems, United Kingdom), 15mg lysozyme (from Sigma-
Aldrich, United Kingdom) was added up to 1 ml of nuclease free water 
(Ambion/Applied Biosystems, United Kingdom). 
For extraction, 200µl (15mg/ml) of the lysozyme Tris-EDTA buffer has been 
added to the pellets followed by vortexing for 10 seconds using a rotmixer (Hook 
and Tucker Instruments, United Kingdom), before incubating for 15 min at room 
temperature with vortexing every 2 mins for 10 seconds. For cells lysis, 700µl of 
RLT buffer was added after which the tubes were vortexed for 10 seconds using 
a Qiagen RNeasy Mini Kit (Qiagen RNeasy MINI KIT, Qiagen, United Kingdom). 
These lysates were transferred into a 1.5 ml microcentrifuge tube (Greiner Bio 
One, Germany) which had been prepared in advance to contain 25-50mg of 
100µl glass beads (Sigma-Aldrich, United Kingdom). To facilitate cells disruption, 
a Hybaid Ribolyser (Hybaid, United Kingdom) was run for 20 seconds three times 
at a speed of four prior to centrifuging in Eppendorf tubes (Eppendorf centrifuge 
5417C, USA) for 10 seconds at 13,000 rpm. After that, 900µl of supernatants was 
collected and transferred to a new 1.5 ml microcentrifuge tube (Greiner Bio 
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One, Germany). Five hundred micro-litres of 100% Ethanol (Fisher Scientific, 
United Kingdom) was added before mixing the supernatants. 
From this mixture, 700µl was added in a RNeasy Mini column (Qiagen RNeasy 
MINI KIT, Qiagen, United Kingdom) followed by centrifuging at room 
temperature for 30 seconds at 13000 rpm (Eppendorf centrifuge 5417C, USA). 
The flow-through was discarded and the remaining 700µl was added onto the 
same RNeasy Mini column before centrifuging at room temperature for 30 
seconds at 13,000 rpm. Then, 350µl of RW1 buffer was added to the RNeasy Mini 
column (Qiagen RNeasy MINI KIT, Qiagen, United Kingdom) prior to similarly 
centrifuging at the same temperature and speed but for 5 min.  
Ten micro-litres of DNase I stock solution was transferred onto 70µl of RDD 
buffer (Qiagen RNase–free DNase Set, Qiagen, United Kingdom) after which the 
tube was mixed and gently flicked for collecting liquid from the tube sides. This 
80µl was then pipetted into the column directly (RNeasy Mini column silica-gel 
membrane) before incubating at room temperature for 15 min on the benchtop. 
An amount of 350µl RW1 buffer was pipetted to the RNeasy column prior to 
centrifuging at 13,000 rpm for 30 seconds followed by discarding the flow-
through. Again, RW1 was added, but 700µl instead of 350µl, to the RNeasy Mini 
column and centrifuged for another 30 seconds at 13,000 rpm before discarding 
the flow-through. Five hundred micro-litres of RPE buffer was added onto the 
RNeasy Mini column and centrifuged for 30 seconds at 13,000 rpm. Further 500µl 
of RPE buffer was added after discarding the flow-through to the RNeasy Mini 
column that was followed by centrifuging for 2 min at 13,000 rpm for drying the 
membrane of the silica-gel.  
In order to elute, 50µl of nuclease free water (Ambion/Applied Biosystems, 
United Kingdom) was transferred to the silica-gel membrane after the RNeasy 
Mini column had been pipetted onto a new 1.5 ml collection tube. All tubes 
were placed for 3 min to stand before centrifuging at 13,000 rpm for 1 min. 
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Furthermore, possible existence of DNA was treated, for a second time, to be 
removed by eluting each sample to a nuclease free water (Ambion/Applied 
Biosystems, United Kingdom) before addition of 1µl Ambion TURBO DNA-freeTM 
(Ambion/Applied Biosystems, United Kingdom). The tubes were then incubated 
in a block heater for 30 min at 37ºC prior to transferring supernatants containing 
RNA after centrifuging for 2 min at 10,000 rpm.  
To assess the RNA purity, 5µl was kept separately as an aliquot from each 
sample to be sent for an Agilent 2100 bioanalyser (Agilent Technologies, United 
Kingdom). RNA integrity was considered above 9 to have a sufficiently high 
quality. Additionally, Nanodrop ND-100 spectrophotometer (Agilent 
Technologies, United Kingdom) was used for the RNA quantification. Until 
required, all remaining samples of this stock were stored at -80ºC. 
2.5.3 Polymerase Chain Reaction (PCR) 
To confirm the absence of cDNA in the above RNA extractions from the three 
different conditions (aerobic, anaerobic and oxygenated), the existence of ply, 
as a conserved gene in S. pneumoniae, was tested with the primers (Table 2-3) 
52Q (forward) and 52R (reverse) using a Techegene thermal cycler (Bibby 
Scientific, United Kingdom).  
Table  2-3 Primers used for PCR amplification of ply gene 
 
 
 
 
Primer 
 
Name 
 
DNA sequence 5'-3' 
 
Use 
52Q ply forward ATTTCTGTAACAGCTACCAACGA Amplification of ply gene 
52R ply reverse GAATTCCCTGTCTTTTCAAAGTC Amplification of ply gene 
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This has been performed according to the following reaction for each of the 
triplicate extracted RNA samples: 
PCR reaction conditions: 
• 94ºC for 5 min  1 cycle 
 94ºC for 30 s 
 85ºC for 30 s  30 cycles 
 72ºC for 45 s 
• 72ºC for 5 min  1 cycle 
• Held at 4ºC  
The volume for each sample was 25µl which contained 2µl Go Taq® DNA 
polymerase (Promega, USA), 5µl Go Taq® buffer (Promega, USA), 3µl dNTPs 
(Invitrogen, United Kingdom), 0.2µl forward primer, 0.2 µl reverse primer, 0.5µl 
of S.pneumoniae TIGR4 genomic DNA, 0.5µl of an extracted RNA sample and 
15.9µl PCR water. 
2.5.4 Gel electrophoresis 
For demonstrating bands of DNA to assess their quality before using them in 
microarray experiments, the PCR products were mixed with DNA loading buffer 
[0.25% bromophenol blue, 40% (w/v) sucrose in dH2O], and then run in 50 ml of 
0.8% agarose gel (Agarose MP, Roche Diagnostics, Germany) in TE with 2µl of 
SYBERSAFE stain (Invitrogen, United Kingdom), and viewed under ultraviolet 
light in a UVIpro Gold Gel-doc system (UVItec, United Kingdom) to confirm that 
the PCR reaction was successful. 
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2.5.5 Preparation of cDNA 
After confirming the high RNA quality, which consists of integrity above 9 on 
Agilent 2011 Bioanalyser (Agilent Technologies, United Kingdom), 2 µg of the 
high quality extracted RNA was mixed with 1µl Random primers [3µg/µl 
(Invitrogen™, United Kingdom)] and up to the total volume of 11µl, nuclease 
free water was added (Ambion/Applied Biosystems, United Kingdom). To allow 
primers to bind to the samples, all tubes were heated for 10 min at 70ºC in a 
Techegene thermal cycler (Bibby Scientific, United Kingdom) before placing 
them on ice.  
Five micro-litres of 5× first strand buffer (Invitrogen™, United Kingdom) was 
added to each sample, 2.5µl of 100mM (DTT), dithiothritol (Invitrogen™, United 
Kingdom), 2.3µl of dNTPs containing 5mM dATP, 5mM dGTP, 5mM dTTP and 2mM 
dCTP) (Invitrogen™, United Kingdom). After this, 2.5µl of SuperScript® II 
(Invitrogen™, United Kingdom) was added onto each of the extracted RNA 
samples, whereas 2.5µl of nuclease free water (Ambion/Applied Biosystems, 
United Kingdom) was added to the sample-associated control instead of the 
SuperScript® II. All samples then were incubated at 25ºC for 10 min prior to 
setting the reaction for 90 min at 42ºC.  
2.5.6 Microarray protocol 
The microarray slides used in this study were obtained from the Bacterial 
Microarray Group at St. George’s Hospital, University of London (BmG@S). The 
slides have the genes for the entire TIGR4 genome (Tettelin et al., 2001). 
Additionally, there are 117 genes from the strain R6 genome (Hoskins et al., 
2001). All of these have been attached to an aminosilane coated glass slide 
(Hinds et al., 2002a). The procedures of this bacterial microarray were 
described previously (Hinds et al., 2002b). Other similar published work used the 
same technique to study gene expression in S. aureus (Witney et al., 2005) and 
Campylobacter jejuni (Dorrell et al., 2005). 
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The above prepared RNA extracts were used in triplicates in the microarray 
experiments (as explained in a digram shoing the main steps in the introduction 
chapter, section 1.2.2) for scanning the whole genome expression of TIGR4 cells 
grown under different levels of oxygen (aerobic, anaerobic and oxygenated). 
According to the manufacturer’s protocol, 8.75ml of pre-hybridization saline-
sodium citrate (20x SSC) (Ambion/Applied Biosciences, United Kingdom) was 
mixed with 250µl of 20% SDS (Ambion/Applied Biosciences, United Kingdom) and 
5ml of 100mg/ml (BSA) Bovine Serum Albumin (Sigma-Aldrich, United Kingdom). 
The total volume of this mixture was made up to 50ml with double sterile 
distilled water [sterilisation and filtration using a 0.2µm filter (Millipore, United 
Kingdom)]. This solution was pre-warmed for 30 min at 65ºC in a Coplin jar 
(Fisher Scientific, United Kingdom) after being placed in a Techne Hybridizer 
HB-1D (Bibby Scientific, United Kingdom).  
In the array procedure, 9.12µl of nuclease free water (Ambion/Applied 
Biosciences, United Kingdom) was added to a fresh tube (18 tubes, 9 RNA 
samples and 9 controls) followed by the addition of  a 2µg sample before making 
the total volume up to 10µl with nuclease free water (Ambion/Applied 
Biosciences, United Kingdom). One micro-litre of a random primer (Invitrogen, 
United Kingdom) was pipetted into both groups of tubes sample and controls. All 
tubes were heated up at 70ºC for 10 min in a Techegene thermal cycler (Bibby 
Scientific, United Kingdom) before snapping all tubes on ice and exposing them 
to a short centrifuge. After this, an addition was performed to each sample and 
control with 5µl 5× first strand buffer (Invitrogen™, United Kingdom), 2.5µl of 
100mM DTT (Invitrogen™, United Kingdom), 2.3µl dNTPs, containing 5mM of the 
following: dATP, dGTP, dTTP and 2mM dCTP (Invitrogen™, United Kingdom), 
2.5µl of superscript® II (Invitrogen™, United Kingdom), and dyes [Cy3 and Cy5 
(GE Healthcare, United Kingdom)]; 1.7µl of Cy3 was added to each control 
whereas 1.7µl of Cy5 was used for each sample. The tubes were incubated in a 
Techgene thermal cycler (Bibby Scientific, United Kingdom) in the dark at 25ºC 
for 10 min followed by 42ºC for 90 min. To purify Cy3 and Cy5, labelled RNA 
3.5µl 2% filtered SDS was added in a new RNA tube and 4.6µl 20x SCC.  
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The hybridized arrays were washed with 400ml of double distilled water in a 
Coplin jar (Fisher Scientific, United Kingdom) for 1 min prior to washing again 
for another 1 min in 400ml of propan-2-ol (VWR International, USA). Each array 
was put in a falcon centrifuge tube for centrifuging at 1,500 rpm for 5 min 
before placing in a dust-free box to be ready for hybridization.  
cDNA samples were labelled with Cy3 and Cy5 after being combined in a Qiagen 
Minelute purification column (Qiagen, United Kingdom). Five hundred micro-
litres of the PB buffer was transferred to this combination before spinning at 
room temperature for 1 min at 13,000 rpm (Eppendorf centrifuge 5417C, USA), 
discarding the flow-through and adding 500µl followed by a similar centrifuging 
speed and time. The flow-through was again discarded, adding to the same 
column 250µl PE buffer, centrifuged for 1 min at 13,000 rpm, discarded the 
flow-through, spun at 13,000 rpm for 1 min without adding the PE buffer to dry 
before placing the column in a fresh 1.5ml collection tube. This was centrifuged 
at 13,000 rpm for 1 min and left for 3 min to stand after transferring 15.9µl 
nuclease free water (Ambion/Applied Biosciences, United Kingdom) onto the 
membrane centre to elute for hybridization.  
The slides then were covered by lifter slips (Erie Scientific Company, USA), and 
each sample was injected carefully between a cover slip and the array surface, 
and the arrays were transferred onto hybridization cassettes, sealed and 
incubated in water at 65ºC  for 20 hr in a Techne- Hybridiser HB-1D (Techne, 
USA) in the dark. 
After this hybridization, the arrays were submerged with agitation for 4 min in 
20ml of 20× SSC solution and similarly in 1ml of 20% SDS that was made up to 
400ml of double sterile distilled water:  all of these had been pre-warmed at 
65ºC in a Coplin jar (Fisher Scientific, United Kingdom). Microarrays were 
centrifuged in 50ml centrifuge tubes for 5 min at 1,500 rpm. 
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2.5.7 Analysis of gene expression 
For scanning the slides, one by one they were placed in ScanArray Express™ 
(Packard Biosciences Biochip Technologies, Perkin Elmer) before capturing TIFF 
images. These were loaded into Bluefuse (BlueGnome Ltd, Cambridge, United 
Kingdom) for Microarrays 3.5 © BlueGnome Ltd using Channel 1 for Cy3 labelled 
image and Channel 2 for Cy5. Gridmap files were purchased from the Bacterial 
Microarray Group at St. George’s Hospital, University of London (BmG@S). 
Processing analysis of spots was initially involved exclusion of unreliable data 
because of poor hybridisation. Findings estimated with a confidence of less than 
0.1 so have been discarded because of poor hybridization.  
Normalization was achieved after importing the Output_fused.xls files into 
Genespring GX 7.3.1 (Agilent Technologies, USA). Data generated by Genespring 
GX 7.3.1 (Agilent Technologies, USA) was statistically analyzed using 1-way 
ANOVA. False discovery rate given %5 false genes as it was set to the p-value 
0.05 followed by applying multiple testing correction method using a Benjamini 
and Hochberg False Discovery Rate.  
For comparison, the whole TIGR4 was then transferred to Microsoft Office Excel 
2003, (Microsoft, United Kingdom). This gave master list containing the 
expression of S. pneumoniae TIGR4 genes under all of the different levels of 
oxygen used.  
Fold changes for each of the 2,336 pneumococcal genes were then calculated 
individually; 1) In oxygenated versus anaerobic, 2) Aerobic versus anaerobic and 
3) Aerobic versus oxygenated. Furthermore, finding known biological functions 
for each single gene that was significantly expressed was performed using the 
CLC (Genomics Workbench programme). Additionally, Comprehensive Microbial 
Resource (CMR) http://cmr.jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi and 
Nucleotide BLAST at  the National Centre for Biotechnology Information (NCBI) 
http://www.blast.ncbi.nlm.nih.gov/Blast.cgi were accessed online for gene 
comparison, functions and even for tracking putative pneumococcal metabolism 
pathways. 
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2.6 Quantitative Reverse Transcriptase PCR (qRT-PCR) 
It is worth mentioning here that the importance of confirming gene expression 
for genes of interest through performing qRT-PCR for measuring mRNA levels 
following what microarray experiments detect is attributed to the fact that 
arrays may underestimate gene expression. Conway and colleagues concluded 
that arrays probably cannot reflect the actual ratios for gene induction (Conway 
et al., 2003). 
qRT-PCR Quantitative Real Time PCR experiments were performed in a 
Techgene thermal cycler (Bibby Scientific, United Kingdom) after the microarray 
experiments for several genes listed in Table 4-2 in order to confirm their 
expression. 
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Table  2-4 Genes selected for qRT-PCR and their primers 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene NO. Product Primer 
SP_1227 TCS02 RTF- GGTCGTGAAGCGCTAGAG RTR- TACGAATGGTCTTAGCAACTT 
SP_0387 TCS03 RTF- GACCTCCAAGACGATGTAGA RTR- ATTGCTAAGGTCGCGTCA 
SP_2082 TCS04 RTF- GTGACAAATGGACGGAAG RTR- ATTCATCACTTTTCGCAGA 
SP_2798 TCS05 RTF- GATTTTGCTGGATTTGATGTTGCC RTR- CCGCTCCCAGTTCAAATCCAT 
SP_2193 TCS06 RTF- TGAGTGCTCTGGGAGATGAAACT RTR- CGCCAAAGATCCTCTATGACG 
SP_0083 TCS08 RTF- GGCAGGTTATCAGGTCTTGG AGGCTGCTCTGGTGATAAGTA 
SP_2000 TCS11 RTF- GCTTCAACCGGATGTAGAG RTR- TTCTGCTCGTATCCACTCC 
SP_2235 TCS12 RTF- CCAATATCATACAAGACAACG RTR- GAGCCACTTCAAATCCCT 
SP_0526 TCS13 RTF- AAAGCACATCATATCATTCC RTR- AGTCCCTTCATCTCTTCATT 
SP_0376 TCS orf RTF- CCAGAAAGAGCAGTATCGG RTR- TCGGCTCAATTTTTCTGC 
SP_1219 GyrA RTF- GCGCGAGCTCTTCCTGATGT RTR- TATGGGGTTTGTCTGGGGTC 
SP_1923 PLY RTF- GATGGCAAATAAAGCAGTAAATGACT RTR- TGATGCCACTTAGCCAACAAATCG 
SP_2190 PspC RTF- GAAAACGAAGGAAGTACCCAAGCA RTR- CTTTAACTTTCACATCGAACTCAGC 
SP_0461 RlrA RTF- CCATCGCAACAGGCTACC RTR- TGTGACCCAATCCATACTTCC 
SP_0462 RrgA RTF- AACCAGTCCAGCGATAGG RTR- CTTCTGTCAAGGTGTATGTCC 
SP_0463 RrgB RTF- ATACACCTGTGAACCACCAAG RTR- CATTCTATCGCTCCAGTTTGC 
SP_0464 RrgC RTF- GTATCTTCTTTGTTATGGCTCTG RTR- ATCATCATAGGAATACGAATCATC 
SP_0466 SrtB RTF- GGTGTCTCGCTTGTATTATCG RTR- TGTCAGCCTCATCCAACG 
SP_0467 SrtC RTF- GTGTCTCGTTATTATTATCGTATTG RTR- CCTCAAGTTCTGCCTTATCC 
SP_0468 SrtD RTF- TCTCGCCTACAATCAACGC RTR- ATAATCTGCTCCCAAATAAACCG 
SP_1651 Tpx RTF- ATGGAAGAAAAAAGATTGGAGT RTR- CGTGTTTGAGTTGAGCAGAT 
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TIGR4 genomic DNA (gDNA) was used as a positive control, whereas the negative 
control was nuclease free water (Ambion/Applied Biosciences, United Kingdom). 
The pneumococcal gene encoding the enzyme DNA gyrase, was used as the 
reference gene for normalisation. RNA samples which had NRT (No Reverse 
Transcriptase, SuperScript® II from Invitrogen™, United Kingdom) when 
preparing cDNA were used as negative controls. Apart from the gDNA controls, 
all qRT-PCR reactions for genes of interest have been performed in triplicate 
along with their associated triplicate NRTs controls for the three different levels 
of oxygen conditions. qRT-PCR plates used for running samples (ABgene, Fisher 
Scientific, United Kingdom) or 200µl white 8-well strips (ABgene, Fisher 
Scientific, United Kingdom). The chosen genes, their products and primers used 
are listed above in Table 2-4. 
The total volume for each of the 21 qRT-PCR reactions was 25µl using Mj white 
plates (Kisker Biotech GmbH, Germany). In each experiment, 12.5µl of 2× Roche 
SYBR green mastermix (Roche, United Kingdom), 1µl forward primer and 1µl 
reverse primer, 10µl nuclease free water (Ambion/Applied Biosystems, United 
Kingdom) and 0.625µl sample were then added to the mastermix.  
To choose the best cDNA concentration for the qRT-PCR reactions, ply was 
tested after preparing three serial dilutions; neat, 1:10 and 1:50. The NRTs were 
similarly diluted before measuring their (samples and controls) concentrations 
with Qubit fluorometer (Life Technologies, United Kingdom). Working solutions 
were prepared and standardised according to the Qubit manufacturer´s 
instructions. Once the best concentration was detected after qRT-PCR, the 
dilution factor was used to prepare all of other samples, which had been 
recovered from different pneumococcal growth conditions.  
The reaction condition used for these qRT-PCR experiments was as follows: 
50ºC  2 mins (1 cycle) 
95ºC 10 mins (1 cycle) 
95ºC 15 seconds 
55ºC 30 seconds (40 cycles) 
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72ºC seconds 
72ºC 5 mins (1 cycle) 
Stored at 4ºC 
Primer temperatures were changed according to melting temperature. 
 
2.6.1 Testing ply qRT-PCR primers  
qRT-PCR gene-specific primers for ply were designed according to (Ogunniyi et 
al., 2002) and tested using TIGR4 gDNA with PCR (Figure  2-1) before performing 
qRT-PCR for all the cDNA prepared samples. The mastermix and PCR reaction 
was performed as outlined in Section 2.5.3. 
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        1                 2                 3                4                5 
384 bp 
 
 
Figure  2-1 Testing ply qRT-PCR primers before using in all other cDNA samples 
 
Lanes 1: ladder used, its full size is 1 kb (Life Technologies, United Kingdom), 2: ply, 3: 
negative control (PCR water used), 4: cps as positive control and 5: the ladder 1 kb. 
Annealing temperature was 54ºC according to the provider datasheet (Eurofins MWG, United 
Kingdom). PCR products were mixed with DNA loading buffer 0.25% bromophenol blue, 40% 
(w/v) sucrose in dH2O, and then run in 50ml 0.8% agarose gel (Agarose MP, Roche 
Diagnostics, Germany) in TE with 2µl of SYBERSAFE stain (Invitrogen, United Kingdom) and 
viewed under ultraviolet light in a UVIpro Gold Gel-doc system (UVItec, United Kingdom). 
 
2.6.2 qRT-PCR analysis 
To relatively assess the mRNA levels for each gene of the 21 qRT-PCR 
experiments, data collected after performing these reactions were analysed 
using the software Opticon Monitor 3.1.32 (MJ Genework, Bio-Rad Laboratories), 
and Microsoft Office Excel 2003 used for percentage calculations. With using 
Excel 2003, a table was made listing all gene expression showing calculated 
numbers representing up-regulation (above zero) and down-regulation below 
zero for the conditions used, oxygenated and anaerobic. Statistical analysis was 
performed in Graph pad (GraphPad Prism 5, USA 2007). Bars showed means of 
triplicate experiments for each sample plus/minus error bars of standard 
deviation. A 1-way ANOVA comparing the data cycle threshold (dCT) values (Ct 
of test gene minus Ct of control genes, gyrA).  
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2.7 Biological activities and virulence factors 
2.7.1 Biofilm formation 
According to (del Prado et al., 2010) with modification, each pneumococcus 
listed in Table 2-1 has been grown in triplicate in two different environmental 
conditions; oxygenated and anaerobic, until the end of its death phase. For the 
oxygenated biofilm assays, broth culture (BHI medium) in a flat 96-well plate 
(Costar, United Kingdom) was incubated and shaken at 180 rpm for 24 hr at 37ºC 
before inoculating 20µl of 2×103 CFU/ml pneumococci (105 CFU/ml) onto 180µl 
pre-warmed BHI. The plates were incubated under the same conditions until the 
decline phase prior to adding 200µl of 1% crystal violet to each well; they were 
incubated then at 20-22ºC for 10 min. The crystal violet was discarded, washed 
four times with sterile distilled water prior to all plates dried at 37ºC for 1 hr 
followed by addition 200µl absolute ethanol to each well.  
For the anaerobic biofilms, similar plates were incubated for 24 hr in a static 
anaerobic station (miniMACS, Anaerobic Workstation) with 180µl of the same 
batch of the media BHI and inoculated using the same standard bacterial inocula 
as described above.  
To analyse these biofilms, a FLUOstar Optima plate reader (BMG Labtech, United 
Kingdom) was used at 600nm as described in the literature (Pericone et al., 
2003). BHI medium without pneumococcal inoculation was used as a negative 
control in triplicate, and P. aeruginosa was used as a positive control. 
2.7.2 Preparation of TIGR4 cell lysates 
In order to study the effect of different oxygen levels on several tested proteins, 
pneumococci were grown until OD600nm: 0.35 under the anaerobic or oxygenated 
growth conditions. The start inocula were approximately 105 CFU/ml in 50ml 
falcon tubes (Millipore, United Kingdom) of overnight pre-warmed at 37ºC BHI 
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medium. Then, broth cultures in the tubes were centrifuged at 5,000 rpm for 20 
min at 4ºC in Sigma Laboratory centrifuge 4K15 (Philip Harris, United Kingdom).  
Pellets were washed and re-suspended in 1ml PBS, cooled on ice in a 1.5ml 
Eppendorf tube (Eppendorf centrifuge 5417C, USA) with a protease inhibitor 
(Roche, United Kingdom) before sonication on ice at 10% amplitude for five 
repeats of 30 seconds with 30 seconds rest using a Soniprep 150 sonicator (MSE, 
United Kingdom). Pneumococcal cell lysates were also prepared for blotting 
cytoplasmic and the bacterial cell surface proteins. To isolate the cell surface 
protein PspC, samples were washed with 2% choline chloride. 
All samples were measured for their total protein contents using a Nanodrop ND-
1000 spectrophotometer (Agilent Technologies, United Kingdom). Haemolytic 
assays were then performed prior to storing the rest of the samples at -20ºC for 
further use. 
2.7.3 Toxin activity 
The haemolytic activity of the toxin Ply was measured in culture lysates or in 
purified Ply according to Walker and colleagues (Walker et al., 1987). 
Fifty-five micro-litres of Phosphate-Buffered Saline (PBS) was added to all wells 
in a round-bottom 96-well plate (Costar, United Kingdom), and double diluted 
50µl of the samples [centrifuged cell lysates at 13,000 rpm for 10 min in a 
bench-top centrifuge (Centrifuge 5417C, Eppendorf, United Kingdom)]. Purified 
Ply of TIGR4 (performed in our group as described by (Mitchell et al., 1989) at a 
concentration of 0.31mg/ml) was also diluted similarly in volume to be used as a 
positive control, whereas the negative control was only 50µl of PBS. 
Additionally, D39 `ply was tested as another negative control. Then, 50µl of 
10mM of freshly prepared DTT (Sigma-Aldrich, United Kingdom) was added to 
each well, before covering the plate and incubating for 15 min at 37ºC. 
A fresh solution of 2% (vol/vol) of horse erythrocytes (E & O Laboratories, 
Scotland) in PBS was prepared and 50µl was added to each well. The 96-well 
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plate was incubated at 37ºC for 30 min. Then, 50µl PBS to each well was added 
before centrifuging the plates at 1000 rpm for 2 min in a 4K15 centrifuge 
(Sigma-Aldrich, United Kingdom). These haemolytic assays have been repeated 
at least 3 times for each growth condition. 
2.7.4 SDS-PAGE  
Pneumococcal cell lysates were diluted 3:1 in NuPAGE loading buffer 
(Invitrogen, Scotland) before heating up in a digital dry bath (Accublock™ Digital 
Dry Bath, Labnet International, Inc., United Kingdom) at 72oC for 10 min. The 
samples then were loaded onto a pre-cast gel (Invitrogen, Scotland).  
The marker used was SeeBlue Plus2 standard marker (Invitrogen, Scotland). A 
sample volume of 10µl was loaded in each well, and the gel run for 50 min at 
200V using MOPS as a running buffer (Invitrogen, Scotland). SDS-PAGE (Sodium 
Dodecyl Sulphate – Polyacrylamide Gel Electrophoresis, Ambion/Applied 
Biosystems, United Kingdom) gels were stained overnight in Coomassie stain 
solution (45 ml dH2O, 45 ml methanol, 10ml acetic acid, 0.25g Coomassie 
Brilliant blue R250), and destained with 45ml dH2O, 45ml methanol, and 10ml 
acetic acid. Descriptions for different running buffers and other solutions; stain 
and de-stain buffers used are shown in Table 2-5. 
  Table  2-5 Reagents and buffers used for SDS-PAGE 
 
Buffer Composition 
1 1x NuPAGE MOPS Proprietary formulation 
2 1x NuPAGE MES Proprietary formulation 
3 10x Tricine running 30g Tris,144g Glycine,10g SDS 
4 Coomassie R250 stain 1.25g/L coomassie R250,40% EtOH,10% glacial acetic acid 
5 Coomassie destain 40% EtOH, 10% glacial acetic acid 
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2.7.5 Western Blot  
Immunoblotting, was done after running proteins of interest in gels (Section 
2.7.4) but without staining. Gels were transferred to Hybond-C nitrocellulose 
membrane (Amersham Biosciences, United Kingdom) to be blotted at 30V for 1 
hr using an Xcell II blotting module (Invitrogen, United Kingdom) following the 
manufacturer´s instruction.  
In order to block the membrane, it was kept at 4oC for overnight in 3% skimmed 
milk (Marvel, United Kingdom) in Tris NaCl, pH 7.4 (10mM Tris, 150mM NaCl, 
8mM HCl). After this, the membrane was incubated with a 1/500 dilution of 
primary anti-body rabbit (anti-pneumolysin) at 37 oC for 2 hr with shaking at 200 
rpm before washing 3 times in 40ml Tris NaCl at pH7.4 for 5 min. The membrane 
then was incubated at 37oC for 1 hr in 3% skimmed milk in the Tris-NaCl with 
1/1000 dilution of secondary anti-body (Anti-Rabbit IgG raised in donkey, GE 
Healthcare, United Kingdom) prior to washing again 3 times in 40ml of the Tris 
NaCl for 5 min. The membrane was developed in either 4-chloronapthol or 
Immobilion Western HRP Chemiluminescent substrate purchased from Millipore 
(Millipore, United Kingdom). In terms of using a developing buffer, 4-
chloronapthol, 30mg 4-chloro-1-naphthol, 10ml Methanol, 40ml Tris NaCl, pH 7.4 
and 30µl Hydrogen peroxide were prepared freshly before submerging the 
membrane for a few minutes at room temperature. This developing method was 
then stopped with dH2O.  
For the Immobilion Western hybridisation, two reagents were used after protein-
membrane blotting. From each reagent, 2ml were mixed immediately before 
treating the membrane on the mixture. It was developed then in the dark room 
after being exposed to a photographic film. Antibodies used for developing in 
the dark room were highly diluted 1:20000 due to the high sensitivity as 
compared to the dilution factor used when using 4-chloronapthol, which was 
1:500.  
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Immunoblot experiments performed for different proteins, sources of their 
antibodies, dilution factors used and the development procedures are listed in 
Table 2-6.   
   Table  2-6  Antibodies used in Western Blot 
 
 
2.7.6 Adhesion assays 
Eukaryotic human lung alveolar epithelial carcinoma cells A549 (Human lung 
epithelial carcinoma cell line, ATCC-CCL-185) (LGC Standards, American Type 
Culture Collection, United Kingdom) were cultured in an F-12K medium (LGC 
Standards, American Type Culture Collection, United Kingdom) supplemented 
with 1% fungizone (Gibco®, Life Technologies, United Kingdom), 1% L-
Glutaminase (Sigma-Aldrich, United Kingdom), 10% foetal bovine serum (FBS) 
(Biosera, United Kingdom), 1% streptomycin and 1% penicillin (Sigma-Aldrich, 
United Kingdom). Similarly, F-12K was prepared but without adding the anti 
bacterial agents (streptomycin and penicillin) and used as a bacterial growth 
culture. The epithelial cells were grown in a 25cm2 culturing flask prior to 
seeding 2ml cell suspension at density of 2×105/ml in each of the 24 well. These 
were incubated for 48 hr at 37ºC in a 5% CO2 incubator till reaching 70 to 90% 
confluence.  
Pneumococci (TIGR4, TIGR4∆cps, OXC141 and P1041) were grown under 
anaerobic and oxygenated environments until optical density of OD600nm ~0.35 
before inoculating at 1×107 CFU/ml onto the culture. Adherence was allowed for 
1 hr followed by washing with sterile pre-warmed Dulbeccos PBS (D-PBS, Sigma-
Antibody Source Dilution factor Development 
1 Anti-Ply Rabbit 1/500 4-chloronapthol 
2 Anti-PspC Rabbit 1/500 4-chloronapthol 
3 Anti-RrgB Rabbit 1/20000 Dark room 
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Aldrich, United Kingdom) and treating the host cells using 250µl trypsin (Sigma-
Aldrich, United Kingdom) for detaching. Both adherent and non-adherent 
bacteria were counted after being serially diluted and plated on BA overnight. 
Data analysis was performed in the programme Graph Pad (GraphPad Prism 5, 
USA 2007). 
88 
2.8 Genome alignments 
Each of the pneumococcal genome was downloaded individually from NCBI 
before isolating the target sequence in a smaller segment out of the whole 
bacterial genome.  
Insert use of Blast and BLAST website link plus CLC package details and general 
handling of sequence files, use of BLAST within CLC software suite and the use 
of alignment tools including ClustalAlignment.  
Target sequences of candidate regions identified by function, relevance to 
observed phenotype and from gene expression data were investigated in more 
detail and genes compared across the available genome sequences of strains 
included in this project. 
All these genome sequences were transulated then to their proteins using CLC 
programme and compared all pneumococci to each other using TIGR4 as a 
reference strain for each particular gene including flanks in order to detect 
mutations; Synonymous SNPs, Non-Synonymous SNPs, deletions and insertions.   
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Chapter 3 – Pneumococcal Growth 
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3 Pneumococcal Growth 
Bacterial growth under specific conditions usually reflects their growth pattern, 
and this might be used to show what their behavioural responses in that 
particular condition are. Accordingly, comparison between several bacterial 
growth curves can represent their phenotypic differences, the way they behave 
in vitro to respond to the surrounding changes.  
The pathogen S. pneumoniae is known to encounter different levels of oxygen 
during the infection cycle including colonising the host upper airway system 
where oxygen levels are around 21 %. This decreases to 10-15 % in the lower 
respiratory system into the alveoli, more reduction in human tissues at 5 % 
(Burghout et al., 2010), and much lower oxygen tension in the middle ear and 
during pneumonia (Hathaway et al., 2007); whereas the host bloodstream is 
assumed to be an anaerobic environment (Yesilkaya et al., 2013). 
Therefore, this chapter focuses on studying several points including the effects 
of different environmental factors such as variant levels of oxygen and host-
derived fluids on pneumococcal growth. This may enable us to dissect in vitro 
bacterial growth characteristics (phenotypic differences) as a baseline in this 
topic, which will be used for the rest of the study. This basic step was 
performed after growing 11 pneumococcal strains with known genome 
sequences to closely investigate their growth traits under different incubation 
conditions. All of the strains have been genome sequenced as a collaborative 
project between our group and the Sanger institute.  
There are a number of reasons behind the choice of these pneumococcal strains: 
1) They all have been genome sequenced.  
2) The most studied clinical strain that has been considerably understood, from 
a genetic point of view, is TIGR4. 
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3) Serotypes 1 and 8 are known to be hyper-virulent (Williams et al., 2012), and 
they have been clinically isolated from patients who were reported with PID.  
4) Type 3 pneumococci were selected for slightly different reasons:  
I. Two strains were isolated from different sites of a patient.  
II. OXC141 strain is mostly found as a host coloniser.  
III. A45 is the only equine isolate (in the study) and has never been isolated   
    from a human. 
 
3.1 Aerobic pneumococcal growth 
Growth curves of several pneumococcal strains representing the serotypes 1, 3, 
4 and 8 (listed in 3-1) were obtained and the standardised start inoculation was 
~105 CFU/ml at 37ºC. 
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Table  3-1 The pneumococcal strains used in this project 
 * Strains isolated from one patient. MLTS: Multi Locus Sequence Typing. 
 
All pneumococci (Table 3-1) were grown in a standard medium (one batch was 
prepared and used for all bacterial growth) under the same incubation 
conditions. Absorbance of OD at 600nm and viability (CFU/ml) were measured at 
set time-points in triplicate. Each strain was grown at least twice and the mean 
of the triplicate readings is represented herein. Under the same incubation 
procedures, the mutants D39`ply and TIGR4`cps were grown for different 
purposes in the study, which will be explained later in a related experiment.  
Strain Identifier Host Serotype MLST 
1 TIGR4 Human 4 205 
2 TIGR4-403 Avirulent 4 205 
3 03-3038 Human 1 306 
4 NCTC7465 Human 1 615 
5 P1041 Human 1 217 
6 INV104B Human 1 227 
7 99-4039* Human 3 180 
8 99-4038* Human 3 180 
9 OXC141 Human 3 180 
10 A45 Equine Disease 3 6934 
11 ATCC6308 Human 8 N/A 
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3.1.1 Serotype 4 (TIGR4 and TIGR4-403) 
 Serotype 4 growth curves
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Figure  3-1 TIGR4 and TIGR4-403 growth curves aerobically 
 
Optical density (OD) (A) and viable counts (VC) (B). The log phase started in TIGR4 after 2 hr 
and the whole pattern of growth lasted approximately 9 hr, whereas TIGR4-403 (the TIGR4 
avirulent strain) started the log phase 3 hr until reaching a higher bacterial population 
unlike TIGR4. OD is the optical density and CFU is the colony forming unit for cells viability. 
The growth curve was repeated at least three times and each time-point is the mean of 
three replicates represented as error bars show the standard error of the mean, calculated 
using Graph Pad (GraphPad Prism 5, USA 2007) 
Viable count (VC), which is represented as CFU/ml, of a growth curve typically 
has four phases: lag, logarithmic (log), stationary and decline phase (also called 
death phase). Similarly, OD curves have these phases except the decline 
because cells are counted even after dying, as the spectrophotometer 
equipment measures both live and dead bacteria. This may explain why the OD 
curve does not reduce after reaching the highest point during the bacterial 
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growth, and in terms of the CFU, it will be discussed briefly in all of the 
following growth curves.  
The pathogenic strain TIGR4 took 2 hr before logarithmically reaching the 
growth peak that lasted for 4 hr. Then, the bacterial cells started to die 
entering the death phase for a further 3 hr (Figure  3-1, B). The avirulent strain 
had a higher and longer stationary phase after 4 hr in the exponential phase. 
Another 4 hr were taken for the cells death. Its population reached around 800 
million greater than the clinical isolate TIGR4 (Figure  3-1, B).  
The avirulent TIGR4-403 strain slowly grew in its exponential phase resulting in 
longer generation time, but reaching a higher bacterial population during its 
growth, about 1.5×109 compared to the growth peak in TIGR4 which was  
0.8×109. 
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3.1.2 Serotype 1 strains 
Serotype 1 growth curves
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Figure  3-2 aerobic growth curves of serotype 1 pneumococci  
 
Pneumococcal optical densities for serotype 1 growth curves (A) and their viable counts as 
CFU/ml (B). Four clinical isolates representing serotype 1; 03-3038, NCTC7465, P1041 and 
INV141. 03-3038 and NCTC7486. They have a generally similar growth pattern, with 03-3038 
VC growth showing the highest bacterial population. All survived until about 12 hr. The 
clinical strain P1041 made a very weak log phase among all of the other grown serotype one 
representatives, resulting in the slowest recorded generation time. Error bars represent the 
standard error of the mean using Graph Pad (GraphPad Prism 5, USA 2007) 
Growth curves are different between diverse pneumococcal strains. An example 
can be seen in the growth curve of the isolate 03-3038; the stationary phase 
took nearly 3 hr after growing exponentially for four hours, the growth then 
reduced for another 3 hr as shown in Figure  3-2. Regardless of the higher 
bacterial population and the slight changes in the growth, the isolate NCTC7465 
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had a similar growth curve to 03-3038 but longer by about an hour in each 
phase. Both have reached the end of their death phase after almost 12 hr.  
With regard to the clinical organism P1041, the graph (Figure 3-2) demonstrates 
that the life span was also 12 hr resembling 03-3038 and NCTC7486. However, 
P1041 very slow growth rate its group representatives. As aresult, its doubling 
time was 63 min, showing the weakest growth rate amongst serotype 1. 
Moreover, the repeated experiments revealed a high similarity in its growth 
curves. It seems to be that P1041 has the most reproducible growth curves - 
when repeated - among all of the clinical strains used in the study. 
In addition, the above chart shows that the strain INV104B took approximately 4 
hr before starting the sharp logarithmic phase (Figure  3-2). Both of the curves, 
OD and VC, reached the peak at about 7 hr, and then the viability of the cells 
gradually decreased for another 2 hr before the growth rate dropped in an 
approximately parallel direction to the log phase representing the bacterium 
death phase. 
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3.1.3 Serotype 3 strains 
Serotype 3 growth curves
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Figure  3-3 Growth curves for serotype 3 pneumococci 
 
Pneumococcal optical densities for serotype 3 growth curves (A) and their viable counts as 
CFU/ml (B). Four clinical isolates belonging to serotype three; 99-4039 (isolated from CSF in 
a patient), 99-4038 (isolated from the same patient but from the blood), OXC141 mostly 
found as a coloniser and the equine isolated strain A45 that has never been seen in humans. 
Statistical t-test analysis using Graph Pad (GraphPad Prism 5, USA 2007)) showed significant 
differences with p=value 0.0211 between growth curves of 99-4038 and OXC141. Also the p-
value for 99-4038 to OXC141 was 0.0421. Error bars represent the standard error of the 
mean. 
The strains 99-4039 and 99-4038 have been isolated from the same patient but 
different sites, cerebrospinal fluid (CSF) and the patient’s blood respectively. 
The CSF isolate 99-4039 lasted for 16 hr in the lag phase (the longest lag phase 
period as compared to all of the 11 other pneumococcal strains), followed by 
the logarithmic growth for 2 hr; 3 hr were taken in the stationary and the death 
phase started after 23 hr for a few further hours (Figure  3-3, B).    
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The growth readings showed that the isolate 99-4038 started its log phase at 6 
hr before turning to the logarithmic phase. Then it lasted 2 hr, dropped 
dramatically for 30 min and adjusted to be horizontal-like for another 2 hr 
before death (Figure  3-3, B). Compared to 99-4039, the whole growth pattern in 
99-4038 was shifted 10 hr to the left. 
Moreover and in spite of both serotype 3 micro-organisms A45 and OXC141 
isolated from different host types, a horse strain (that has never been isolated 
from humans) and a human coloniser, respectively, both grew in vitro in a 
similar pattern. They all started growing logarithmically at 5 hr for around an 
hour. Then they died after 13 hr.  
However, the A45 growth curve demonstrates a sharper log phase (~45 min) 
after the first five hours taken in the lag phase (Figure  3-3, B). The pathogen 
started its decline phase after 6 hr after which it was reduced for another 6 hr. 
Statistical data analysis revealed significant growth differences              
(P=0.0211) between 99-4038 and OXC141, and also between 99-4039 and 
OXC141, respectively, as shown in Figure  3-3, B.  
These manifest differences among the same pneumococcal serotypes grown 
under some condition, reflecting their in vitro phenotypic variations. 
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3.1.4 Serotype 8 (ATCC6308) 
 
Growth curves of the isolate ATCC6308
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Figure  3-4 Aerobic growth curve for serotype 8 (ATCC6308) 
 
Optical density (A) and viable counts as CFU/ml (B). Error bars represent the standard error 
of the mean using Graph Pad (GraphPad Prism 5, USA 2007). 
 
In Figure  3-4, the medical isolate ATCC6308 took 3 hr to start the log phase in 
which 5 hr were taken, and then there was a gradual decrease for almost 6 hr. 
The approximate time for the whole growth was 15 hr. 
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3.2 Effect of oxygen on pneumococcal growth 
A collection of pneumococci was chosen from different serotypes to be grown 
under aerobic and anaerobic growth conditions. This was to assess how the 
availability of oxygen could affect their growth pattern under both incubation 
condition. The selected bacteria were type 4 (TIGR4), type 1 (P1041) and three 
isolates representing type 3 (99-4039, 99-4038 and OXC141). 
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Figure  3-5 TIGR4 growth in aerobic or anaerobic growth conditions 
 
Pneumococcus optical density (A) and viable cells as CFU/ml (B). S. pneumoniae TIGR4 grows 
better anaerobically, sharper log phase and more typical pattern of growth. Error bars 
represent the standard error of the mean and growth variation is not significant, calculated 
using Graph Pad (GraphPad Prism 5, USA 2007), and growth curves under both conditions 
were repeated for at least three independent experiments.  
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The anaerobic growth conditions of TIGR4 slightly seemed to provide a 
preferable environment as the bacterium showed a typical growth curve 
anaerobically as compared to the aerobic. TIGR4 has made an earlier and 
sharper logarithmic phase under the anaerobic conditions, a typical stationary 
bacterial phase, and parallel death to the log phase as seen above in Figure  3-5, 
B.  
It is noteworthy that this figure (Figure  3-5) shows difference between the 
pneumococcal viable counts but not in their OD values. This could be because 
the spectrophotometer measures absorbance resulting from bacterial cells, their 
debris and dead organisms when reading a sample, whereas plating on an agar 
plate will only reflect live pneumococci. Therefore, although ODs suggest that 
bacterial growth curves are similar, analysis of VCs showed some differences, 
which are believed to be reflecting true growth states. 
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Aerobic and anaerobic growth of P1041
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Figure  3-6 P1041 growth in aerobic or anaerobic growth conditions 
 
Bacterial optical densities (A) and CFUs (B). Later log phase in the atmospheric growth 
environment and the microorganisms had both incubation conditions, similar growth rates 
and a dramatic sharp death phase. Error bars represent the standard error of the mean and 
differences between growth curves were not significant using Graph Pad (GraphPad Prism 5, 
USA 2007). 
Although P1041 grew better anaerobically (Figure  3-6, A and B), roughly in the 
same way as TIGR4, it took a shorter time in the anaerobic growth conditions 
(only about an hour) during the enzymatic preparation stage (the lag phase). 
Pneumococcal growth curves in BHI were reported to show enhanced growth 
rates in anaerobic conditions (Baettig et al., 2006). Affected growth patterns 
with oxygen molecules were also demonstrated in S. mutans (Ahn et al., 2007). 
The figure shows that there was a prolonged log phase in both of the growth 
patterns, aerobic and anaerobic. As a result, the doubling time in these two 
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conditions was similar, as well as their dramatically sharp decline phase, unlike 
the TIGR4 growth rate.     
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Figure  3-7 99-4039 growth in aerobic or anaerobic growth conditions 
 
Bacterial optical density (A) and colony forming unit (B). Dramatic changes occurred to the 
CSF strain in the absence of O2. Seven hours earlier the log phase was reported anaerobically 
but with similarities in their growth rates. Error bars represent the standard error of the 
mean using Graph Pad (GraphPad Prism 5, USA 2007). 
A clinically isolated microbe 99-4039 isolated from CSF, preferred the 
environment with limited oxygen. It started the log phase 7 hr earlier 
anaerobically, and long lag phases in pneumococci have been linked to a number 
of serotypes associated with virulence (Baettig et al., 2006). The isolate then 
took a longer time in the stationary phase compared to the aerobic stationary 
growth phase (Figure  3-7, B). In addition, the anaerobic grown bacteria died 
slowly compared to the sharp aerobic decline phase.   
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Aerobic and anaerobic growth of 99-4038
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Figure  3-8 99-4038 growth in aerobic or anaerobic growth conditions  
 
Optical density of the grown cells (A) and their CFUs (B). Error bars represent the standard 
error of the mean using Graph Pad (GraphPad Prism 5, USA 2007). 
Serotype 3, 99-4038 (the blood isolated pathogen) showed a predicted faster lag 
phase anaerobically, resembling the S. pneumoniae CSF clinical isolate, before 
taking 11 hr in the stationary phase (Figure  3-8), showing the longest stationary 
time taken amongst all of the other tested pneumococci in this project. The 
whole anaerobic pattern of growth lasted for 24 hr, and that was an 
enhancement of nearly 10 hr compared to its growth in the presence of oxygen.  
Growth curves of pneumococci representing different serotypes showed 
anaerobic typical growth phases aerobically grown pneumococci (Figure 3-5, 6, 7 
and 8). In fact, it has been reported that elimination of H2O2 from the growth 
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cultures has led to a significant prolonged stationary phase (Regev-Yochay et al., 
2007).  
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Figure  3-9 OXC141 growth in aerobic or anaerobic growth conditions 
 
The strain OD (A) and viable counts as CFU/ml (B). OXC141 grew dramatically for four hours 
exponentially after taking about 3 hr in the lag phase. This was followed by a similar sharp 
death phase. Both growth curves (aerobic and anaerobic) were homologous under both 
incubation conditions, and it is the only bacterium that grows similarly in aerobic and 
anaerobic environments compared to other strains tested. Error bars represent the standard 
error of the mean and growth curves are not significantly different using Graph Pad 
(GraphPad Prism 5, USA 2007). 
The strain OXC141, which is found mostly in carriage (as a coloniser) rather than 
as a cause of IPD, grew with almost identical and parallel growth patterns in the 
presence and absence of oxygen (Figure  3-9, B),  
All of the above aerobic-anaerobic growth patterns (serotype 4; TIGR4, serotype 
1; P1041 and serotype 3; 99-4039 and 99-4038) had, to some extent, earlier log 
and longer stationary phases anaerobically reflecting generally greater growth 
rates anaerobically. Dissimilarly, OXC141 viable cells counted during the 
bacterial growth in both environments (Figure  3-9) have shown that there is a 
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slightly longer stationary phase under the aerobic conditions in comparison to 
the absent stationary phase anaerobically. A further confirmation for this 
outcome was performed. 
These pneumococcal phenotypic differences in the aerobic and anaerobic growth 
conditions could be due to the production of H2O2 under oxygen availability 
compared to its absence as a consequence of pyruvate oxidase activity, hence, 
peroxide production. Thus, these strains have remarkably different growth 
patterns that reflect some genetic variation. Differences in 15 pneumococcal 
growth patterns were studied in BHI and variation was clear between 
pneumococci (Baettig et al., 2006). It was decided then to perform H2O2 assays 
for TIGR4 growth in oxygenated and anaerobic growth environments.     
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3.3 Production of H2O2 by TIGR4 
H2O2 assay was performed to compare the produced amount after growing TIGR4 
in both oxygenated and anaerobic growth conditions. 
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Figure  3-10 Production of H2O2 in TIGR4 grown in oxygenated and anaerobic conditions. 
 
The oxygenated growth has led to a massive hydrogen peroxide production compared to the 
anaerobic growth conditions. The arrow indicates reaction of the oxygenated sample that 
contained high concentration of H2O2 versus anaerobic samples on the right. Each bar shows 
an average of three readings and error bars represent the standard error of the mean. 
Statistical analysis was performed using t-test in Graph Pad (GraphPad Prism 5, USA 2007).  
The oxygenated growth of TIGR4 led to a statistically significant production of 
H2O2 compared to cells grown in the absence of oxygen, indicating proper 
incubation conditions used (Figure  3-10). Analysis of this assay showed that the 
amount of peroxide produced by TIGR4 during oxygenated growth conditions was 
above the range of the calibration range. However, production of peroxide by 
pneumococci has been determined in some pneumococcal serotypes. For 
instance, type 9V, 2 and 19 generated approximately 2.7 mM, 2.3 mM, and 5 mM 
respectively (Pericone et al., 2002; Taniai et al., 2008).  
From this and because of the fact that the blood contains the catalase enzyme, 
the aerobic growth reduction was noticed in several pneumococci, representing 
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different serotype groups, might be restored if the microbe were grown in the 
medium but with the addition of blood. As mentioned earlier, supplementing 
pneumococcal media with catalase to eliminate H2O2 has resulted in a significant 
prolonged stationary phase (Regev-Yochay et al., 2007).  
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3.4 Pneumococcal growth in blood 
It is known that blood contains the catalase enzyme, which breaks hydrogen 
peroxide down into water and oxygen, suggesting that growing pneumococci, 
that lack catalase, will lead to greater growth rate in the blood. Therefore, 
TIGR4 was grown with and without adding 5 % of sheep’s blood. Moreover, the 
clinical blood-isolated strain 99-4038 was also grown similarly to determine its 
growth in this mixture, BHI-blood medium. 
0 2 3 4 5 6 7 8 9 10
0.0
1.0×1009
2.0×1009
3.0×1009
4.0×1009
5.0×1009
TIGR4 with blood
TIGR4 without blood
Time (hr)
CF
U/
m
l
2 4 6 8 10 12 14
0.0
5.0×1007
1.0×1008
1.5×1008
99-4038 with blood
99-4038 without blood
Time (hr)
CF
U/
m
l
A 
B 
 
Figure  3-11 Comparison of pneumococcal growth rates with and without blood 
 
Growth curves CFU/ml in BHI without and with 5% blood addition of strains TIGR4 (A) and 99-
4038 (B). There was a three times increase in bacterial population of TIGR4 once grown in 
the BHI provided with 5% blood, whereas the strain 99-4038 had an almost similar growth 
peak but grew clearly earlier in blood. Error bars represent the standard error of the mean 
using Graph Pad (GraphPad Prism 5, USA 2007). 
S. pneumoniae TIGR4 was able to grow and exceed three-fold in the BHI-blood 
medium compared to its growth without adding 5 % blood. It took a similar time 
in the lag phase when growing in blood (Figure  3-11, A). 
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The growth of the isolate 99-4038 revealed a sharper log phase in the BHI 
supplemented with 5 % blood and obviously preferred blood containing broth as 
it grew 6 hr earlier and showed a longer stationary phase relative to its growth 
without blood addition. This indicates that the pathogen was growing in a less 
stressful environment compared with its growth without the addition of blood. 
Marked differences in bacterial growth curves might be because of the way that 
the bacterium forms its growth chains. Formation of the chain length could 
hugely affect the spectrophotometer readings, as this apparatus may count a 
long chain as one bacterium if a chain randomly faces the sensor vertically. 
Furthermore, viable counts would be affected as each bacterial chain could form 
a colony; on the other hand, an individual bacterium will form one colony as 
well leading to incorrect CFU/ml. Therefore, samples were vortexed before 
taking readings to avoid a vast number of chains being counted as individual 
cells, resulting in a false and small final number. It was worth then to clarify this 
theory by a microscopic examination of TIGR4 growth without vortexing to 
investigate if oxygen has an effect on the microbial chain morphology during 
growth; for instance, chain length under variant incubation methods including 
aerobic, anaerobic and growing in host-derived fluids such as blood.  
3.5 Microscopic investigation in different conditions 
TIGR4 strain was grown aerobically and anaerobically to microscopically 
investigate how generally oxygen affects the pathogen morphology. It was grown 
in both incubation states until their mid-log phase before films were prepared on 
slides and Gram staining carried out. 
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Figure  3-12 Microscopic examination of TIGR4 cells grown aerobically (A) and anaerobically 
(B) 
 
Examination of TIGR4 un-vortexed growth under these two conditions showed that O2 does 
affect the bacterial morphology. TIGR4 demonstrated a tendency in forming clumps A. In 
contrast, they tended to be in diplococci in the absence of oxygen than grouping together B. 
Images captured at a magnification of 1×103 after Gram staining of bacterial mid-log phase 
after fixing aerobic and anaerobic grown cells.  
The microscopic examination has revealed that the bacterium seems to form 
clumps, sticking to each other when exposed to the aerobic conditions (Figure 
 3-12). In contrast, they tend grow separately in the absence of oxygen, forming 
diplococci or short-chains instead of clumps. However, no changes in chain 
length were observed. 
Furthermore, TIGR4 was also grown aerobically with the addition of 5 % horse 
blood to the medium used to microscopically assess its growth morphology in the 
presence of blood-BHI media. 
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Figure  3-13 S. pneumoniae TIGR4 grown in the BHI-blood medium 
 
Microscopically examined TIGR4 in their mid-log growth without vortexing reflects longer 
bacterial chains compared to their shape under the aerobic/anaerobic growth conditions 
shown in Figure 3-12. The image was taken at a magnification of 1×103 after Gram staining of 
the bacterial mid-log phase grown in the blood-BHI broth culture. 
Figure  3-13 illustrates different growth pattern when cells were grown in the 
blood-BHI broth culture when compared to their growth with and without 
oxygen. They formed long chains rather than being in clumps or forming 
separate diplococci as in the aerobic or anaerobic growth conditions, as seen in 
Figure  3-12. 
In addition to these factors (aerobic, anaerobic and growth in the presense of 
blood) the acidity levels can strongly affect bacterial growth rates. This may 
widely vary during growth in different levels of oxygen according to the 
metabolic pathway employed under each growth condition. 
3.6 pH during TIGR4 growth 
Pneumococci are well known for producing lactic acid as an outcome of their 
sugar metabolism. The aim of this experiment is to determine the acidity levels 
when cells are grown in different levels of oxygen. Therefore, S. pneumoniae 
TIGR4 was grown for 7 hr and the pH was measured in hourly intervals. Cells 
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were grown under three different levels of oxygen: aerobic, anaerobic and 
oxygenated conditions.  
TIGR4 pH during growth in different levels of O2
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Figure  3-14 pH assay for TIGR4 growth under three different levels of oxygen 
 
Measurement of pH during TIGR4 growth shows that the pH was gradually reduced till it 
reached around pH 4.3 in both aerobic and anaerobic conditions, but it did not drop to acidic 
levels in the oxygenated culture as there was not sufficient bacterial growth. Error bars 
represent the standard error of the mean using Graph Pad (GraphPad Prism 5, USA 2007).  
In the pH assays, all of the different growth conditions had pH 7.2 in the 
beginning. The findings showed a gradual decrease in pH in three different 
environmental conditions. There was not significant difference between the 
aerobic and anaerobic growth conditions (Figure  3-14). However, the oxygenated 
growth did not bring about the same acidity levels found in aerobic/anaerobic 
growth. This could be due to the very weak pneumococcal growth rate in 
oxygenated broth culture. 
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3.7 Pneumococcal phenotypic differences 
After gathering several pneumococcal growth characteristics from the above 
experiments under different growth environments, the period taken in growth 
pattern and length of lag phase of different strains of S. pneumoniae are shown 
in Table 3-2. 
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Table  3-2 Characterisation of pneumococcal strains  
 
1) Time taken during the whole growth period. 2) Length of the lag phase. *Strains isolated 
from 1 patient but 2 sites with the same infection profile, blood and cerebrospinal fluid 
(CSF). Ae stands for aerobic, Ox is oxygenated, whereas An means anaerobic and NA: not 
assessed. 
  
 
Strain Genome Sequence Serotype MLST 
Growth 
time(hr)1 
Lag phase 
(hr)2 
Ae. 10 2 
An. 9 2 TIGR4 
(Tettelin et al., 
2001) 
4 205 
Ox. 10 2 
TIGR4-403 Glasgow 4 205 13 4 
03-3038 Glasgow /Sanger 1 306 12 3 
NCTC7465 Glasgow /Sanger 1 615 12 4 
Ae. 12:30 4.30 
P1041 Glasgow /Sanger 1 217 
An. 12 1 
INV104B Glasgow /Sanger 1 227 12 3 
Ae. 28 16 
99-4039 * Glasgow /Sanger 3 180 
An. 31 11.30 
Ae. 15 6 
99-4038 * Glasgow /Sanger 3 180 
An. 24 3 
Ae. 15 3 
OXC141 Glasgow /Sanger 3 180 
An. 14 3 
A45 Glasgow /Sanger 3 6934 13 3 
ATCC6308 Glasgow 8 NA 15 5 
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Table 3-2 shows that the bacterial strains behaved differently in the way they 
react to oxygen as these pneumococci reflected different phenotypes in terms of 
their relationship to oxygen availability. For instance, TIGR4 generation times, 
which are shown in Figure  3-15, illustrated a shorter time anaerobically as 
compared to its aerobic growth rates indicating that the more oxygen provided 
to the growth conditions the less generation time the pneumococcus will reveal.    
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Figure  3-15 Generation times for pneumococci used in this study 
 
TIGR4 generation time was different depending on the oxygen provided to its broth culture. 
When oxygen is available, the doubling time is decreased. P1041 demonstrates the longest 
aerobic and anaerobic generation times among all serotype 1 strains. Pneumococci 
representing serotype 3 had also variant times and similarities in presence/absence of 
oxygen in the strains 99-4038, 99-4039 and OXC141. (OA) indicates only aerobic as not all 
pneumococcal strains were grown aerobically and anaerobobaccly, just some representing 
each serotype used in this study were growth in the two conditions, aerobic and anaerobic. 
Each coloumn represents three generation times and error bars represent standard error of 
the mean using Microsoft Office Excel 2003. Statistical analysis using Graph Pad (GraphPad 
Prism 5, USA 2007) showed no significant differences comparing to TIGR4.   
However, Table 3-2 illustrates that P1041 grows similarly under both growth 
conditions and very slowly, giving the longest generation time among all of the 
other serotype 1 strains. As a result, its doubling time was the same in the 
presence or absence of oxygen. 
Several questions and ideas can be inferred from these differences in growth 
characteristics. For example, the variant generation times in the isolates 99-
4038 and 99-4039 were interesting. Genome sequencing has shown that their 
genomes are very closely related with only 3 SNPs that were different, and one 
of these SNPs was shown recently to alter the expression of PatA/B (pump efflux 
proteins) which may be responsible for this slow growth rate (Croucher et al., 
2013), in press.   
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It is worth mentioning here that these two strains have been isolated from one 
patient but from two different sites; 99-4038 was from the patient’s blood, 
whereas 99-4039 from the CSF. 
OXC141 also had almost the same doubling time aerobically and anaerobically 
and grew greater and more rapidly under the available or restricted oxygen 
compared to P1041. This suggests that they may have particular differences in 
their genetic expression under aerobic versus anaerobic growth environments; 
such differences could be related to their metabolic pathways. These 
differences are investigated in the following experiments. 
3.8 Genome comparison 
Three key genes can be identified from S. pneumoniae because of their 
involvement in the pneumococcal oxidative stress response. In order to compare 
these three major genes, several alignments were performed using nine 
pneumococcal genomes as listed in Table 3-3. Two strains (ATCC6308 and TIGR4-
403) from the set used in this study have not been included in the following 
alignments. The strain ATCC6308 has not been sequenced, and the strain TIGR4-
403 has not been published yet. However, the draft genome sequence of TIGR4-
403 was compared at these three loci and was found to be 100% identical to 
parent TIGR4 genomic sequence (A.M.Mitchell, personal communication). 
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Table  3-3 Gene numbers of tpx, spxB and sodA 
 
Where no gene number is available, contig number has been used instead. NA = not 
annotated.    
Gene number or contig number 
Accession Number Strain 
tpx (thiol 
peroxidase) 
sodA (superoxide 
dismutase) 
spxB (pyruvate 
oxidase) 
NC_003028 TIGR4 SP_1651 SP_0766 SP_0730 
NC_018594 A45 SPNA45_00589 SPNA45_01090 SPNA45_01061 
NZ_CACE01000000 P1041 NZ_CACE01000021 NZ_CACE01000002 NZ_CACE01000002 
NZ_CACF01000000 SPN7465 NZ_CACF01000008 NZ_CACF01000001 NZ_CACF01000001 
NC_017591 INV104B INV104_14040 INV104_06370 INV104_06090 
NC_021004 03-3038 NA NA NA 
NC_017592 OXC141 SPNOXC_14500 SPNOXC_06930 SPNOXC_06620 
NC_021026 SPN994038 SPN994038_14360 SPN994038_06830 SPN994038_06520 
NC_021005 SPN994039 SPN994039_14370 SPN994039_06840 SPN994039_06530 
 
Table 2-1 showing nine pneumococcal genomes used in this project. Alignments 
of relevant loci for these nine strains were performed in order to compare three 
kay genes; tpx, spxB and sodA. Each of these targeted gene loci with its flanking 
sequence is shown in Figure 3-16. 
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Figure  3-16 Three genes tpx, spxB and sodA with flanking sides 
 
Arrows indicated tpx SP_1651 (A), spxB SP_0730 (B) and sodA SP_0766 (C), as shown in light blue, with at least 2 kb, which were taken into account as 
flanking regions for each gene.   
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The three targeted gene sequences were extracted from the TIGR4 genome with 
at least 2 kb flanking sequence from each side, upstream and downstream. This 
was followed by a BLAST search against all available pneumococcal genomes to 
investigate and compare these genes across this subset of strains. Accession 
numbers are as listed in Table 2-1 (Section 2.1.1).  
The TIGR4 gene sequence was used as a reference strain, compared then to the 
other eight available pneumococcal genomes. It is worth mentioning here that 
unlike spxB and sodA, flanking regions for the tpx gene (Figure  3-16) were set 
further away comparing to the rest as psa operon was included. Thus, it was 
worth comparing genomic regions in case of any mutations in the rest of the 
operon that might affect the Tpx activity. As explained early (Sections 1.5.7 and 
1.10), psaD (also called tpx) is a part of psa operon, known as part of a 
manganese transporting system, and recently shown to encode the vital 
pneumococcal antioxidant, thiol peroxidase (Hajaj et al., 2012). Manganase 
cations are known as key microneutrient factors, particularly for pneumococcal 
pathogenicity (Ogunniyi et al., 2010).  
TIGR4 and 403 were studied in this topic for any possible genatic changes in tpx, 
spxB and sodA, but no SNPs were detected (either Synonymous or Non-
Synonynous) between all tested pneumococci. On the other hand, other 
pneumococci have shown genetic changes in the three tested genes which can 
be seen in Figure 3-17.  
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Figure  3-17 Overview of three alignments for tpx, spxB and sodA in nine different pneumococcal strains 
 
Targeted genes tpx (A), spxB (B) and sodA (C) with the flanking regions (at least 2 kb) upstream and downstream. The vertical black lines across the red plot 
show SNPs detected by CLC programme, and dark navy in (C), sodA gene, reflects deletions in which lighter navy represents SNPs. The gene tpx is located 
between the bp number 2885 and 3377, spxB from 2456 to 4233 and sodA 2703 to 3321.  
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Overview panels A, B and C in Figure 3-17 illustate the genetic changes detected 
in the three tested genes (tpx, spxB and sodA) between pneumococci listed in 
Table 3-3. The Figure also shows that spxB gene is highly conserved across all 
the genomes displayed. An example of one of the several noticed SNPs was 
found in serotype 1 (P1041) is shown in the below alignments between the study 
pneumococci. It revealed a unique mutation (Figure  3-18).  
   
                                                
 
Figure  3-18 Alignment for tpx between pneumococci used in the study 
 
These three snapshots alignments display examples of nucleotide changes (positions 3790, 
5100 and 5251). These all observed in the strain P1041.   
As it was reported early in this chapter (Section 3.1.2), pneumococcal growth 
charasteristics have showed that P1041, which represents serotype 1, had the 
slowest log phase among all serotype one strains. For confirmation, its growth 
was repeated three times (Figure  3-2, B). Consequently, the calculated 
generation time for P1041 was 63 min, reflecting the weakest growth rate in this 
serotype group as demonestreted in Figure 3-15. Therefore, it might be that this 
unique mutation in P1041 is involved in the pneumococcal growth somehow, but 
this requires further investigation to be assured.  
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Although that there are a number of detected genomic changes, it is possible 
that some SNPs are silent, known as Synonymous SNPs, which have different 
alleles encoding the same amino acid (NCBI), therefore, not any changes will 
lead to a different protein or altering its biological activity. DNA alighnment and 
its transulation to proteins revealed that the majority of the SNPs were silent; 
an example of this is shown in Figure  3-19. 
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Figure  3-19 Synonymous SNPs and Non-Synonymous SNPs detected in tpx gene  
 
Synonymous SNPs: three-hundered bp alignment of tpx DNA sequence (A), its 100 amino acid after transulating (B) and a Non-Synonymous SNP with its 
amino acid change from G (gly) which stands for Glycine to V as Valine (val) (C). 
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Due to the major number of Synonymous SNPs detected in the three tested 
genes that will be listed later in this section, Table 3-4 shows the Non-
Synonymous SNPs found in each gene.  
Table  3-4 List of Non-Synonymous SNPs detected in tpx, spxB and sodA 
 
TIGR4 was used as a refrence strain. Both Non-Synonymous SNPs and Synonymous SNPs were 
studied in all targeted genes using CLC Genomics Workbench. Amino acids letters are as 
follow: N stands for asparagine, H: histidine, P: proline, Y: tyrosine, S: serine, A: alanine, K: 
lysine, D: aspartate, C: cysteine, T: threonine and L: leucine.   
Strain Gene 
Refrence 
(TIGR4) 
Amino acid 
changed 
Amino 
acid 
position 
Conservation 
sodA N D 994 67% 
tpx H C 1011 89% 
tpx P T 1019 56% 
tpx Y H 1020 89% 
tpx P L 1029 89% 
tpx S L 1032 67% 
tpx A D 1033 89% 
tpx K T 1034 89% 
99-4038 
spxB N D 1378 89% 
sodA N D 994 67% 
tpx H C 1011 89% 
tpx P T 1019 56% 
tpx Y H 1020 89% 
tpx P L 1029 89% 
tpx S L 1032 67% 
tpx A D 1033 89% 
tpx K T 1034 89% 
99-4039 
spxB N D 1378 89% 
sodA N D 994 67% 
tpx H C 1011 89% 
tpx P T 1019 56% 
tpx Y H 1020 89% 
tpx P L 1029 89% 
tpx S L 1032 67% 
tpx A D 1033 89% 
tpx K T 1034 89% 
OXC141 
spxB N D 1378 89% 
tpx H C 1011 89% 
tpx Y H 1020 89% 
tpx P L 1029 89% 
tpx A D 1033 89% 
A45 
tpx K T 1034 89% 
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spxB N D 1378 89% 
tpx H C 1011 89% 
tpx P T 1019 56% 
tpx Y H 1020 89% 
tpx P L 1029 89% 
tpx A D 1033 89% 
tpx K T 1034 89% 
P1041 
spxB N D 1378 89% 
sodA P S 906 78% 
spxB V I 906 78% 
tpx H C 1011 89% 
tpx Y H 1020 89% 
tpx P L 1029 89% 
tpx A D 1033 89% 
tpx K T 1034 89% 
03-3038 
spxB N D 1378 89% 
tpx H C 1011 89% 
tpx Y H 1020 89% 
tpx P L 1029 89% 
tpx A D 1033 89% 
tpx K T 1034 89% 
NCTC7465 
spxB N D 1378 89% 
sodA P S 906 78% 
spxB V I 906 78% 
tpx H C 1011 89% 
tpx Y H 1020 89% 
tpx P L 1029 89% 
tpx A D 1033 89% 
tpx K T 1034 89% 
INV104B 
spxB N D 1378 89% 
 
There were deletions and insertions observed in the coding regions of tpx, spxB 
and sodA and will be stated later in the section, 62 Non-Synonymous SNPs in the 
three genes were detected (Table 3-4). The most strains found with up to 9 Non-
Synonymous SNPs are 99-4039, 99-4038 and OXC141, in contrast to A45 which 
had only 6 SNPs. Other pneumococci were in between, 7 and 8 Non-Synonymous 
SNPs. Moreover, although all strains had Non-Synonymous SNPs in tpx, spxB and 
sodA, A45, P1041 and NCTC7465 had no Non-Synonymous SNPs in sodA, only in 
tpx and spxB.  
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Non-Synonymous SNPs were also observed in the flanking regions of each gene 
with a large number of deletions and insertions. The gene tpx is located 
between the bp 2885 and 3377, spxB from 2456 to 4233 and sodA from 2703 to 
3321, shown in Figure 3-17. Investigating of tpx flanks (showed above in Figure 
3-16) using CLC programme demonstrated 80 Non-Synonymous SNPs, 136 
deletions in the strains 99-4039, 99-4038, OXC141, 03-3038 and INV104B 
togather, and 153 insertions in the same five pathogens. spxB revealed 19 Non-
Synonymous SNPs in the flanks only, whereas sodA showed 132 Non-Synonymous 
SNPs, 12 deletions in TIGR4 sodA, and for the same gene 6 deletions were 
noticed in both 03-3038 and INV104B, 536 insertions in 03-3038 and 347 
insertions in INV104B as compared to the refernce strain, TIGR4. Hence, several 
genes are possible candidates for oxidative stress and could be for future work 
to be studied not only in these three genes (tpx, spxB and sodA) but also in even 
much bigger list of genes.   
3.9 Discussion 
Bacterial growth under specific conditions generally reflects their relationship to 
that particular environment, and evidence has shown that molecular 
mechanisms, bacterial fitness and virulence factors are largely changed based on 
ecological growth conditions (Baettig et al., 2006; Mahdi et al., 2008; Mazzola et 
al., 2003; Oggioni et al., 2006; Orihuela et al., 2004a). 
Pneumococci are known as facultative anaerobe micro-organism preferring 
anoxygenic growth conditions, but they encounter different oxygen levels during 
the infection cycle (Burghout et al., 2010; Yesilkaya et al., 2013). The bacterium 
lacks a large number of proteins known in other bacteria to be required for 
resisting oxidative stress such as catalase (Pesakhov et al., 2007). This obviously 
highlights that S. pneumoniae possesses unknown factors allowing the bacterium 
to grow and survive in aerobic growth condition. Therefore, in order to study 
their growth characteristics in different oxygen concentration, several 
pneumococcal strains representing different serotypes were investigated. 
Growth rates of the pneumococci TIGR4, P1041, OXC141, 99-4038 and 99-4039 
aerobically and anaerobically showed variations in response to oxygen 
availability (Figure  3-20).   
128 
3 6 9 12 15 18 23
0.0
2.0×1008
4.0×1008
6.0×1008
8.0×1008
1.0×1009
TIGR4
P1041
OXC141
Effect of O2 on different serotypes growth
99-4039
99-4038
Time (hr)
CF
U/
m
l
3 6 9 12 15 18 21
0.0
2.0×1008
4.0×1008
6.0×1008
8.0×1008
1.0×1009
Effect of AnO2 on different serotypes growth
OXC141
99-4039
99-4038
TIGR4
P1041
Time (hr)
CF
U/
m
l
A 
B 
Effect of O2 on growth of different serotypes 
Effect of AnO2 on growth of different serotypes 
 
Figure  3-20 Pneumococcal growth under aerobic and anaerobic incubation conditions 
 
Aerobic growth (A) and anaerobic (B). Error bars represent the standard error of the mean 
using Graph Pad (GraphPad Prism 5, USA 2007). 
From the above figure, all serotypes had greater growth rates when oxygen was 
absent. Pneumococcus has been shown an increase in its growth rate when 
grown anaerobically (Baettig et al., 2006), and less growth rates were shown 
with S. mutans cells when grown in aerated growth conditions (Ahn et al., 2007).  
This might relate to effects of H2O2 toxicity resulting from the aerobic 
pneumococcal metabolism (Spellerberg et al., 1996). Taniai and colleagues 
highlighted that catalase is required in pneumococcal liquid culture to obtain 
full growth while growing pneumococcus aerobically leads to loss of bacterial 
viability which can be prevented with the addition of catalase (Taniai et al., 
2008). Additionally, it has been stated that exogenous addition or endogenous 
production of H2O2 leads to a decrease in the total growth as chemical 
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sublimenting of bacterial broths with catalase has prolonged the pneumococcal 
stationary phase (Regev-Yochay et al., 2007). This was recently supported as 
serotype 2 pneumococci produced greater levels of H2O2 resulting in a reduction 
in the bacterial growth rate (Carvalho et al., 2013). Furthermore, in other 
bacteria that have defence mechanisms against oxidative stress such as E. coli, 
catalase along with alkyl hydroperoxidse have been reported to play a 
complementary role in improving the bacterial growth rates, and protected 
them from both exogenous and endogenous sources of H2O2 (Carvalho et al., 
2013). Another possible explanation about these changes in pneumococcal 
growth patterns could be attributed to their variant genetic content, which may 
result in bacterial consumption of different carbohydrates and consequently 
generate different levels of H2O2, enabling pneumococci with greater or poorer 
tolerance. 
The figure also demonstrated lag phase differences between pneumococci. For 
example, the invasive strains 99-4039 and 99-4038 had prolonged lag phases in 
comparison with a similar serotype OXC141 strain, which is mostly isolated as a 
coloniser strain. This relationship linking the long lag phase to invasiveness and 
short phase to colonisation has been reported (Baettig et al., 2006). Moreover, 
long lag phase has been associated with pneumococcal antibiotic resistance 
(Mazzola et al., 2003). In line with our results, Mazzola et al have also reported 
that lag phases in pneumococcal clinical isolates generally lasted 2 hr once cells 
are re-grown in the same media in which their stock inocula have been 
prepared, and the ranges of their generation times were from 24 to 36 min. 
Similarly in an earlier study, doubling time was found in serotype 3 pneumococci 
grown in vitro to be 21 min in broth cultures (Tauber et al., 1984a).      
Hydrogen peroxide is produced by pneumococci during growth in oxygenated 
conditions (Spellerberg et al., 1996; Taniai et al., 2008), and lead to their death 
at the stationary phase as its elimination allows the pneumococcus to carry out a 
longer stationary phase (Regev-Yochay et al., 2007). H2O2 production by S. 
pneumoniae was documented in several pneumococci. Among these is serotype 
9V and 2 which produced 2.7 mM and 2.3 mM respectively (Pericone et al., 
2002); type 19 (GTC13809 strains) generated approximately 5 mM H2O2 during 
growth in the mid-exponential phase (Taniai et al., 2008).  
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One of the considerable procedures to scavenge H2O2 is to grow the 
pneumococcus in blood due to the presence of catalase, which is clearly shown 
in growth curves of isolates representing serotypes 4 and 3, TIGR4 and 99-4038, 
respectively, as they apparently had greater biomass when BHI cultures were 
supplemented with blood (Figure  3-11). Consistently, Bae and collaborators 
compared S. pneumoniae gene expression after growing D39 strains with and 
without blood. They observed global changes in the bacterial protein profile as 
blood affected up to 414 proteins (Bae et al., 2006). They have stated that this 
high level of protein variation mainly occurred in the bacterial cellular 
metabolism such as synthesis of proteins, DNA/RNA metabolism, as well as 
carbohydrate metabolism. We microscopically examined the pneumococcal 
morphology during growth with and without blood, and interestingly determined 
long chains, in 10-20 cell chain formation (Figure  3-11); whereas diplococcal 
phenotype showed in both aerobic and anaerobic cultures without blood. Early 
researchers have frequently noticed chain variations in pneumococci (Austrian 
1953; Dawson 1934), and GAS chain formation was also found in samples 
gathered clinically from patients (Ekstedt et al., 1960a; Ekstedt et al., 1960b). 
Recently, it was reported that long chains facilitated pneumococcal adhesion 
and colonisation, while short chains were linked to promoting PID (Rodriguez et 
al., 2012). Consistently, our examination revealed short-chain forms or 
diplococci under aerobic and anaerobic growth conditions, respectively, but long 
chains were only noticed during pneumococcal growth in blood.  
Pneumococcal growth reduces pH which is counted as one of the possibilities 
responsible for entering the growth into the death phase, which can result from 
accumulation of lactic acid from sugar fermentation (Moura Leal et al., 2011). 
Pneumococcal broth cultures have been shown to decrease the pH causing rapid 
death when pH reaches below 6.0 (Liberman et al., 2008). This growth cessation 
is also confirmed with our pH assays that was performed with TIGR4 under three 
different levels of oxygen. A dramatic drop in growth was obvious once the pH 
reached 6.0, except in the oxygenated growth cultures where the bacterial 
population did not grow sufficiently (Figure  3-14). Similarly, S. aglactiae was 
recently found to grow greater at pH 7.0 compared to the growth yield at pH 5.0 
(Yang et al., 2012). Moreover, it has been recently stated that a constant pH at 
6.5 had a positive effect on pneumococcal growth rate (Carvalho et al., 2013). 
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Carvalho et al detected a 2-fold increase in total biomass of R6 (type 2) 
pneumococci when pH was under control, but surprisingly D39 showed 64% less 
growth rate compared to R6 under the same incubation conditions. This growth 
pH-independence could be attributed to differences in the central metabolism 
(Carvalho et al., 2013). 
Additionally, pH has been linked in a recent investigation to bacterial virulence. 
The productivity of the pneumococcal key factor CPS was highly increased when 
compared to bacterial cultivation without pH adjustment (Moura Leal et al., 
2011).        
Microscopic examination of TIGR4 growing under aerobic and anaerobic 
environments markedly illustrated bacterial agglutination associated with 
oxygen availability. In contrast, hypoxic growth environments reflected separate 
diplococcal cells. This may indicate more pneumococcal ability to form biofilms 
in oxygen versus its absence. Recently, Bortoni et al discovered that Rgg 
regulator is implicated in both oxidative stress and biofilms. They documented 
that the loss of its function resulted in pneumococcal sensitivity to oxygen and 
paraquat, and the ability to form biofilm was largely reduced (Bortoni et al., 
2009).  
According to Ahn and colleagues, oxygen was negatively involved in regulating 
biofilms in S. mutans (Ahn et al., 2007). In contrast, we detected greater 
pneumococcal tendency for forming biofilms in oxygen (initial biofilm formation 
showed as pneumococcal clumps when oxygen is available). If this divergence 
scenario is true with pneumococci, they may then utilise available oxygen in the 
nasopharynx to develop biofilms for greater colonisation, which is well known as 
a major step for IPDs, communication, resisting adverse conditions and elevating 
growth rate. Another possible hypothesis could be that pneumococci living 
commensally in the URT exploit oxygen availability to establish biofilms in which 
the environment is considered to be less oxygenated.    
To assess how the pneumococcus TIGR4 genetically reacts to oxygen availability, 
it was firstly decided to study the effect of oxygen on the whole genome to 
compare gene expression profiles in the presence and absence of oxygen. This 
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was through scanning the entire pneumococcal genome by microarrays. This will 
be discussed in the following chapter (Chapter 4).  
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Chapter 4 – Effect of Aerobiosis on 
Pneumococcal Gene Expression
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4 Effect of Aerobiosis on Pneumococcal Gene 
Expression 
Most microorganisms including the genera Staphylococci and Enterobacteriaceae 
are able to defend themselves from oxidative stress; however, S. pneumoniae 
lacks some of the required agents such as catalase, PerR and SoxR to eliminate 
and regulate ROS generated from pneumococcal aerobic metabolism. Hence, it 
is still to be completely understood how pneumococci survive and what could be 
their favoured manipulation strategy during growth in an oxidative environment; 
colonising human upper airway tracts is a good example. 
It is well known that organisms alter their gene expression in response to their 
surrounding environment, and a comparison of genes expressed under different 
incubation conditions is highly useful in order to study how genes are regulated 
in different environments. Consequently, the entire bacterial genome was 
studied in this chapter to investigate which genes are induced in the presence of 
oxygen when compared to gene expression during anaerobic environmental 
growth conditions. Consequently, RNA was collected in the bacterial logarithmic 
growth phase in both oxygenated and anaerobic growth conditions (Section 
2.1.2). Aerated liquid culture was used to mimic the human nasopharynx niche. 
Therefore, the in vitro gene expression might translate the in vivo 
pneumococcal expression when colonising the URT; whereas pneumococcal gene 
expression in host blood after transmission could be reflected during their 
growth in oxygen-restricted growth conditions. Moreover, transcription, 
biological activity, and protein production of the key pneumococcal toxin Ply 
was evaluated in this chapter using three pneumococcal serotypes, 1, 3 and 4. 
4.1 TIGR4 Growth conditions 
Three different growth conditions were used primarily for growing S. 
pneumoniae: aerobically, anaerobically and in an oxygenated environment. In 
the aerobic condition, the liquid cultures used were pre-warmed overnight 
statically in a water bath (as explained in materials and methods, Section 2.2.1). 
Similarly, other cultures of the same batch of media were incubated 
anaerobically, whereas the oxygenated broth cultures were shaken overnight to 
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expose S. pneumoniae to oxygen in the BHI medium.  All these cultures were 
pre-warmed for 24 hr before starting the experiment, which was considered 
more than enough time to ensure three targeted points; 1) The medium integrity 
from any possible source of contamination occurring during preparation. 2) Pre-
warming the broth to the pathogen optimal temperature, and 3) Removing the 
existing oxygen for the anaerobic growth environments. TIGR4 growth patterns 
under these three different levels of oxygen are shown (Figure  4-1). 
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Figure  4-1 TIGR4 growth curves in aerobic, anaerobic and oxygenated environments 
 
Growth curves in three different levels of oxygen are represented by optical density. Under 
all different growth conditions, the log phase started after three hours. The aerobic and 
anaerobic environments indicate sharper log phase relative to aerated grown pneumococci 
which grew significantly weaker (p=0.0454). Averages of at least three independent 
experiments are presented in each curve. Error bars represent the standard error of the 
mean. Statistical analysis was performed using a non-parametric Mann-Whitney test in Graph 
Pad (GraphPad Prism 5, USA 2007). 
Growing TIGR4 in the different oxygen concentrations (Figure  4-1) illustrated no 
significant growth variations between aerobic and anaerobic cultures. In 
contrast, the oxygenated cells showed a statistically significant reduction 
(p=0.0454) in the growth rates compared to anaerobic growth. This might reffer 
to the significant high level of H2O2 production during pneumococcal growth in 
oxygenated states, shown in Chapter 3. It is well known that shaking bacterial 
growth cultures provides more oxygen concentrations to the medium than 
incubation in aerobic growth (Baldoni et al., 2010).  
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These three cultures were grown in order to extract RNA at a specific optical 
density under all conditions.  
4.2 RNA extraction 
RNA was extracted from the three conditions used (aerobic, anaerobic and 
oxygenated) and concentrations were measured by nano-drop, adjusted by 
dilution to make them all approximately 300 ng/µl; testing the purity of RNA 
extracts was confirmed using Bioanalyser 2100 (Agilent Technologies, United 
Kingdom) (Figure 4-2). The figure below illustrates that total RNA extracted 
under the three different levels of oxygen were sufficient and pure enough for 
microarray experiments. 
  
 
 
 
Figure  4-2 Purity of RNA extraction 
    
RNA extraction from aerobic (AE), anaerobic (AN) and oxygenated (OX) cultures have been analysed to nano-drop. FU stands for fluorescent unit, and nt 
indicates nucleotides. All samples were tested for purity and found sufficient to perform microarrays. 16S and 23S peaks are rRNA, whereas the flat line 
represents mRNA integrity (Agilent Technologies, United Kingdom).     
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In light of the fact that the gene for pneumolysin is highly conserved in S. 
pneumoniae, and in order to ensure no DNA was present after extraction of RNA, 
PCR was carried out to amplify the ply gene (Figure  4-3). Lack of a product 
indicates no DNA was present in any RNA samples.  
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Figure  4-3 PCR of ply for confirming absence of DNA 
 
Gel shows a complete absence of DNA in all RNA samples prepared. Positive control is TIGR4 
genomic DNA. Negative is the PCR water used in all other PCR samples. ae lanes indicate 
aerobic, an shows anaerobic and (L) is the DNA size marker in the 1 Kb plus DNA ladder (Life 
Technologies, United Kingdom). 
PCR for all extracts shows - except the positive control – that no ply 
amplification of gene representing pure RNA extracts for microarray 
experiments. 
4.3 Microarray 
After extracting RNA from TIGR4 strain, microarray experiments were performed 
using florescence dyes as explained in materials and methods (Section 2.5.6) in 
order to label cDNA samples from all conditions, oxygenated, aerobic and 
anaerobic. Microarray aminosaline slides were prepared by the bacterial 
microarray group at St. Georges hospital (University of London BµG@S) carrying 
PCR product for all TIGR4 genes. Hybridisation was then performed on the slides 
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between probes and microarrays. The slides then were scanned to be visually 
observed. Moreover, data were normalised due to morphology of the spots. This 
was achieved using the statistical packages Bluefuse for Microarray 3.5 and 
Genespring GX 7.3.1.  
After normalisation, 420 genes out of 2,336 were found to be differentially 
expressed under oxygenated conditions compared to anaerobic growth, and 262 
genes were shown to be up-regulated during oxygenated pneumococcal growth. 
Gene expression for aerobic versus anaerobic resulted in 205 differentially 
expressed genes, whereas oxygenated against aerobic expression profiles 
showed 67 genes expressed differentially. These are only the significant gene 
expressions (p=<0.05). 
4.4 Microarray data analysis 
Pneumococcal growth curves showed when comparing oxygenated to anaerobic 
growth conditions, hence anaerobic and oxygenated conditions were chosen for 
performing most experiments in the rest of the study. Moreover, gene 
expression for these two conditions was focused on herein, whereas the other 
expression profiles (aerobic versus anaerobic and oxygenated versus aerobic) 
were analysed in more detail in several tables in the appendices.  
As explained in materials and methods (Section 2.5.6) the triplicate scanned 
slides were analysed using the programme Bluefuse for Microarray 3.5 and 
Genespring GX 7.3.1 giving master list spreadsheets containing expressions of 
the 2,336 genes under both conditions used (oxygenated and anaerobic). Fold 
changes were then calculated in these two conditions for each gene and their 
biological functions were found using CLC Genomics Workbench programme, 
Comprehensive Microbial Resource (CMR) http://cmr.jcvi.org/tigr-
scripts/CMR/CmrHomePage.cgi and Nucleotide BLAST at the National Centre for 
Biotechnology Information (NCBI). Furthermore, all these genomic analyses were 
similarly investigated for those genes that expressed differentially during 
pneumococcal growth in other tested conditions; aerobic/anaerobic and 
oxygenated/aerobic, as outlined in the appendices. It is worth to mention here 
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that gene expression less than 2-fold has been reported to be biologically 
significant (Chaussee et al., 2002).   
4.5 Microarray results 
A selection of genes that were up-regulated in the presence of oxygenated 
compared to expression in the absence of oxygen is shown in Table 4-1. Only 
genes with significant (p=<0.05) changes in expression are listed. 
Examples of several key groups were classified in the table and then each 
section was sorted into ascending order according to gene numbers. The groups 
include virulence factors, competence, stress and DNA repair, energy 
metabolism, transporters and amino acid biosynthesis, transcription, translation 
and hypothetical genes. Hypothetical genes selected in this table are above 
three-fold over-expression in oxygenated growth environment. A complete gene 
list is presented in the appendices.  
Table  4-1 List of TIGR4 genes significantly expressed in oxygenated versus anaerobic 
 
The table shows gene expression of several functionally classified groups and sorted in 
ascending order according to the gene numbers; gene expression above 1.5-fold cut-off is 
listed in the table including virulence factors, competence, stress and DNA repair, energy 
metabolism, transporters and amino acid biosynthesis, transcription, translation, 
hypothetical proteins above three-fold over-expression. Genes have been identified by 
Genespring GX 7.3.1. and their expressions were detected by microarray as either 
significantly (p=value<0.05) up-regulated (red numbers) or down-regulated (blue numbers) 
in oxygenic grown cells compared to expression in anaerobic growth conditions. P<0.05 with 
Benjamini and Hochberg correction applied for multiple testing using 1 way ANOVA test. 
Gene p-value Fold change in O2 Annotation 
Virulence factors 
SpTIGR4-0532 0.0425 2.88+ Bacteriocin, blpJ 
SpTIGR4-0545 0.0203 1.93+ immunity protein, blpY 
SpTIGR4-0730 0.00752 3.36+ pyruvate oxidase,spxB 
SpTIGR4-1225 0.0179 1.97+ vicX protein 
SpTIGR4-2190 0.022 1.50+ Choline binding protein A (cbpA/pspC) 
SpTIGR4-2239 0.00704 2.50+ serine protease, htrA 
Competence, stress and DNA repair 
SpTIGR4-0165 0.0402 1.88+ Flavoprotein 
SpTIGR4-0338 0.00411 26+ ATP-dependent Clp protease ATP-binding 
subunit 
SpTIGR4-0515 0.0477 1.65+ heat-inducibal transcription repressor, hrcA 
SpTIGR4-0766 0.0193 4.17+ superoxide dismutase, sodA 
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SpTIGR4-0784 0.00411 3.27+ glutathione reductase 
SpTIGR4-1000 0.00845 2.37+ thioredoxin family protein 
SpTIGR4-1471 0.03 3.63- oxidoreductase 
SpTIGR4-1472 0.01 4.14- oxidoreductase 
SpTIGR4-1651 0.00704 6.96+ thiol peroxidase, tpx 
SpTIGR4-1776 0.0365 2.17+ Thioredoxin 
SpTIGR4-2203 0.0365 1.63+ replicative DNA helicase 
Energy metabolism 
SpTIGR4-0324 0.0237 4+ PTS system, IIC component 
SpTIGR4-0325 0.021 4.81+ PTS system, IID component 
SpTIGR4-0715 0.0245 1.71+ lactate oxidase 
SpTIGR4-0875 0.026 1.77- Lactose phosphotransferase system repressor 
SpTIGR4-1161 0.0434 2.66+ acetoin dehydrogenase complex, E3 component 
SpTIGR4-1163 0.00525 2.29+ acetoin dehydrogenase, E1 component, beta 
subunit 
SpTIGR4-1164 0.00418 2.23+ acetoin dehyrogenase, E1 component alpha 
subunit 
SpTIGR4-1361 0.0425 1.53+ homoserine dehydrogenase 
SpTIGR4-1415 0.033 2.41+ glucosamine-6-phosphate isomerase 
SpTIGR4-1587 0.0192 24+ antiporter 
SpTIGR4-1852 0.00581 2.47+ galactose-1-phosphate uridylytransferase 
SpTIGR4-1884 0.0265 2.25+ trehalose PTS system, IIABC components 
SpTIGR4-1894 0.0139 2.28+ sucrose phosphorylase 
SpTIGR4-2106 0.00562 3.42+ glycogen phosphrylase family protein 
SpTIGR4-2107 0.0154 3.50+ 4-alpha-glucanotransferase 
SpTIGR4-0199 0.03 1.82+ cardiolipin synthetase 
Transporters and amino acid biosynthesis 
SpTIGR4-0044 0.0486 15.43+ phosphoribosylaminomidazole-
succinocarboxamide synthase 
SpTIGR4-0529 0.0327 1.66+ BlpC ABC transporter 
SpTIGR4-0530 0.0224 2.14+ BlpC ABC transporter ATP-binding protein, blpA 
SpTIGR4-0709 0.0371 1.51+ amino acid ABC transporter ATP-binding proten 
SpTIGR4-0710 0.0431 2.73+ amino acid ABC transporter permease 
SpTIGR4-0711 0.0254 2.89+ amino acid ABC transporter permease 
SpTIGR4-0867 0.00581 3.87+ ABC transporter ATP-binding protein 
SpTIGR4-0869 0.012 7.16+ aminotransferase, class-V 
SpTIGR4-1357 0.00562 1.72+ ABC transpoter ATP-binding protein/permease 
SpTIGR4-1358 0.0344 1.63+ ABC transpoter ATP-binding protein/permease 
SpTIGR4-1438 0.0431 2.24+ ABC transpoter ATP-binding protein 
SpTIGR4-1499 0.00451 2.52+ bacteriocin transport accessory protein 
SpTIGR4-1690 0.0343 2.20+ ABC-transporter supstrate-binding protein 
SpTIGR4-1717 0.0095 1.71+ ABC transpoter ATP-binding protein 
SpTIGR4-1860 0.0368 2.6+ choline transporter 
SpTIGR4-1861 0.0245 2.82+ choline transporter 
SpTIGR4-1869 0.00664 2.60+ iron-compound ABC transporter permease 
SpTIGR4-1871 0.0254 2.43+ iron-compound ABC transporter ATP-binding protein 
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SpTIGR4-1872 0.0429 2.29+ iron-compound ABC transporter iron-compound-binding protein 
SpTIGR4-1895 0.0094 2.21+ sugar ABC tranporter permease 
SpTIGR4-1896 0.0201 2.54+ sugar ABC tranporter permease 
SpTIGR4-1897 0.0047 2.43+ sugar ABC transporter substrate-binding protein 
SpTIGR4-1898 0.00722 2.51+ alpha-glactosidase 
SpTIGR4-2073 0.0293 1.58+ ABC transpoter ATP-binding protein/permease 
SpTIGR4-2075 0.00562 1.76+ ABC transpoter ATP-binding protein/permease 
SpTIGR4-2084 0.014 1.88+ phosphate ABC transporter phosphate-binding protein 
SpTIGR4-2085 0.0398 2.08+ phosphate ABC transporter permease 
SpTIGR4-2086 0.0236 2.09+ phosphate ABC transporter permease 
SpTIGR4-2088 0.0357 2.10+ phosphate transporter system regulator protein, phoU 
Transcription 
SpTIGR4-0046 0.0414 13.82+ amidophosphorobosyltransferase 
SpTIGR4-0330 0.00704 1.74+ suger binding transcriptional regulator, regR 
SpTIGR4-0716 0.0444 2.10+ Transcriptional regulator 
SpTIGR4-0798 0.0302 1.56+ DNA-binding response regulator, ciaR 
SpTIGR4-0799 0.0151 1.60+ sensor hitidine kinase, ciaH 
SpTIGR4-1226 0.00581 2.12+ sensory box sensor histidine kinase 
SpTIGR4-1227 0.0047 2.21+ DNA-binding response regulator 
SpTIGR4-1809 0.0223 1.87+ transcriptional regulator 
SpTIGR4-2192 0.0119 1.65+ sensor hesitidine kinase 
SpTIGR4-2193 0.0119 1.51+ DNA-binding response regulator 
Hypothetical proteins above three-fold over-expression 
SpTIGR4-0095 0.00688 36+ hypothetical protein 
SpTIGR4-0868 0.0156 5.92+ hypothetical protein 
SpTIGR4-1546 0.0119 4.41+ hypothetical protein 
SpTIGR4-2054 0.0281 3.90+ hypothetical protein 
SpTIGR4-2017 0.00411 4.34+ hypothetical protein 
SpTIGR4-2187 0.0363 10.33+ hypothetical protein 
 
As can be seen in Table 4-1, a number of key genes were up-regulated 
significantly in oxygenated conditions compared to anaerobic growth with a p-
value less than 0.05. Over-expressed genes included several TCSs that are linked 
to pneumococcal pathogenicity such as TCS02 and TCS05. Other virulence-
related genes were also up-regulated in oxygenated relative to anaerobic growth 
such as blpR, blpJ, blpY, blpU, vicX, htrA and spxB. HtrA and SpxB are involved 
in oxidative stress response. Expressions of several other S. pneumoniae stress 
related genes such as thiol peroxidase, thioredoxin family protein, thioredoxin 
reductase, glutathione reductase, flavoprotein and superoxide dismutase have 
been shown to be induced by oxygenated environment, suggesting that the 
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incubation condition used in this study were properly established. Thiol 
peroxidise was significantly elevated, 7-fold higher when oxygenated, compared 
to anaerobic growth (master lists for all gene expression are shown in the 
Appendices, Table A-1, A-2, A-3 and A-4).  
In S. mutans, TCS02 (Vic) loss of function was reported to alter a number of vital 
streptococcal stages such as growth, adhesion, biofilm formation and 
development of competence (Senadheera et al., 2005). Additionally, a number 
of bacteriocins were similarly induced, which may indicate greater 
pneumococcal ability to compete with other microflora by inhibiting their 
growth. Pneumococci generating this toxicity have been shown to be protected 
from the toxin effect (Dawid et al., 2007).   
Energy metabolism and related transporters were significantly increased in 
oxygenated conditions compared to anaerobic grown pneumococci. Among these 
are several PTSs such as IIC, IIA and IID, amino acid ABC transporter permeases, 
ABC transporter ATP-binding proteins including iron and sugar transporters. 
Similarly, a vast number of amino acid ABC transporters were elevated during 
TIGR4 oxygenated growth. Notably, the gene SP1587 (transporter) was over-
expressed 24-fold when oxygenated growth, and the anaerobic array largely 
showed a significant down-regulation for the same gene (Appendices, Table A- 
3). It encodes a major pneumococcal antiporter which acts as a transporter 
facilitator for energy metabolism (Orihuela et al., 2004b), reflecting high levels 
in the bacterial physiology during growth in oxygen. PTS expression was similarly 
reported to be induced in oxygenated growth conditions by Bortoni and co-
researchers (Bortoni et al., 2009). Bortoni et al (2009) also detected an 
interesting gene with an induction in oxygen compared to anaerobic growth 
condition known as a regulator called rgg (SP2123). Our data did not show this 
gene, possibly because of different pneumococcal broth cultures with oxygen. 
Data analysis of our array results revealed that flanking genes were up-regulated 
in oxygenated growth conditions versus anaerobic (Table A-4, in the 
Appendices).  
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Findings of stress response from this study were generally in agreement with 
Bortoni et al., (2009). Examples of genes induced when pneumococci were 
grown in oxygenated experiment are seen in several hypothetical genes such as 
SP0095, SP2017, SP0731, SP0992, and SP1802, a number of ABC transporter ATP-
binding proteins, Bgl (Table A-4, in the Appendices), PTS, superoxide dismutase 
and thiol peroxidise.  
Interestingly, several hypothetical genes were significantly over-expressed in 
oxygenated relative to bacteria grown anaerobically. For example, SP2187, 
SP2054 and SP0095 were induced 10.33, 3.90 and 36-fold, respectively, 
indicating their roles in response to oxygen. As determined after accessing and 
performing genome comparison on web sites such as BLAST at NCBI 
http://www.blast.ncbi.nlm.nih.gov/Blast.cgi, SP0095 is a transferase, 
contributing to detoxification in S. pneumoniae AP200, 19A and 19F. SP2054 is 
an antioxidant in 19A. Likewise, analysing the array data for TIGR4 cells grown 
anaerobically also confirm the same tendency of the expression of three genes 
as they were significantly under-expressed in the anaerobic growth conditions 
(Table A-1 and Table A - 3, Appendices).   
Comparing data from this study with Bortoni et al (2009) for those genes that 
were under-expressed in oxygenated conditions was also relatively comparable. 
Among these is pfl SP0459 which codes for Pyruvate Formate Lyase (PFL) (Table 
A – 2, Appendices) and oxidoreductase enzymes such as SP1472 (Table A – 3, 
Appendices). These oxidureductases were also up-regulated in anaerobic 
environments which confirmed their detected expression in the oxygenated 
versus anoxygenated growth conditions (Appendices). 
Transcriptional genes reflect an increase in oxygenic conditions such as 
amidophosphoribosyltransferase, transcriptional regulators and 
phosphoribosylaminomidazole-succinocarboxamide synthase.  
ATP-dependent Clp protease was significantly over-expressed (26-fold) in 
oxygenated versus anoxic incubation conditions. Additionally, proteases (HtrA is 
a good example) are generally known as vital factors for degrading damaged 
145 
proteins resulting from cells grown in stress conditions (Clarke 1999). Clp family 
members have been reported to be involved in the pneumococcal response to 
temperature (heat shock proteins),  adhesion in vitro, play a role in genetic 
transformation, and most importantly clpC-deficient mutant was not able to 
express pneumolysin or a number of CBPs including PspC (Charpentier et al., 
2000). Charpentier et al also showed that the mutants were defective in the 
nasopharyngeal colonisation and survival in the LRT in vivo post-inoculation 
intranasally. ClpP was recently shown to respond particularly to oxidative stress 
(Park et al., 2010).  
The cell surface protein (choline-binding protein) PspC, two choline transporters 
(SP1860 and SP1861), and cardiolipin synthetase involved in fatty acid 
metabolism (found in CLC programme and was reported by Orihuela et al., 
(2004) that were elevated by oxygenated conditions rather than in their 
anaerobic expression. 
mRNA levels for a number of genes (listed below in Table 4-2) were then 
measured using qRT-PCR in order to confirm the expression under the 
oxygenated and anaerobic incubation environments.  
4.6 qRT-PCR for a selection of genes 
Among the data obtained from the array experiments and because of some of 
the known key virulence factors, a selection of genes were chosen in order to 
confirm their gene expression. The selection was only from those which had 
significant differential expression (p<0.05). Moreover, based on the array data 
listed in Table 4-1, it was decided that due to the fact that main regulatory 
pathways in pneumococci are believed to be TCSs, it would be interesting to 
study their gene expression with a more sensitive technique, qRT-PCR. The 
selection of the genes confirmed by qRT-PCR is listed below in Table 4-2. 
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Table  4-2 List of genes for qRT-PCR 
 
Genes selected for qRT-PCR to confirm their expression. These include several TCSs, a 
housekeeping gene, ply, pspC, PI-1 proteins and tpx. All will be shown in more detail next in 
Chapter 5. P<0.05 with Benjamini and Hochberg correction applied for multiple testing using 
1 way ANOVA test. 
 
mRNA levels for the qRT-PCR selection shown in the above table (21 genes) will 
be discussed in the next chapter (Chapter 5). They are listed here to highlight 
the selected genes from the array data analysis and other interesting virulence 
related genes. 
TIGR4 Gene Product Biological function References 
1 SP_1227 TCS02 
Key for life, involves in virulence 
and competence 
(Lange et al., 1999) 
2 SP_0387 TCS03 Involves in stress response 
(Haas et al., 2005; Song et 
al., 2009)  
3 SP_2082 TCS04 
Contributes to virulence & involves 
in oxidative stress 
(McCluskey et al., 2004b) 
4 SP_0798 TCS05 
Linked to HtrA, colonisation, 
antibiotic and stress response 
(Paterson et al., 2006; 
Sebert et al., 2002) 
5 SP_2193 TCS06 
Involved in virulence, regulates 
PspC 
(Ma et al., 2007; Standish et 
al., 2005) 
6 SP_0083 TCS08 For survival in vivo  (Throup et al ., 2000) 
7 SP_2000 TCS11 Stress response (Haas et al., 2005) 
8 SP_2235 TCS12 Competence (ComE) (Iannelli et al., 2005) 
9 SP_0526 TCS13 Bacteriocin-like peptide (blpR) (de Saizieu et al., 2000) 
10 SP_0376 rr orf Iron repressor (ritR) (de Saizieu et al., 2000) 
11 SP_1219 GyrA Housekeeping gene (Johnson et al., 2005) 
12 SP_1923 Ply Multi-functional toxin 
(Berry et al., 1989; Steinfort 
et al., 1989) 
13 SP_2190 PspC Adhesion to host cells (Ogunniyi et al., 2007) 
14 SP_0461 RlrA Pilus islet (Basset et al., 2011) 
15 SP_0462 RrgA Pilus adhesion (Kreikemeyer et al., 2011) 
16 SP_0463 RrgB Pilus backbone (Kreikemeyer et al., 2011) 
17 SP_0464 RrgC Pilus structuring (Kreikemeyer et al., 2011) 
18 SP_0466 SrtB Pilus assembling (Kreikemeyer et al., 2011) 
19 SP_0467 SrtC Pilus assembling (Kreikemeyer et al., 2011) 
20 SP_0468 SrtD Pilus assembling (Kreikemeyer et al., 2011) 
21 SP_1651 Tpx Anti-oxidant (Hajaj et al., 2012) 
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4.6.1 Pneumolysin 
Here, the expression of ply, its production and lytic activity are considered 
examples of the key virulence gene in pneumococci. To choose the best cDNA 
concentration for the qRT-PCR reactions, ply was tested after preparing three 
serial dilutions; neat, 1:10 and 1:50. Their associated controls, which had no 
reverse transcriptase, were similarly diluted. 
  
Neat 
gDNA 
1:10 
1:50 
 
Figure  4-4 qRT-PCR for different concentrations of cDNA 
 
Several dilutions performed after cDNA preparation for detecting the best concentration 
before using qRT-PCR. The tested dilutions of 1:50 (the blue curve) were the choice as it 
was between 15 and 25, in the middle. The green curve represents the 1:10 dilution and 
showed higher levels of mRNA, whereas the neat (its original concentration in the reaction 
was ng/µl from which 1µl was taken when the above two concentrations were prepared, 
1:10 and 1:50) had the highest concentration (the red curve). The top curve was the 
positive control used, TIGR4 gDNA. qRT-PCR data analysis was performed with MJ 
OpticonMonitor version 3.1. Each curve represents the mean of triplicate readings.  
Once the best concentration was detected after performing qRT-PCR for three 
serially diluted samples (Figure  4-4), the dilution factor 1:50 was used to 
prepare all of the other qRT-PCR samples, listed in Table 4-2, which have been 
recovered from different pneumococcal growth conditions, oxygenated and 
anaerobic.   
qRT-PCR was performed to confirm any differences in the pneumolysin mRNA 
levels when oxygenated compared to absence of oxygen. Its level was 2.081-fold 
greater when the clinical isolate TIGR4 was grown in oxygenated versus 
anaerobic conditions (Figure  4-5).  
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Figure  4-5 qRT-PCR for of ply mRNA under oxygenated and anaerobic growth 
 
Pneumolysin fold changes in oxygenated and TCS05, which is known as a stress responder, 
compared to pneumolysin mRNA levels under the same growth conditions (A), ply mRNA 
averages in aerated and anaerobic environments (B), the green curve represents the mean 
of triplicates of mRNA levels detected in oxygenated, whereas the red curve shows gene 
expression during the anaerobic growth condition. The housekeeping gene – gyrA was used 
to be reffered to, and the arrow shows curves with no changes in expression in the three 
conditions; aerobic, anaerobic and oxygenated (C). The negative control used for all was a 
sample without the addition of reverse transcriptase, whereas TIGR4 gDNA was used as the 
positive control. Data analysis was performed with MJ OpticonMonitor version 3.1. and 
Graph Pad (GraphPad Prism 5, USA 2007) for qRT-PCR analysis. 
4.6.1.1 SDS-PAGE and Western Blotting of Ply in TIGR4  
To investigate the translation of the pneumolysin gene into protein in S. 
pneumoniae TIGR4, cultures were compared using Western blot analysis 
performed on cell lysates gathered after growing the pathogen in both 
environmental conditions, oxygenated and anaerobic. The finding revealed that 
the pneumolysin intensity was clearly increased in the oxygenated sample 
compared to the anaerobic one (Figure  4-6).    
149 
  
 
 
 
 
 
 
 
      
      M   O2  AnO2       M   O2  AnO2 
A B 
51kDa 
64kDa 
97kDa 
 
Figure  4-6 Western blot of Ply from oxygenated and anaerobic grown TIGR4 
 
SDS-PAGE for oxygenated and anaerobic bacterial lysates grown until log phases (A) and 
Western immunoblot (B) of pneumolysin from a corresponding concentration of the 
bacterium supernatants. A higher intensity of Ply was detected in oxygenated grown cells 
compared to anaerobically recovered samples (B). The arrow points to Ply with its known 
molecular weight recognised by the antibodies used. M indicates the marker used 
(SeeBlue®Plus2, invitrogen, Scotland).  
Translational investigation by immunoblot (Figure  4-6) confirms the 
transcriptional stage seen in qRT-PCR data (Figure  4-5). Both stages proved an 
enhancement in the protein Ply in oxygenated conditions compared to anaerobic 
environmental growth. 
In light of previous findings, the post-transcriptional step was studied to clarify 
the protein biology. For example, detecting the haemolytic activity of the toxin 
pneumolysin after growing S. pneumoniae TIGR4 under both levels of oxygen, 
aerobic and anaerobic.  
4.6.1.2 Biological activity 
Under the aerobic conditions, there was an increase in levels of pneumolysin as 
shown with Western Blot (Figure 4-6); therefore, we hypothesised whether or 
not the lytic activity would increase similarly under the effect of oxygen versus 
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the anaerobic conditions. Figure  4-7 shows that the biological lytic activity was 
obviously increased in the aerobic growth conditions.  
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Figure  4-7 Haemolytic assay of TIGR4 Ply from aerobic and anaerobic grown cells 
 
Cells were grown under aerobic and anaerobic conditions until log phases at 37°C, lysed and 
serially diluted. Samples collected from aerobic growth at different time-points (A), 
haemolytic activity during bacterial growth in the presence of oxygen, OD represented with 
a red line shows optical dencity, wheras the blue line PA is the pneumolycin activity (B), 
haemolytic activity anaerobically at the same time-points, OD represented with a red line 
shows the bacterial optical dencity, wheras the blue line PA which stands for pneumolycin 
activity (C) and haemolytic activity during bacterial growth in the absence of oxygen (D). 
Positive control was a purified pneumolysin. Negative control is D39 Tply. OD means optical 
density and Ply stands for pneumolysin. Numbers in the Y axis in the graphs (B and D) are 
estimated to show the haemolytic activities.  
The above figure shows assays of horse red blood cells which were lysed after 4 
hr during the growth curve (log phase) once the bacterial population of S. 
pneumoniae reached approximately 1х108 CFU/ml, corresponding to the optical 
density of around 0.35 of OD600 (Figure  4-7, A and B). The anaerobic bacterial 
growth showed a complete absence of the pneumococcus TIGR4 lytic activity at 
the same time-points and bacterial population of the oxygenated grown bacteria 
(Figure  4-7, C and D).  
Interestingly, early studies have shown that Ply is oxygen-labile (Smyth et al., 
1978). Therefore, one could expect that Ply will lose its activity in the presense 
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of oxygen. However, haemolytic assays were performed directly with adding DTT 
which is known as a reducing agent leads to retain all proteins in their reduce 
state.  
In the context of these experiments, it was not clear whether the anaerobic 
collected pneumolysin is not fully active or it just was not expressed at high 
levels. To practically do this, purified Ply could be run on a gel after preparing 
several dilutions to get a similar amount to the anaerobic band as in Figure  4-6. 
Then, a similar amount can be tested with a haemolytic assay to determine if it 
is able to lyse RBCs.  
However, whatever the reasons are, Figure  4-7 shows that in terms of total 
haemolytic activity, anaerobic grown pneumococci were not capable of showing 
any haemolysis, either due to not producing a sufficient amount of the toxin or 
the toxin was not active. Another possible explanation is that the bacterium 
itself may express greater ply in the URT (where O2 concentration is close to the 
natural atmospheric level) to facilitate either host invasion through tissue 
damage or to obtain more nutrients. Then, pneumococci might accidently 
spread to the bloodstream and down-regulate ply expression as the circulation 
system contains less oxygen. This hypothesis is supported with a number of 
experiments including ply expression confirmed by qRT-PCR as seen in Figure 
 4-5, immunoblot of Ply in Figure  4-6 and the Ply haemolytic activity.    
We wondered then how Ply in other pneumococcal serotypes would appear on 
Western blot membrane if the cells have been grown in the same conditions, 
oxygenated and anaerobic. 
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4.7 Western blot of Ply in other serotypes 
 
         
       1  2  3   4  5     6   7    8    9 
53 kDa 
 
Figure  4-8 Western blot of Ply gathered from oxygenated and anaerobic growth of different 
bacterial serotypes 
 
Immunoblot membrane of pneumococcal lysates grown in oxygenated and anaerobic growth 
conditions until the exponential phases. Lane 1: marker (SeeBlue®Plus2, invitrogen, 
Scotland), 2: Ply detected from oxygenated growth of TIGR4, 3: anaerobic TIGR4, 4: 
oxygenated P1041, 5: anaerobic P1041, 6: oxygenated OXC141, 7: anaerobic OXC141, 8: 
PBS with the loading buffer used as a negative control and 9: positive control of purified 
pneumolysin. There were higher protein intensities of Ply detected in oxygenated grown 
cells compared with anaerobically collected samples in TIGR4 and OXC141, type four and 
three, respectively. In contrast, the serotype one isolate P1041 had similar protein 
produced under both oxygenated and anaerobic growth conditions. The 53kDa illustrated Ply 
known molecular weight has been successfully recognised with the antibodies used. 
The immunoblot for the toxin pneumolysin has shown that the protein may be 
differently produced in different types of pneumococcal isolates collected after 
growing under the presence or absence of oxygen. The strains TIGR4 (type 4) 
and OXC141 (type 3) demonstrated greater toxin intensity after recovering 
samples from the oxygenated grown cells in comparison to anaerobically grown 
bacteria (Figure  4-8), whereas the type 1 organisms P1041 showed greater 
homology of Ply intensity gathered form both cells grown under oxygenated and 
anaerobic growth environments. One of the possible reasons for these variations 
when reacting to oxygen is a difference in the gene sequence. To evaluate this, 
an alignment of the ply genes from the different serotypes presented in Figure 
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 4-8 was performed using the CLC Genomics Workbench programme. However, it 
was found that the majority pneumococci had very similar ply coding sequences 
with similar predicted molecular weights.   
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4.8 Discussion 
TIGR4 growth rates had a significant reduction during exposure to oxygenated 
compared to anoxygenated environmental conditions (Figure  4-1). As explained 
in the previous chapter, insufficient biomass in high oxygen levels was reported 
to be due to pneumococcal production of H2O2 which has been shown to be 
associated with their growth in oxygen availability (Spellerberg et al., 1996). In 
addition, genetic absence of catalase in pneumococci largely contributes to 
pneumococcal failure to scavenge H2O2 (Pericone et al 2002), as removing H2O2 
from the bacterial growth cultures escalated the total growth rate in S. 
pneumoniae (Regev-Yochay et al., 2007; Taniai et al., 2008).    
Microarray analysis of S. pneumoniae TIGR4 gene expression during growth in 
oxygenated and anaerobic incubation conditions has shown a massive number of 
phenotypic differences. In total, there were 420 genes of 2,336 (almost 18% of 
the whole TIGR4 genome) differentially expressed in aerated versus anoxic 
growth environments. In the oxygenated growth forms, 262 genes were up-
regulated (11%) indicating the magnitude of roles of oxygen on the 
pneumococcal gene profile, whereas 158 genes were down-regulated 
(representing 7% of TIGR4 genes) during anaerobic growth conditions. Effect of 
oxygen was also shown to alter the S. mutans genome. Its gene profile was 
differentially expressed by roughly 5% when bacteria were grown in aerated 
growth conditions (Ahn et al., 2007). Moreover, a recent study described that 
oxygen availability in the mucosal surface could modulate virulence in Shigella, 
and the investigators showed that oxygen molecules were responsible for 
activating the bacterial virulence (Marteyn et al., 2010). Furthermore, an early 
investigation of possible oxygen influences on S. aureus pathogenicity 
determined that staphylococcal growth in aeration conditions was associated 
with an increase in the bacterial ability to develop abscess (Schmidt et al., 
1967). Additionally, virulence of GBS was modulated with oxygen molecules as 
the streptococcal invasion in animal models was optimal when bacteria were 
grown in oxygen, but they showed a significant reduction in virulence without 
growth in oxygen (Johri et al., 2003). They also concluded that bacterial 
exposure to oxygen could be a strong signal to induce GBS invasiveness.       
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Some key virulence factors and related genes including ply, pspC, blp, spxB and 
htrA were up-regulated in oxygenic conditions relative to hypoxic. In vivo 
studies have documented variation in pneumococcal gene expression from 
diverse host ecological niches in which oxygen levels are known to be different. 
Therefore, comparison between in vivo gene expressions using S. pneumoniae is 
outlined in Table 4-3. Similar to our data, expression in nasopharynx or during in 
vitro adhesion assays is generally considered to be associated with oxygenated 
environments, while in vivo sites such as blood circulation system and CSF are 
supposed to have limited levels of oxygen.   
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Table  4-3 Comparison between pneunococcal expression in different environments 
 
References of studies undertook in vivo gene expression are Ogunniyi et al., (2002); Orihuela et al., (2004) and (Oggioni et al., 2006) (their   
reference was in vitro gene expression), LeMessurier et al.,(2008), Mahdi et al.,(2006), and pneumococcal gene expression in 
aerobiosis/anaerobiosis conditions (Bortoni et al., 2009). cps: capsular polysaccharide, com: competence, pspC: pococcal surface protein C, htrA: 
heat temperature requirement A, tpx: thiolperoxide, spxB: streptococcus pyruvate oxide B, sodA: soper oxide dismutase, NS* indicates not shown, 
G.R** is Glutathione reductase, ECC stands for epithelial cell contact, NP means nasopharynx, CSF is cerebro-spinal fluid, AnO2: anaerobic and O2 
indicates oxygenated conditions. *** P<0.05 with Benjamini and Hochberg correction applied for multiple testing using 1 way ANOVA test. 
Genes and studies  
Gene Reference 
Expression in  nasopharynx (NP) or  
epithelial cell contact  (ECC) 
Expression in blood or CSF 
Expression from our findings 
 (p <0.05) *** 
 
ply     Ogunniyi 
 
          Orihuela 
 
          LeMessurier 
 
          Mahdi 
 
          Oggioni 
 
NS* 
 
-9.8 in ECC 
 
Greater in NP vs blood 
 
Greater vs blood 
 
+0.2 in lung 
+3 in blood 
 
-5.6 in CSF 
 
Less in blood vs NP 
 
Less in blood vs NP 
 
+1.3 in blood 
+1.22 in O2 
 
pspC   Ogunniyi 
 
           Orihuela 
 
           LeMessurier 
 
           Mahdi 
 
          Oggioni 
 
NS 
 
+2.3 in ECC 
 
Greater in NP vs in blood 
 
Up-regulated vs blood 
 
+1.2 in lung 
In blood as in vitro 
 
NS 
 
Less in blood vs NP 
 
Down-regulated 
 
+1.8 in blood 
+1.50 in O2 
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cps  
 
cps2A Ogunniyi 
 
cps4A Oggioni 
 
cps4A Orihuela 
 
cps4C Orihuela 
 
cpsA   LeMessurier 
 
cpsA   Mahdi 
 
 
 
NS 
 
+1.6 in lung 
 
+2.2 in ECC 
 
NS 
 
NS 
 
Greater in NP vs blood 
 
 
 
+4 in blood 
 
+1.2 in blood 
 
NS 
 
3.9 in CSF 
 
NS 
 
Less vs NP 
 
 
 
 
 
-1.21 cps4F in O2 
 
-1.25 cps4J 
 
-1.21 cps4K 
 
comE   Orihuela 
 
           Oggioni 
 
comF   Bortoni 
 
NS 
 
+4.1 in lung 
 
+12  O2 vs AnO2 
-15.0 in CSF 
 
+1.3 in blood 
 
NS 
+1.45 in O2 
G.R**   Orihuela 
 
           Bortoni 
 
NS 
 
+8 in O2 vs AnO2 
 
 
-2.2 in CSF 
 
NS 
 
+3.27 in O2 
htrA    Orihuela 8.2 in ECC NS +2.50 in O2 
tpx      Bortoni +12  O2 vs AnO2 NS 
 
+6.69 in O2 
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spxB    Orihuela 
 
           LeMessurier 
 
           Mahdi 
 
NS 
 
Up-regulated in NP 
 
Up-regulated in NP 
 
-2.6 in CSF 
 
Down-regulated in blood 
 
Down-regulated in blood 
 
+3.36 in  O2 
sodA    Bortoni 
 
           Orihuela 
 
           Oggioni 
 
+8  O2 vs AnO2 
 
NS 
 
+13.9 in lung 
 
NS 
 
-3.5 in CSF 
 
+1.5 in blood 
+4.17 in  O2 
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There were a number of DNA related genes found up-regulated in oxygenated 
conditions when compared to anoxic growth conditions. Examples for these are 
DNA polymerase (SP_0032), DNA repair (SP_0036), flavoprotein (SP_0165) and 
DNA helicase (SP_2203). These are known for their responsibility in repairing 
damaged DNA. Therefore, it could be that their oxygenated induction was to 
repair and replace damage in pneumococcal nucleic acids resulting from 
potential H2O2 (Mostertz et al., 2003).  
Gene expression of several genes involved in metabolism such as carbohydrate 
transporters (ABC and PTS) that are responsible for nutrient uptake, and radicals 
removal such as thioredoxin and efflux protein have been found elevated in 
oxygenated conditions, indicating the greater metabolic energy is required in 
this growth environment versus anaerobic. This induction supports importance of 
carbohydrate transporters´ role in oxidative stress response. Consistent with 
this, expression of certain transporters was greatly increased in S. mutans during 
aerobic growth relative to absence of oxygen (Ahn et al., 2007). We also showed 
an oxygenated over-expression (up to five-fold) in several PTSs, which is in 
agreement with another recent related study (Bortoni et al., 2009). It is worthy 
to mention here that Bortoni et al have shown less gene cohort comparing to our 
study. This may be attributed to methodology and statistical analysis used in 
both studies. They provided the pneumococcal cutures with filtered pubbules to 
generate oxygen, whereas pneumococci were exposed to oxygen in our study by 
shaken methods. Furthermore, they selected genes which were over-expressed 
above 2-fold, but we considered expression changes below 2-fold as biologically 
significant according to what Chaussee et al reported (Chaussee et al., 2002).  
Other important genes (SP1869, SP1871 and SP1872) encoding several iron 
transporters were similarly induced in oxygenated conditions. However, this 
expression was in contrast to Bortoni and co-workers (2009), as they 
demonstrated a reduction in iron transporters when oxygenated relative to 
anaerobic growth conditions, which could be attributed to strain differences 
used in the two studies. Consistent with the results presented in our work, Mahdi 
et al and other studies have measured mRNA levels in pneumococci recovered 
from infected animal models. They found that piaA gene, an iron transporter, 
showed variations in the gene transcription between different strains, but it was 
generally up-regulated in the nasopharynx where oxygen is high as compared to 
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the blood collected samples (Mahdi et al., 2008; LeMessurier et al., 2006). The 
authors have also reported another example of genes variation from using 
different strains. They stated that although spxB was largely elevated in the 
brain for WCH16, its transcription was opposite in the same environmental niche 
for the strain WCH43.  
In fact, iron is well known as a fundamental growth factor for pneumococci as 
well as for other bacteria and it could be that pneumococci require iron 
irrespective of the environmental conditions they grow in. This might be 
explained by other studies which illustrate that piaA in pneumococci was up-
regulated in the nasopharyngeal niche (LeMessurier et al., 2006; Mahdi et al., 
2008), and that may translate the magnitude of the pneumococcal needed for 
iron consumption as a survival factor even if this metal increases oxidative 
stress.   
Most importantly, the hypothetical proteins SP2187 and SP0095 showed 
tremendous increase in expression, 10.33-fold and 36-fold respectively, 
suggesting their fundamental roles in oxidative stress defence in S. pneumoniae 
TIGR4. Genomic analysis using CLC Genomics Bench Work programme revealed 
that both flanking genes are also hypothetical proteins.  
Clp protease was over-expressed in our data analysis with 26-fold in oxygenated 
conditions, and its key role in degrading damaged proteins has been well 
documented in E. coli (Gottesman 1996). In bacteria and higher plants, Clp 
proteases are mainly for degrading misfolded and damaged proteins as a result 
of stress-fluctuation due to adverse environments (Clarke 1999). Further 
investigation in pneumococci has illustrated that both ClpP and HtrA are 
involved in responding to oxidative stress and virulence (Ibrahim et al., 2005). 
Moreover, Clp proteases were reported in pneumococci to play critical roles in 
oxidative stress response (Charpentier et al., 2000; Park et al., 2010). Similar to 
our findings, ClpB protease and virulence attributes such as bacteriocins in S. 
mutans were profoundly induced in oxygenated versus anaerobic growth 
conditions (Ahn et al., 2007). In addition, Charpentier et al stated that 
pneumococcal deficiency in ClpC has resulted in an inability to express several 
virulence factors including the two important determinants Ply and PspC 
(Charpentier et al., 2000). Furthermore, clpP mutants were unable to colonise 
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mice nasopharynx, did not survive in the lungs after intranasal challenge, were 
cleared faster by macrophages cell line and the bacterial virulence was 
attenuated (Kwon et al., 2004).   
The cytolytic Ply was produced differentially between serotypes grown in 
different levels of oxygen (Figure  4-8). Unlike other tested types, serotype 1 
pneumococci (ST217) expressed similar amounts of toxin under both growth 
conditions. It seemed that oxygen does not regulate their Ply production. 
However, it is not known whether the haemolytic activity is active or inactive 
after pneumococcal growth in the presence/absence of oxygen. These type 1 
representatives are hyper-virulent (Harvey et al., 2011b; Williams et al., 2012), 
and it might be able to develop severe manifestations in all environments 
regardless of oxygen availability. Pneumococcus type 1 has been described as 
associating with bacteraemia, pneumonia in North America and Europe, and 
meningitis in Ghana (Kirkham et al., 2006). 
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Chapter 5 - Effect of Oxygen on 
Pneumococcal Adhesion Factors and 
Pathogenicity 
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5 Effect of Oxygen on Pneumococcal Pathogenicity 
As reported in the previous chapter, an oxygenated condition has significantly 
affected ply gene expression, production and its haemolytic activity. In this 
chapter, potential effects of oxygenated growth environments on other key 
virulence determinants are investigated, principally some of the pneumococcal 
adhesion factors. Microarray findings (as detailed in Chapter 4) showed a 
significant increase in several CBPs including the adhesin PspC in oxygenated 
growth conditions compared to anaerobic. This induction was ensured with 
Western blot and adhesion assays herein.  
We also investigate in this chapter the potential effect of oxygenated growth 
patterns on pneumococcal adhesion to human cell line using different strains 
representing diverse serotypes. Furthermore, measuring mRNA for 10 selected 
TCSs to confirm the array data, the expression of seven genes responsible for 
pneumococcal pili, detecting pilins production with immunoblot, biofilm 
formation and finally capsular formation were investigated in this chapter.  
5.1 Pneumococcal Surface Protein C (PspC) 
A number of CBPs such as PspC, CbpD, CbpF and CbpJ and two choline 
transporters were up-regulated under the effect of oxygenated compared to 
hypoxic growth conditions. These are listed in Table 5-1; their gene numbers, 
fold change in oxygenated relative to anaerobic growth, as well as their 
biological roles that have been studied.  
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Table  5-1 Effect of oxygen on gene expression of choline-binding proteins (CBPs) 
 
Data analysis for gene expression of a number of pneumococcal choline-binding proteins 
showed that pspC, cbpD, cbpF and cbpJ have been up-regulated in oxygenated versus 
anaerobic growth. Furthermore, choline transporters were affected similarly during 
oxygenated incubation. These transporters have been analysed using CLC Genomics 
Workbench programme. P<0.05 with Benjamini and Hochberg correction applied for multiple 
testing using 1 way ANOVA test. 
 
In addition to the up-regulated pspC, cbpD, cbpF and cbpJ, genes encoding 
choline transporters including SP1861 and SP1860 were also up-regulated in 
oxygenated growth suggesting that these aerated conditions may contribute to 
binding more CBPs onto the pneumococcal cell wall. We further confirmed pspC 
transcription with measuring its mRNA levels. This showed that the protein was 
slightly induced in the oxygenated pneumococcal growth 1.23-fold relative to 
anoxygenated conditions. It was decided then to test the protein translational 
stage to confirm whether more PspC is produced in oxygenated conditions when 
compared to anaerobic growth.  
5.1.1 SDS-PAGE and Western blot of PspC 
In order to investigate whether the choline-binding protein PspC is found on the 
bacterial cell surfaces or intracellularly in the bacterium, immunoblotting of 
CBPs Gene 
number 
Fold 
change in 
O2 
Biological function Reference 
 binds to epithelial cells (Ma et al., 2007) 
binds immunoglobulin receptor that 
transfers IgA 
(Hammerschmidt et 
al., 1997) 
. binds factor H (Dave et al., 2004a) 
 binds complement 3 (Cheng et al., 2000) 
 induces IL-8 (Madsen et al., 2000) 
PspC SP_2190 1.50+ 
regulated by TCS06 (Standish et al., 2005) 
 competence-induced cell lysis 
(Hakenbeck et al., 
2009; Kausmally et 
al., 2005) CbpD SP_2201 1.38+ 
 plays a role in colonization (Bergmann et al., 2006) 
CbpF SP_0391 1.43+ inhibits LytC activity but not LytA (Molina et al.,  2009) 
CbpJ SP_0378 1.32+ binds to C-Reactive Prptein (CRP) (Frolet et al., 2010) 
Chol- 
transp. SP_1861 2.82+ transporting CBPs CLC 
Chol- 
transp. SP_1860 2.6+ transporting CBPs CLC 
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bacterial cell wall washes and the bacterial cell content were performed. SDS-
PAGE and Western blots were performed using specific antibodies to the PspC as 
shown in Figure  5-1.  
                    
     M  1  2   3   4    5   6  M         
64kD 
 
Figure  5-1 Western blot of PspC extracted from TIGR4 grown both oxygenated and 
anaerobically 
 
Lysates of S. pneumoniae TIGR4 gathered from cultures grown under different oxygen levels 
(oxygenated and anaerobic) until the log phases were at about optical density OD600 = 0.35. 
Western blot of PspC found in the cytoplasm of the oxygenated grown bacteria with total 
protein content measured as 24.10 mg/ml (1), cytoplasmic PspC collected from anaerobically 
grown TIGR4 measured as 24.38 mg/ml (2), oxygenated cell surface PspC measured as 2.52 
mg/ml (3), anaerobic cell surface PspC measured as 2.85 mg/ml (4), PBS as a negative control 
was 0.00 mg/ml (5) and part of PspC as a positive control, which was purefied previously by a 
PhD student in TJM group (6). All samples were collected at the same oxygenated and 
anaerobic ODs. M: indicates the marker used (SeeBlue®Plus2, Invitrogen, Scotland).  
   
Western blot of PspC protein on the bacterial cell surface and in the cytoplasmic 
proteins resulted in greater protein intensity on the cell wall (extracellular) 
when TIGR4 cells were grown in oxygen compared to the anaerobic grown 
bacteria.  
It is worth mentioning here that the two component system 6 (TCS06) has been 
reported to regulate the adhesive agent PspC, and the expression of this CBP 
(SP_2190) was found in our microarray findings as well as TCS06 (SP_2192 & 
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SP_2193) to be significantly up-regulated in oxygenated relative to anoxic grown 
cells (Chapter 4, Table 4-1). From this, it was predicted that the pathogen S. 
pneumoniae TIGR4 is able to bind to human epithelial cells more efficiently if it 
is grown in oxygen when compared to anaerobically grown organisms. To assess 
this hypothesis, the clinical strain was grown until the log phase (optical density 
OD600=0.35) in both oxygenated and anoxygenated growth conditions before 
being seeding on confluent lung cells (pneumocytes II, A549 cell line). One hour 
was allowed for bacterial adhesion. 
5.1.2  Effect of aerobiosis on PspC in TIGR4 adhesion 
Adhesion assays for TIGR4 grown in both oxygenated and anaerobic environments 
were performed to test the bacterial adhesion in the presence or absence of 
oxygen. 
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Figure  5-2 Effect of oxygen on TIGR4 adhesion to the human pneumocytes A549 
 
WT TIGR4 grown in oxygenated environment adhered significantly better (p-value=0.0001) 
to the host cells A549 compared to what the anaerobic grown pneumococci did.  Percentage 
of bacterial adherence was calculated after one hour following seeding oxygenated or 
anaerobic grown TIGR4 on a monolayer grown cell line. O2 indicates pneumococci which 
have been grown in the oxygenated growth conditions, whereas AnO2 means the 
anaerobically grown TIGR4 cells. Statistical analysis was performed using t.test in Graph Pad 
(GraphPad Prism 5, USA 2007). Each bar is an average of three replicates, and the error bars 
represent the standard error of the mean. 
Figure  5-2 illustrates that around 2% of the inoculated S. pneumoniae TIGR4 
were able to significantly (p=0.0001) adhere after bacterial growth in 
oxygenated versus anaerobic. Anaerobiosis conditions led to significantly weak 
adhesion, indicating less pneumococcal adhesion ability when oxygen is absent. 
167 
This low adherence percentage could be due to the presence of the capsular 
polysaccharide (CPS) as pneumococci possess this key virulence factor which 
coats most the bacterial cell wall, preventing proper adhesion. As a 
consequence, a reduction in CPS thickness may facilitate bacterial-host 
interaction that could result in better microbial attachment.  
The significant oxygenated adhesion ability to the human cell line A549 reported 
here (Figure  5-2) could be attributed to two reasons; i. Oxygenated reduction 
occurred in the CPS gene expression, ii. Oxygenated increase in both the 
adhesive factor PspC and its transporters, which also have been proved in this 
chapter as can be seen in Table 5-1.  Therefore, it was necessary to investigate 
the role of the capsule in these assays and these two reasons have led us to 
repeat the adherence assay experiments using the same strain but lacking the 
capsule. It was expected then that the adhesion ability would be increased when 
pneumococci are grown in oxygenated growth environments.  
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Figure  5-3 Effect of oxygenated growth on TIGR4∆cps adhesion to the human pneumocytes 
A549 
 
The unencapsulated TIGR4 had the ability to bind the epithelial monolayer significantly after 
growing in the oxygenated incubation conditions as compared to the anaerobically grown 
cells with 0.0044 p-value. TIGR4Dcps is the mutant that lacks capsular polysaccharide used 
in this adherence assay. Statistical analysis was performed using t.test in Graph Pad 
(GraphPad Prism 5, USA 2007). Each bar is an average of three replicates, and the error bars 
represent the standard error of the mean. 
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TIGR4∆cps was able to bind the host cell line after growing in oxygenated 
environment significantly greater than the anaerobic grown bacteria (p-
value=0.0044) (Figure  5-3), and the percentage of the adherent pneumococci 
rose from 2 % when using the WT TIGR4 (Figure  5-2) to about 20 % under the 
oxygenated conditions. This high ability of adhesion was expected due to the 
vast effect of the capsule phase variation as the pathogen is known to reduce 
CPS expression during colonising the host nasopharynx as compared to its 
expression in the blood circulation system, and the reduction was comparable 
with the capsular amounts observed in R6, the non-encapsulated strain 
(Hammerschmidt et al., 2005). Figure  5-4 illustrates how the capsule thickness 
could coat the whole bacterium.      
 
Figure  5-4 Capsular polysaccharide (CPS) of S. pneumoniae 
 
The bacterium is coated with a thick CPS covering cell wall agents including CBPs. Quoted 
from Nature Reviews, Genetics, (Joyce et al., 2002).  
This significant increase of pneumococcal binding to the human cell line under 
oxygenated compared to anaerobic growth conditions suggested a possible role 
for PspC in this adhesion process. To investigate this, TIGR4∆pspC was used and 
the adherence assay experiments were repeated under both of the incubation 
growth conditions, oxygenated and anaerobic (Figure  5-5).  
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Figure  5-5 Adherence assay of TIGR4∆pspC in oxygenated and anaerobic environments 
 
Ablation of pneumococcal surface protein C in TIGR4 (TIGR4DpspC) revealed approximately 
analogue percentages of adherent microbes to the host cells used after growing the bacteria 
under oxygenated and anaerobic incubation growth forms. Each bar is an average of three 
replicates, and the error bars represent the standard error of the mean and no significance 
variation was found using Graph Pad (GraphPad Prism 5, USA 2007). 
It is interesting that the previous significant differences in the bacterial-host 
adhesion, as shown in Figure  5-2 and Figure  5-3, using the WT TIGR4 under both 
oxygenated and anaerobic conditions disappeared in Figure  5-5, suggesting that 
PspC plays a key role in pneumococcal ability for binding the human lung cells 
once they are exposed to oxygenated growth conditions. Moreover, our previous 
findings for the transcriptional and post-transcriptional stages after scanning the 
whole bacterial genome and after blotting the protein showed increased levels 
of PspC on the bacterial cell wall that supported these adhesion assays. This 
confers a greater bacterial attachment under oxygenated conditions to the 
epithelial tissues used. Hence, it was important to determine this ability if 
repeating the adhesion assays but using different pneumococcal serotypes grown 
in the same growth forms.  
5.1.3 Adhesion by other pneumococcal serotypes 
Due to the significant adhesion ability observed in serotype 4 pneumococci 
grown in oxygenated environments, other serotypes (type 3, OXC141 and type 1, 
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P1041) have been studied here for their adhesion to the same human cell line 
A549. S. pneumoniae OXC141 is mostly found in human colonisation rather than 
causing an invasive pneumococcal disease.    
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Figure  5-6 Adhesion assay for OXC141 grown in oxygenated and anaerobic growth conditions 
 
Significant (p-value<0.0001) ability of pneumococcal strain OXC141 associated with 
colonisation once it was grown in oxygenated versus the anaerobically grown bacteria. 
Statistical analysis performed used t.test in Graph Pad (GraphPad Prism 5, USA 2007). Each 
bar is an average of three replicates, and the error bars represent the standard error of the 
mean. 
The strain OXC141 associated with colonisation had a significant ability to 
adhere after growing in the oxygenated incubation conditions in comparison to 
the anaerobic grown cells (Figure  5-6). This statistical significant reduction 
(p<0.0001) in anaerobic capability of adhesion indicates that the bacterium is 
highly equipped with adhesion factors when it is exposed to oxygenated growth 
conditions. 
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Figure  5-7 Adhesion assay for P1041 grown in oxygen and anaerobically 
 
The hyper-virulent microorganism P1041 revealed no considerable differences in adhesion to 
the host epithelial cells after growing under the oxygenated or anaerobic growth 
environments. Statistical analysis was performed using t.test in Graph Pad (GraphPad Prism 
5, USA 2007) and showed no significant differences between the pneumococcal adhesion in 
both condotions, aerobic and anaeroboc. Each bar is an average of three replicates, and the 
error bars represent the standard error of the mean. 
In contrast to serotype four (TIGR4) and three (OXC141), the performed adhesion 
assay (Figure  5-7) of the P1041 clinical isolate, which represents serotype 1,  
clearly showed no significant differences in the organism adherent percentages 
under oxygenated and anaerobic growth conditions.  
5.2 Pilus  
5.2.1 SDS-PAGE AND Western blot for TIGR4 pilus 
Pneumococcal pili are well known to participate in colonisation similar to PspC, 
and it was predicted that the main protein involved in the pili structure, RrgB, 
could be produced at a higher intensity if it is collected from the oxygenated 
grown bacteria and compared to the anaerobic growth conditions. Consequently, 
bacterial cell lysates at optical density OD 0.35, a growth OD which was chosen 
for the microarray and haemolytic assay experiments (Chapter 4), was separated 
on SDS-PAGE and electroblotted using Western blot.  
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Figure  5-8 Western blot for the pilin RrgB under oxygenated and anaerobic conditions 
 
Bacterial cell lysates (SDS-PAGE) (A), lane 1 aerated (total protein concentration is 24.10 
mg/ml) and 2 anaerobic (24.38 mg/ml). Immunoblot for both prepared samples gathered 
from the two oxygenated and anaerobic conditions (B), lane 3 shows greater RrgB intensity 
in oxygen compared to lane 4 that represents the anaerobic bacterial sample.   
The immunoblot performed on samples gathered from oxygenated and anaerobic 
grown pneumococci showed an increase in the protein RrgB intensity in aerated 
grown cells (Figure  5-8, A and B). RrgB forms the backbone of the bacterial pili. 
This suggests a possible oxygenated enhancement in those genes, which are 
involved in structuring and assembling the pneumococcal pilus.  
These results were supported by another similar investigation performed by 
Jenny Herbert in a thesis submitted to the University of Glasgow in 2012. In 
addition, she also proved this with FACS and stated: 
 
“A clear shift to the left in the FITC pilus positive population 
 grown under anaerobic conditions, suggesting a decrease in 
 the amount of pili on a single cell.”  
 
 
To assess how TIGR4 pilus expression is controlled under both conditions used, 
mRNA levels were measured by doing qRT-PCR for those genes which are 
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responsible for both structuring (including rrgA, rrgB, rrgC, rlrA), and 
assembling enzymes (srtB, srtC, srtD). 
5.2.2 qRT-PCR for TIGR4 pilus RNA genes 
Quantitative RT-PCR showed an oxygenated up-regulation in all of those genes 
responsible for controlling the pili structuring and assembling enzymes, which 
localise pneumococcal pilins on the bacterial cell wall.    
mRNA levels of pilus genes in TIGR4
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Figure  5-9 qRT-PCR for structural and assembling pili genes on oxygenated versus anaerobic 
 
All pilins mRNA levels are up-regulated in pneumococci grown in oxygen in comparison to the 
anaerobic microbial growth. RrgA and RrgC are ancillary to each other. RrgA is located on the 
bacterial pilus shaft at the distal tip, whereas RrgC is placed in the pilus proximal. RrgB 
forms the pilus itself. Srt proteins are involved in pili assembling and all of their gene 
expressions were enhanced in oxygenated growth conditions compared to anaerobic. Each 
bar is an average of three replicates, and the error bars represent the standard error of the 
mean using Graph Pad (GraphPad Prism 5, USA 2007). 
Figure  5-9 shows an oxygenated increase in mRNA levels in all of the tested pili 
involved genes. Except the rrgA gene, genes involved in PI-1 expression were 
detected to be above two-fold in oxygenated growth. RrgA and RrgC are known 
to play a complementary role. RrgA is located on the bacterial shaft of the pilus 
at the distal tip, whereas RrgC is placed in the pilus proximal. RrgB has a key 
motif and functions as a structural protein involved in the pili formation. Its 
mRNA during pneumococcal oxygenated growth was induced 3.5-fold compared 
to anaerobic.  
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Together, the pilus is definitely up-regulated in oxygenated growth which was 
expected in terms of colonisation. One possible mechanism for that induction is 
changes in expression of TCSs as they may involve in regulating pneumococcal 
pili, which is still exclusive. However, up-regulation in a TCS does not always 
mean that there is an induction in a gene due to phosphorylation.    
5.2.3 Genes coding Two-Component Systems (TCSs) 
Investigation of gene expression of the PspC showed a high potential relationship 
between the availability of oxygen and the adhesion to human cells. Moreover, 
immunoblotting of the pneumococcal pilus PI-1 and its structurally involved 
subunits both revealed greater expression in oxygenated rather than anaerobic 
environments. It was decided to confirm all of the TCS genes that have been 
found by the microarray data to be elevated in oxygenated conditions and even 
other important TCSs, listed in Table 5-2. The table shows TCSs, gene number of 
both HK and RR, p-value, fold change in oxygenated compared to anaerobic 
growth conditions and the potential product. 
Table  5-2 List of up-regulated TCS genes in oxygenated against anaerobic conditions 
 
P<0.05 with Benjamini and Hochberg correction applied for multiple testing using 1 way 
ANOVA test. 
TCS Gene p<0.05 Product 
TCS02 RR SP_1226 0.00581 sensory box sensor histidine kinase 
TCS02 HK SP_1227 0.0047 DNA-binding response regulator 
TCS03 HK SP_0386 0.00411 sensor histidine kinase 
TCS03 RR SP_0387 0.0479 DNA-binding response regulator 
TCS04 RR SP_2082 0.009 response regulator 
TCS05 RR SP_0798 0.0302 DNA-binding response regulator CiaR 
TCS05 HK SP_0799 0.0151 sensor hitidine kinase CiaH 
TCS06 RR SP_2193 0.0119 DNA-binding response regulator 
TCS06 HK SP_2192 0.0119 sensor hesitidine kinase 
TCS08 RR SP_0083 0.0146 DNA-binding response regulator 
TCS08 HK SP_0084 0.021 sensor histidine kinase 
TCS11 RR SP_2000 0.00976 DNA-binding response regulator 
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The above table demonstrates that the majority of the 13 known Two-
component system (TCS) genes are up-regulated significantly in the oxygenated 
growth states. The table shows that analysis of the microarray data (Chapter 4, 
Table 4-1) revealed that there were 10 significant over-expressed TCSs in 
oxygenated growth conditions out of the 13. Therefore, in order to confirm gene 
expression for these particular TCSs, mRNA levels for each gene have been 
measured in the following step, focusing on some of the TCSs which have been 
proved by other published studies to be involved in regulating pneumococcal PI-
1.   
5.2.4 qRT-PCR for confirming gene expression of TCSs  
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Figure  5-10  qRT-PCR for Two-component system genes and the response regulator orf 
 
Most of the studied TCSs and the orf rr have been up-regulated in oxygen to different levels 
including those which are involved in controlling the PI-1 such as TCS03 and TCS08. TCS11 
had almost 6-fold up-regulation in oxygenated growth. Each bar is an average of three 
replicates, and the error bars represent the standard error of the mean using Graph Pad 
(GraphPad Prism 5, USA 2007). 
mRNA levels of the tested TCSs are up-regulated in bacterial cells grown in 
oxygenated growth, except TCS12 (Figure  5-10). Approximately, TCS02 and 06 
TCS12 RR SP_2235 0.0273 response regulator ComE 
TCS13 RR SP_0526 0.04 response regulater BlpR 
Orf RR SP_0376 0.0237 response regulator 
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modestly exceeded 1-fold of expression in the aerated environments. Indeed, 
rr06 has been shown to positively involve in regulating pspC (Standish et al., 
2005), but mRNA levels of rr06 in Figure  5-10 did not show an over-expression.  
Moreover, TCS12 was slightly down-regulated under the same oxygenated growth 
forms. In fact, this supports the magnitude of qRT-PCR validation after 
microarray experiments. However, quantitative RT-PCR showed in the above 
figure (Figure 5-10) an induction in TCS03, 04, 05, 08, 11, 13 and the orf 
response regulator. Expression of an important oxidative stress response gene, 
tpx, was previously detected in this study (Chapter 4) with an induction of 7-fold 
in oxygenated growth was induced 180-fold using qRT-PCR.  
Evidence has shown that some of these signalling systems including TCS03 and 
TCS08 are implicated in regulating pneumococcal pilus expression (Song et al., 
2009). They and other laboratories also reported that TCS05 is involved in 
regulating htrA and contributes to the bacterial colonisation (Sebert et al., 
2002). Furthermore, TCS11 has been documented to be involved in the 
pneumococcal stress response when exposed to the antibiotic vancomycin (Haas 
et al., 2005). These TCSs had been previously found in this study with an 
induction in their gene expressions under the oxygenated growth conditions 
(Chapter 4, Table 4-1).  
As the expression of PI-1 was shown in this study by microarray, qRT-PCR and 
Western blot to be increased in oxygenated growth, there is a possible elevation 
in biofilm formation for pneumococci grown in oxygenated growth because pili 
are thought to highly contribute to forming bacterial biofilm.  
5.2.5 Biofilm formation 
Recent studies have shown that biofilm formation and bacterial adhesion are 
both associated with the pilus that exists on bacterial cell wall. Therefore, in 
order to investigate this pili-biofilm relationship, a biofilm formation assay for 
TIGR4 was performed (Figure  5-11). The pathogen was grown until its decline 
phase in oxygenated and anaerobic conditions. 
177 
Effect of Oxygenated growth on TIGR4 Biofilm Formation
0
1
2
3
4
5
TIG
R4
co
ntr
ol BH
I
L.B
Bi
o
fil
m
 
Fo
rm
at
io
n
 
(ab
so
rb
an
ce
 
56
0 
n
m
)
oxygenated
anaerobic
 
P. value 0.0074 
 
Figure  5-11 TIGR4 biofilm formation under oxygenated and anaerobic conditions 
 
TIGR4 formed significantly greater biofilm (p=0.0074) in oxygenated compared to the 
anaerobic growth incubation conditions. The control is P. aeruginosa (as a positive control), 
BHI is the medium alone which used for growing TIGR4 and LB to grow P. aeruginosa. Error 
bars represent standarad error of the mean using Microsoft Office Excel 2003, whereas 
statistical analysis performed using t.test in Graph Pad (GraphPad Prism 5, USA 2007).  
The absorbance of biofilm formation for S. pneumoniae TIGR4 was measured as 
4.2% in pneumococci grown in oxygen representing a significant increase 
(p<0.05) in this condition (See Figure 5-12), whereas the anaerobic biofilm 
absorbance was detected at 2% (Figure  5-11). Moreover, Rgg regulators have 
been found in streptococci to be involved in oxidative stress response and 
biofilm formation, as it was described recently that rgg deficiency in 
unencapsulated type 2 S. pneumoniae showed a significant reduction in forming 
pneumococcal biofilms; and most importantly, the organisms were more 
sensitive to oxygen relative to parental strains (Bortoni et al., 2009). 
Due to this increase in the aerated biofilm formation in TIGR4, it was decided 
then to repeat the biofilm formation experiment to study the rest of the 
pneumococci used in this project to explore their biofilms during their growth in 
oxygenated and anaerobic growth environments (Figure  5-12). 
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Effect of O2 on pneumococcal biofilm formation
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Figure  5-12 Biofilm formation for 11 pneumococcal strains in oxygenated and anaerobic conditions 
 
Different pneumococcal serotypes showed variant abilities to form biofilm. Serotype 1 (03-3038, NCTC7465, P1041 and INV104B) and serotype 8 (ATCC6308) 
revealed significant increased biofilm formation in the absence of oxygen compared to the aerated condition, except the strain 03-3038 which shows similar 
biofilm formation under both conditions used. In contrast, serotype 4 (TIGR4 and 403) illustrated greater biofilm formation in oxygen than anaerobically. 
Members of type 3 show changes in biofilm formation. The experiments performed in triplicates and error bars represent SEM. BHI is the medium alone 
which used for growing pneumococcal strains and LB to grow P. aeruginosa. Statistical analysis was performed using t.test in Graph Pad (GraphPad Prism 5, 
USA 2007). * p<0.05, ** P<0.001 and the stars above the bar represent statistical significance relative to the other biofilm formation growth conditions. 
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The pneumococcal strains studied for changes in their behaviour in forming 
biofilm under both conditions belong to different serotypes including serotype 1 
(03-3038, NCTC7465, P1041 and INV104B), serotype 3 (99-4039, 99-4038, OXC141 
and A45), serotype 4 (TIGR4 and 403) and serotype 8 (ATCC6308). Multi Locus 
Sequence Type (MLST) and other pneumococcal growth characterisations for all 
these strains were listed in detail in Chapter 3, Table 3-2. 
Biofilm formation assays for these pneumococci (Figure  5-12) showed variations 
between the strains used. All of the clinical isolates representing serotype 1 
(NCTC7465, P1041 and INV104B) and 8 (ATCC6308) formed significantly greater 
biofilm in the absence of oxygen. Nevertheless, statistical analysis of the 
pathogen 03-3038 showed no significant differences and was the only bacterium 
that seemed to be slightly similar in forming biofilms under both conditions, 
oxygenic and anaerobic.  
On the other hand, TIGR4, which represents serotype 4, along with its avirulent 
derivative strain 403 showed a significant increase. TIGR4 cells significantly 
formed biofilm in the oxygenated conditions versus the anaerobic incubation 
forms (p=0.0074). This supported our previous data including the oxygenated 
observed up-regulation in TCS genes which are responsible for regulating 
pneumococcal pili, up-regulation in mRNA levels of TIGR4 structural and 
assembling pili proteins and the enhancement of pilus protein RrgB shown by 
Western blot.  
In addition, serotype 3 members behaved differently; 99-4039, which was 
isolated from a patient´s CSF in 1999, formed greater biofilm in oxygen, but it is 
not the case with the highly genetically related isolate 99-4038 which behaved 
oppositely. 99-4038 pneumococci were collected from blood of the same 
patient, which is considered as an anoxia host environment, and preferred the 
anaerobic conditions to form biofilms that showed a statistically significant 
increase. Both (99-4039 and 99-4038) were shown to grow better in anaerobic 
growth environments (Chapter 3, Section 3.2.).  
Together, these closely related strains (99-4039 and 99-4038) reacted to oxygen 
for forming biofilms completely differently. Therefore and due to that biofilm 
formation is believed to be a serious clinical barrier against antibiotics and the 
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immune system, these biofilms variation could affect the medical drugs used, 
considered as a proper procedure for treating the infection. Studies have shown 
that changes in forming pneumococcal biofilms under static growth conditions at 
interval time-points were reported recently in a large number of different 
clinical isolates representing several serotypes (del Prado et al., 2010; Tapiainen 
et al., 2010). 
A very recent study undertook a comparison between the isolates 99-4039 and 
99-4038 and revealed that the pneumococcus 99-4039 is more resistant to 
antibiotics (Croucher et al., 2013, in print). They stated that this may refer to 
an induction in the PatA/B efflux system.  
In some pneumococci, biofilm formation might be linked to a stressful lifestyle. 
As mentioned earlier in this section, Rgg regulators have been shown to play a 
role with both pneumococcal biofilm formation and oxidative stress response 
(Bortoni et al., 2009). Another possible relationship between biofilm formation 
and oxygen is that TIGR4 and OXC141 growth curves, representing serotype 4 
and 3 respectively (as shown in Chapter 3), illustrated no strong variations with 
or without oxygen availability, whereas serotype 1 growth curves demonstrate 
an apparent greater shift once grown anaerobically versus the oxygenated 
growth conditions. Interestingly, del Para et al revealed that serotype 3 
pneumococci showed the highest biofilm formation during growth under aerobic 
conditions (del Prado et al., 2010); on the other hand, Tapiain and colleagues 
demonstrated the opposite using the same strain (Tapiainen et al., 2010). 
Possibly, differences in experimental procedures/protocols could cause these 
discrepancies.  
5.2.6 Pneumococcal aggregation 
It is believed that bacterial ability to aggregate leads to an increase in the 
microbial clumps and therefore a greater capability to form a biofilm. 
Furthermore, early work has stated that there is a relationship between 
bacterial chain length and pathogenicity. Therefore, chains of mid-logarithmic 
growth for the isolate S. pneumoniae TIGR4 were examined microscopically 
under three different levels of oxygen to study how oxygen variations can affect 
bacterial aggregation and in turn its biofilm formation (Figure  5-13).  
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Figure  5-13 TIGR4 aggregation under three different levels of oxygen 
 
Gram stain of un-vortexed mid-log phase TIGR4 grown aerobically showed short 
pneumococcal chains and a few small bacterial clumps formed (A), anaerobic growth in the 
same batch of the medium BHI represented no clumps and shorter chain lengths, almost 
diplococci (B) and the last row illustrates TIGR4 oxygenated growth pattern with long 
pneumococcal chains and several microcolonies showing the link between aggregation, 
biofilm formation and oxygen (C). Two films were captured from different aereas on each 
slide prepared for each condition. The magnification factor used was 40x. 
Gram stained examination of the bacterial mid-log phase under three different 
levels of oxygen (aerobic, anaerobic and oxygenated) showed differences in the 
pneumococcal aggregation ability (Figure  5-13, A, B and C). This figure 
demonstrates that the more oxygen provided to the growing bacteria the longer 
the chains and the greater the biofilms formed following bacterial aggregation. 
The microscopy inspection of the TIGR4 growth in the anaerobic condition 
showed very short chains or even diplococci and a complete absence of 
aggregation (Figure  5-13, B). In contrast, the aerobic growth incubation 
conditions resulted in bacterial tendency for forming slightly longer chains of a 
few microbes and a number of aggregated microcolonies, probably an early 
biofilm formation (Figure  5-13, A). However, when oxygen levels were increased 
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by shaking bacterial cultures in the oxygenated growth conditions, the bacterial 
chains made more junctions and initiated biofilm formation as can be seen 
above in Figure  5-13, C.  
As stated earlier in the introduction chapter, it is well known that CPS 
production can negatively affect microbial biofilm formation. In order to test 
this in pneumococci, the strain OXC141 as a human coloniser, which prefers 
oxygenated conditions to form greater biofilms as seen in Figure  5-12, was 
chosen for studying its CPS production after growing in different levels of 
oxygen.     
5.3   Capsular polysaccharide formation 
5.3.1 Effect of anaerobiosis environment on capsule formation 
Deu to the well known reduction in cps and its phase variation when 
pneumococci grown in oxygen compared to anaerobic growth (Weiser et al., 
1994a; Weiser et al., 1994b), it was decided to study how the bacterial colony 
formations would be affected after exposing another pneumococcal serotype to 
oxygen in comparison to the absence of oxygen. Therefore, growth curves of the 
isolate OXC141 were measured under the two different atmospheric conditions, 
aerobic and anaerobic. The growth curves are shown in Figure  5-14. 
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Figure  5-14: OXC141 growth curves aerobically and anaerobically  
 
Under different levels of oxygen, similar growth curves were observed. All lasted 3 hr in 
their log-phase followed by approximately another 3 hr before entering the death phase, 
which took a further 5 hr. Error bars show SEM using Microsoft Office Excel 2003.  
As Figure  5-14 shows, the growth rates under different conditions used were not 
considerably different. These in vitro growth rates were similar as they took 
about 3 hr to start the log-phase for approximately another 3 hr before dying 
after almost 7 hr. While pneumococci were growing at the mid-log phase, 
samples were gathered and plated directly on BA for overnight incubation as 
explained in the following diagram. 
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Figure  5-15 Effect of oxygen availability on OXC141 colony formation  
 
The blood agar (BA) plate on the right side shows mucoid colonies after being incubated 
anaerobically. In contrast, the left BA plate reflects formation of rough colonies after 
incubating in the presence of oxygen, aerobically. The table demonstrates a short summary 
resulting from pneumococci grown in different atmospheric levels. The organisms were 
grown under each condition until the mid-log phase before plating on blood agar plates.  
 
 
Capsular formation in OXC141 when grown in different levels of O2 
Aerobic  Anaerobic  
Rough colonies Mucoid colonies 
 
 
Aerobic growth 
and incubation 
Anaerobic growth 
and incubation 
Plating on BA plates 
Anaerobic incubation Aerobic incubation 
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Phase variation of rough (spotted) and smooth (mucoid) colonies were noticed 
when culturing OXC141 on BA collected from different growth conditions. The 
environment in which mucoid colonies formed was the anaerobic condition 
(Figure 5-15). These phenotypic differences indicate that oxygen availability in 
the airway tract might suppress the capsule formation in pneumococci, whereas 
less-oxygenated conditions like the bloodstream triggered its production which is 
in agreement with several studies where capsule phase variations, transparent 
and opaque, were observed (Weiser et al., 1994a; Weiser et al., 1994b).  
This CPS variation is consistent and supports the previous results in Figure  5-6 as 
the oxygenated growth environments in Figure  5-6 led to greater than a 10-fold 
significant increase (p<0.0001) in the OXC141 attachment to A549 cell line 
relative to the adhesion assays using anaerobically grown bacteria. This indicates 
less capsule formation resulted in an increase in the adhesion ability when cells 
are grown in oxygen compared to anaerobic growth conditions that Figure  5-15 
clearly shows.  
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5.4 Discussion 
There are a series of steps for S. pneumoniae to develop IPDs. Colonisation of 
host nasopharynx is believed to be the first. The pathogen is highly capable of 
adapting to this anatomical niche, as well as other environmental sites such as 
the bloodstream and the brain. Each has been reported to require different gene 
expression (Orihuela et al., 2004; Ogunniyi et al., 2002), and shown to contain 
variant oxygen concentrations (Burghout et al., 2010; Hathaway et al., 2007; 
Yesilkaya et al., 2009). In this chapter, our array data analysis of pspC, its mRNA 
levels, protein production and adhesion activity under different levels of oxygen 
have been studied. All these have demonstrated greater amounts of PspC protein 
in oxygenated than anaerobically grown bacteria. The immunoblot shows PspC 
increase in both the pneumococcal cytoplasm and on the bacterial cell surface. 
Interestingly, the choline transporters, including SP1860 and SP1861, were also 
over-expressed 2.6 and 2.8-fold in oxygenated growth conditions, respectively, 
indicating more CBPs are anchored onto the pneumococcal cell wall. Consistent 
with this, gene expression of the adhesin factor pspC, which enhances the 
bacterial colonisation, was detected with an increase during pneumococcal 
attachment to human epithelial cells in vitro and in vivo (LeMessurier et al., 
2006; Oggioni et al., 2006; Orihuela et al., 2004a). In addition, Mahdi and 
coresearchers reported that pneumococci in the nasopharynx express greater 
pspC when compared to cells grown in the bloodstream (Mahdi et al., 2006).  
Moreover, transparent phenotype was shown to correlate with colonisation of 
the nasopharynx, and expressed more PspC proteins on the cell surface versus 
opaque pneumococci, which have been linked to invasiveness rather than 
colonisation (Overweg et al., 2000; Rosenow et al., 1997). Further animal 
studies using pneumococci without the pspC gene to assess nasopharyngeal 
colonisation have shown a 100-fold reduction in the attachment ability of 
mutant compared to wild-type strains; such differences were not shown when 
mice were challenged intraperitoneally (Rosenow et al., 1997). Similarly, in 
vitro experiments also revealed that D39 pspC deficient bacteria have 
significantly less adhesion 85% (p=0.001) to the cell line A549 (Standish et al., 
2005).  
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Nevertheless, the contribution of PspC, to virulence was described to be strain-
dependent (Kerr et al., 2006). According to Kerr and colleagues, not all strains 
possess PspC; it is not clear to us if oxygen regulates all pneumococci in the 
same way as shown in our findings, but it does suggest that if adherence is 
mediated by oxygen in all strains, there must be different mechanism(s) because 
not all of them have PspC or they may have different adhesion proteins. 
Therefore, our data (microarray, qRT-PCR and Western blot) led us to examine 
its role in adhesion to human cells after espousing to oxygen against anaerobic 
growth conditions.  
S. pneumoniae OXC141 showed the highest adhesion rate amongst the other 
tested isolates (Figure  5-6). This could be due to presense of prophages in most 
of the pneumococcal colonisers. Unlike TIGR4, OXC141 strains are occasionally 
isolated from human nasopharynx with prophages carried in their genomes. 
These prophage carriers have been reported with a greater ability to adhere to 
nasopharyngeal cells (Loeffler et al., 2006). 
In addition to PspC, our findings illustrated the role of other pneumococcal 
adhesion factors; pili proteins in TIGR4 (six genes encoded structural proteins 
RrgA, RrgB and RrgC) and their assembling enzymes (SrtB, SrtC and SrtD). 
Expression of all these genes was elevated when TIGR4 is exposed to oxygenated 
growth environments (Figure  5-9). Furthermore, 10 of 14 key pneumococcal TCS 
were up-regulated significantly in oxygenic conditions. For instance, TCS03 was 
induced in oxygenated growth and its contribution in stress response has been 
reported (Haas et al., 2005). Similar to our array results, expression of TCS03 
was reduced in CSF of infected animals (Orihuela et al., 2004). CSF is considered 
to be less oxygenated relative to host respiratory airways (Auzat et al., 1999).  
Interestingly, unlike serotype 3 (OXC141), serotype 1 (P1041) displayed an 
extremely low adherece when compared to both serotypes, 4 and 1. A possible 
explanation behind this could be that type 1 pneumococci are hyper-virulent 
organisms and rarely isolated from healthy individuals (Harvey et al., 2011b; 
Williams et al., 2012); therefore, it could be that they have evolved to be more 
successful as invaders than colonisers (opportunistic pathogens). Nevertheless, 
more recent studies undertook swabs from hundreds of children at intervals of 
several days. The researchers were able to detect serotype 1 pneumococci for a 
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few days in host nasopharynx after which the bacteria disappeared (Abdullahi et 
al., 2012).  
Analysing our biofilm assays for a range of pneumococci (11 strains) representing 
different serotypes shows biofilm phenotype variations under oxygen availability 
as shown in Figure  5-12. In fact, several factors have been shown to facilitate 
pneumococcal biofilms; CBPs, pili and free DNA. Our results illustrated that not 
only CBPs but also choline transporters were up-regulated in oxygen when 
compared to anaerobic growth conditions. Investigation of genes involved in 
pneumococcus biofilms revealed a reduction in biofilm formation with CBP 
deficient mutants (Moscoso et al., 2006). This was recently supported after 
constructing a deletion in lic operon, which is involved in choline uptake in other 
bacteria that share the same habitat with pneumococci (Kwak et al., 2002; Rock 
et al., 2001). They showed that lic mutants were unable to form biofilms.   
As discussed earlier in this section, we measured mRNA levels for type 1 pili 
(rlrA islet), encoding three pilins and three sortase enzymes, which revealed 
elevated expression levels in oxygenated growth. Type 1 pili in E. coli 
(Hilleringmann et al., 2009; Wright et al., 2007) and in S. pyogenes (Manetti et 
al., 2007) have been demonstrated to contribute to biofilm formation. 
Interestingly, we showed in this study that all strains representing serotype 1 
pneumococci formed greater biofilms anaerobically, in contrast to serotype 4 
pneumococci, TIGR4. Serotype 1 is genetically known to lack type 1 pili. This 
inability might then explain why oxygen was ineffective to escalate biofilms in 
serotype 1 pneumococci.  
Pneumococci are well characterised as highly transformable pathogens that 
spontaneously release large amounts of DNA. Free DNA was reported to be 
required for biofilm formation as treating the pneumococcal biofilm with DNase 
has significantly reduced the bacterial biomass (Hall-Stoodley et al., 2008).  
However, oxygen molecules were found to down-regulate biofilms in S. mutans 
(Ahn et al., 2007). This presumably may reflect variation in nutrients 
consumption in these two organisms (pneumococcus and mutans) which might 
result in different metabolic pathways from utilising dissimilar carbohydrates.   
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Bacterial CPS is another factor counted to play a role in biofilms. It was shown to 
be down-regulated in pneumococcal biofilms (Hall-Stoodley et al., 2008). A 
study has documented that oxygen levels are limited inside biofilms, and showed 
that the deeper they are in biofilms, the more extreme the anaerobic 
environment detected (Ahn et al., 2007). The capsule has been also reported to 
negatively affect biofilm formation in S. pneumoniae (Moscoso et al., 2006). 
Bortoni and colleagues explained that pneumococci involved in biofilms were 
100-fold greater when using unencapsulated pneumococcal versus encapsulated 
pneumococci (Bortoni et al., 2009). They also showed that biofilms ability by rrg 
mutants of unencapsulated pneumococci was strongly reduced compared with 
parent strains, suggesting a relationship between atmospheric environments and 
biofilm formation in S. pneumoniae. Furthermore, accompanied by our data, CPS 
had a lower expression in the nasopharynx (where oxygen concentration is 
similar to the atmospheric levels) compared to the bloodstream (Mahdi et al., 
2008; Oggioni et al., 2006), indicating that the presence of oxygen reduces 
expression of the pneumococcal capsule, probably for more adhesion ability and 
proper colonisation in the URT. In addition to this, obvious evidence supporting 
this CPS-O2 hypothesis is that environmental changes during growth at the 
pneumococcal stationary phase in a bioreactor from anaerobic to aerobic 
conditions resulted in CPS release in the bacterial growth cultures (Goncalves et 
al., 2006). 
The overall view from the previous chapters suggests that TIGR4 might show 
greater invasiveness when exposed to oxygen compared to absence of the 
molecule. We performed general animal model trials to clarify this theory and 
the results showed a pneumococcal tendency to cause invasive diseases when 
TIGR4 pneumococci are grown in oxygenated incubation conditions. Similar to 
these findings, pathogenicity of GBS was shown to be affected by oxygen. The 
authors demonstrated that growth of GBS in oxygenated conditions has 
significantly elevated the bacterial invasiveness level (Johri et al., 2003). 
Therefore, it could be that oxygen molecules somehow increase pneumococcal 
virulence, but this largely needs to be elucidated.  
Furthermore, bacterial virulence in animal models was increased when Shigella 
were grown under oxygenated conditions (Marteyn et al., 2010). Additionally, 
abscess caused by S. aureus was increased once the bacteria were grown in 
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oxygenated environments. Moreover, animal experiments using `rrg mutants 
showed less pneumococcal virulence, indicating poor bacterial resistance to 
oxidative stress, which possibly has led to adhesion reduction (Bortoni et al., 
2009). 
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6 General discussion and future work 
The pneumococcal infection cycle is challenged by several anatomical niches 
including nasopharynx colonisation, lungs, blood and CSF. The bacterial survival 
in these environments definitely requires high genomic flexibility. From the base 
line growth curves of 11 pneumococci representing several serotypes, growth 
characteristics showed generally different phenotype traits in response to 
changes in concentration of oxygen molecules. Differences in oxygen levels 
mimicked the nasopharynx and blood circulation system in hosts. OXC141, for 
example, illustrated similar growth patterns and generation times regardless of 
oxygen availability, whereas P1041 made greater biomass when grown in strictly 
anaerobic conditions. It could be that oxygen has differentially regulated the 
bacterial metabolism and/or pathogenicity which might explain why some 
pneumococcal strains such as OXC141 are carried while some other strains such 
as P1041 are hyper-virulent and highly considered as invasive strains (Harvey et 
al., 2011b; Williams et al., 2012).  
Growth rates in S. pneumoniae TIGR4 and OXC141 were similar under aerobic 
and anaerobic incubation conditions. However, other pneumococci were largely 
affected when they were grown aerobically rather than anaerobically. This  can 
be seen for example in serotype 1 pneumococci (P1041) and another two strains 
representing serotype 3 (99-4039, the CSF isolate and 99-4038, the blood 
isolate). The peroxide assays results showed that TIGR4 has generated significant 
amounts of H2O2 during growth in oxygenated relative to anaerobic growth 
conditions, but we do not know what the production levels of H2O2 are in these 
other micro-organisms during growth in oxygen and anaerobic growth 
environments. It has been reported that determination of peroxides produced by 
serotype 2 pneumococci was below the detection level when they were grown 
anaerobically (Pericone et al., 2002). Therefore, it would be interesting to 
perform H2O2 assays for these aerobically affected bacteria to detect the levels 
of peroxide toxicity they generate in the conditions used. Another possible 
experiment can be achieved here is to measure inhibition zones on blood agar 
using H2O2 discs. This may reflect different unknown abilities to resist several 
levels of H2O2 that might translate changes observed during growth curves in 
various O2 concentrations (Chapter 3). This highlights why some strains such as 
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OXC141 and TIGR4 grew better in oxygen than others. If this is related to 
susceptibility to H2O2, it might explain why there are differences in virulence in 
terms of pneumonia. It could be highly beneficial if oxygen levels are tracked 
indirectly in different anatomical niches during the pneumococcal infection such 
as nasopharynx, lung, blood, spleen, liver and meninges. This might be feasible 
when fluorescently tagged genes are well known to be over-expressed with 
oxygen such as tpx or SP0095, which has been shown in the present study to be 
induced in oxygenated conditions 36-fold when compared to anaerobic 
expression. This potentially will reveal where pneumococci are exposed to high 
levels of oxygen in vivo.  
It is also possible to genetically compare the spxB gene in those pneumococci in 
order to dissect the gene sequence in all of them. It is worth noting that 
pneumococci have been shown to differentially generate H2O2. For instance, 
GTC13809 strains representing serotype 19 approximately generates 5mM in the 
mid-log phase (Taniai et al., 2008), whereas during growth in the stationary 
phase the serotypes 9V (P10 clinical isolates), 6V (P303 clinical isolates) and 2 
(D39) produced 2.7 mM, 2.2 mM and 2.3 mM, respectively (Pericone et al., 
2002). In addition, another study has detected 0.45 mM in pneumococci 
representing serotype 2 in an hour (Overweg et al., 2000). Interestingly, this 
amount was similar to what host activated neutrophils produced (Pesakhov et 
al., 2007). Hence, if these organisms can grow in such peroxide differences, they 
are able then to resist the killing mechanisms used by immune cells.     
Pneumococcal gene expression revealed that 420 genes were differentially 
expressed under oxygenated as compared to anoxygenated growth states. This 
showed that approximately 20% of the entire TIGR4 genome was affected by 
oxygen availability. However, the analysis of expression was performed during 
the bacterial exponential phase where no starvation or waste accumulation had 
begun. These factors are well known to affect the expression of a large number 
of genes. Accordingly, scanning the TIGR4 genome during its stationary phase 
will be different. Conway and Schoolnik stated that using samples collected from 
the bacterial log phase will not show non-mid-exponential phase-specific genes 
(Conway et al., 2003). We have not investigated more than one time point 
during the TIGR4 growth curve. Therefore, it would be more comprehensive and 
may provide a wider genetic view if gene expression is scanned at a set of time-
194 
points during growth. In addition, we only studied the expression of one strain, 
TIGR4, but how other serotypes would behave under oxygenated/anaerobic 
growth conditions is unknown. The only study to undertake S. pneumoniae rather 
than TIGR4 in these environments is Bortoni et al (2009) which performed similar 
work but used serotype 2 instead.   
Our data analysis of ply mRNA, coded by SP1923 gene, showed that its 
expression was induced in TIGR4 cells during their oxygenated growth 
conditions. Its expression was further studied here under the same incubation 
environments with immunoblots to detect the protein intensity and haemolytic 
assays testing the biological activity of the toxin biology. All these techniques 
have demonstrated greater Ply (transcriptional and post-transcriptional) 
activities when oxygen was available. Western blot showed that Ply intensity in 
oxygenated versus anaerobic environments in both type 3 (OXC141) and type 4 
(TIGR4) was similar as they produce greater amounts in oxygenated conditions. 
In accordance, in vivo investigations of ply gene expression using type 2 (D39) 
have detected an increase in the nasopharynx relative to bacteria recovered 
from the bloodstream of mice (LeMessurier et al., 2006; Mahdi et al., 2008). 
Interestingly, the specific antibodies used in the immuno blot have successfully 
detected same amounts of Ply during anaerobic growth of TIGR4, but these 
showed no lytic activity. Our thought is that Ply could be either at a very low 
level and then was not enough to lyse RBCs, or may be the oxygen absence has 
somehow inactivated the protein after affecting TCS(s). However, blotting of Ply 
after growing type 1 bacteria (P1041) using the same growth conditions showed 
bands homology. Although this suggests that oxygen has no impact on ply gene 
expression in the strain P1041, it is not known whether the toxin activity was 
similar under both conditions. Time permitting, we would have performed 
haemolytic activity assays for P1041 Ply after growth to the same bacterial 
population in the presence/absence of oxygen.  
Another example showing gene variation under the same niche was reported in 
spxB. Its expression was induced in the brain with WCH16 pneumococci but 
reduced under the same conditions with the strains WCH43 (Mahdi et al., 2008). 
This discrepancy in gene expression has been also found in several animal 
studies. For instance, Oggioni and coworkers have documented similar ply 
expression in TIGR4 under three discrete niches; lung, brain and biofilm (Oggioni 
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et al., 2006). In contrast, in 2004, expression of ply was detected to be greater 
during TIGR4 attachment to human nasopharyngeal cells in vitro than those 
which bound to mice-CSF in vivo (Orihuela et al., 2004). Experimental 
differences, data analysis and strain-specificly factors were taken into account 
as being perhaps responsible for these variations. 
The results also revealed that high oxygen levels were significantly implicated in 
positive regulation and served several virulence related factors including 
different CPSs, a number of CBPs along with two choline transporters, ComE, 
SpxB, HtrA, Clp pretease, Tpx, SodA, the vast majority of TCSs and several Blp 
proteins. In other words, the majority of the pneumococcal virulence genes were 
significantly over-expressed in oxygen relative to strict anaerobic conditions, 
indicating strong evidence of oxygen being a critical potential external stimulus 
powering pneumococcal pathogenicity.  
Pneumococcal PspC has largely contributed in host adhesion (Ma et al., 2007; 
Standish et al., 2005). Moreover, its participation in pneumococcal biofilm 
formation has been shown, as well as Lic, choline uptake protein (Kwak et al., 
2002; Moscoso et al., 2006; Rock et al., 2001). Pneumococcal agglutination was 
apparently increased during oxygenated growth, which might be attributed to 
PspC induction. The findings presented in this study showed that pspC in TIGR4 
was significantly expressed in oxygenated relative to anaerobic gathered 
samples. In addition, adhesion ability to the human cell line used was also 
significant and the protein intensities detected were greater in both the 
bacterial cytoplasm and on cell surfaces in oxygenated than anoxygenated 
conditions. However, it is not known if the PspC-relationship to oxygen was 
responsible for the bacterial agglutination or not, and it would be useful to 
perform biofilm assays using a knockout pspC mutant in order to test this theory 
and PspC’s possible role(s) in forming pneumococcal biofilms in oxygen.   
Overall, the results of pneumococcal virulence expression under the conditions 
used are relatively in line with their known roles in pathogenicity such as the 
reported greater adhesion when pneumococci exposed to air, which is believed 
to mimic human nasopharyngeal conditions in vivo. The findings also highlight 
the proper use of vaccine/s, e.g., PspC against the bacterial infection. 
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Table A - 1 List of genes expressed significantly (p<0.05) during pneumococcal TIGR4 growth 
in oxygenated as compared to anoxygenated environmental conditions. P<0.05 with 
Benjamini and Hochberg correction applied for multiple testing using 1 way ANOVA test. 
Gene expression above 1.5-fold cut-off is used in the table. 
 
Gene number P<0.05 Fold change in O2 Biological function 
SpTIGR4-0198 (1F13) 0.01 2.62+ hypothetical protein 
SpTIGR4-0338 (1J19) 0.05 26+ ATP-dependent Clp protease ATP-binding subunit 
SpTIGR4-0372 (1L23) 0 1.54+ hypothetical protein 
SpTIGR4-0386 (2B1) 0.05 1.66+ sensor histidine kinase 
SpTIGR4-0784 (3F2) 0.03 3.27+ glutathione reductase 
SpTIGR4-0869 (3K1) 0.01 7.16+ aminotransferase, class-V 
SpTIGR4-1160 (4F1) 0.04 2.6+ lipoate-protein ligase 
SpTIGR4-1163 (4A2) 0.01 2.29+ acetoin dehydrogenase, E1 
component, beta subunit 
SpTIGR4-2016 (6E12) 0.05 2.90+ nicotinate-nucleotide pyrophospharylase 
SpTIGR4-2017 (6F12) 0.05 4.34+ hypothetical protein 
SpTIGR4-2187 (6G21) 0.04 10.33+ hypothetical protein 
SpTIGR4-0024 (1H3) 0.03 1.69+ hypothetical protein 
SpTIGR4-0044 (1D6) 0.05 15.43+ phosphoribosylaminomidazole-
succinocarboxamide synthase 
SpTIGR4-0046 (1F6) 0.04 13.82+ amidophosphorobosyltransferase 
SpTIGR4-0060 (1D8) 0.04 2.24+ beta-glactosidase 3 
SpTIGR4-0075 (1C10) 0.02 1.65+ phosphorylase Pnp/Udp family protein 
SpTIGR4-0083 (1C11) 0.01 1.9+ DNA-binding response regulator 
SpTIGR4-0084 (1D11) 0.02 1.82+ sensor histidine kinase 
SpTIGR4-0085 (1E11) 0.04 1.75- 30 S ribosomal protein S4 
SpTIGR4-0088 (1H11) 0.03 2.06+ hypothetical protein 
SpTIGR4-0095 (1G12) 0.01 36+ hypothetical protein 
SpTIGR4-0096 (1H12) 0.05 2.25+ hypothetical protein 
SpTIGR4-0107 (1K2) 0.02 3.37+ LysM domain-containing protein 
SpTIGR4-0120 (1P3) 0.01 1.97+ 
tRNA udidine 
5carboxymethylaminomethyl 
modification enzyme GidA 
SpTIGR4-0145 (1I7) 0.03 1.65+ hypothetical protein 
SpTIGR4-0165 (1M9) 0.04 1.88+ flavoprptein 
SpTIGR4-0191 (1O12) 0.05 1.53+ hypothetical protein 
SpTIGR4-0198 (1F13) 0 2.63+ hypothetical protein 
SpTIGR4-0208 (1H14) 0.03 1.63- 30S ribosomal protein S10 
SpTIGR4-0220 (1D16) 0.04 1.51- 50S ribosomal protein L24 
SpTIGR4-0222 (1F16) 0.05 1.69- 30S ribosomal protein S14 
SpTIGR4-0237 (1E18) 0.01 1.55- 50S ribosomal protein L17 
SpTIGR4-0267 (1C22) 0.02 2.12+ hypothetical protein 
SpTIGR4-0289 (1I13) 0.03 1.54+ dihydropteroate synthase 
SpTIGR4-0324 (1L17) 0.02 4+ PTS system, IIC component 
SpTIGR4-0325 (1M17) 0.02 4.81+ PTS system, IID component 
SpTIGR4-0330 (1J18) 0.01 1.74+ suger binding transcriptional 
regulator RegR 
SpTIGR4-0338 (1J19) 0 26+ ATP-dependent Clp protease ATP-binding subunit 
SpTIGR4-0345 (1I20) 0.04 1.52+ IS630-Spn1, transposase 
SpTIGR4-0368 (1P22) 0.03 1.52- cell wall surface anchor family 
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protein 
SpTIGR4-0369 (1I23) 0.02 1.61+ penicillin-binding protein 1A 
SpTIGR4-0386 (2B1) 0 1.66+ sensor histidine kinase 
SpTIGR4-0487 (2N1) 0.05 2.31+ hypothetical protein 
SpTIGR4-0488 (2O1) 0.01 2.66+ hypothetical protein 
SpTIGR4-0489 (2P1) 0.02 1.95+ PAP2 family protein 
SpTIGR4-0490 (2I2) 0.01 1.88+ hypothetical protein 
SpTIGR4-0507 (2J4) 0.03 1.67- type I resteriction-modification 
system, S subunit 
SpTIGR4-0515 (2J5) 0.05 1.65+ heat-inducibal transcription 
repressor 
SpTIGR4-0529 (2P6) 0.03 1.66+ BlpC ABC transporter 
SpTIGR4-0530 (2I7) 0.02 2.14+ BlpC ABC transporter ATP-binding protein 
SpTIGR4-0532 (2K7) 0.04 2.88+ bacteriocin BlpJ 
SpTIGR4-0545 (2P8) 0.02 1.93+ immunity protein BlpY 
SpTIGR4-0547 (2J9) 0.04 1.67+ hypothetical protein 
SpTIGR4-0564 (2J11) 0.04 1.66- hypothetical protein 
SpTIGR4-0648 (2F21) 0.04 1.61+ beta-glactosidase 
SpTIGR4-0663 (2E23) 0.01 1.85+ hypothetical protein 
SpTIGR4-0664 (2F23) 0.03 1.60+ zinc metalloprotease ZmpB 
SpTIGR4-0701 (2K16) 0.02 1.67- orotidine 5-phosphate decarboxylase 
SpTIGR4-0702 (2L16) 0.01 1.97- orotate phosphoribosyltransferase 
SpTIGR4-0709 (2K17) 0.04 1.51+ amino acid ABC transporter ATP-binding proten 
SpTIGR4-0710 (2L17) 0.04 2.73+ amino acid ABC transporter permease 
SpTIGR4-0711 (2M17) 0.03 2.89+ amino acid ABC transporter permease 
SpTIGR4-0715 (2I18) 0.02 1.71+ lactate oxidase 
SpTIGR4-0716 (2J18) 0.04 2.10+ transcriptional regulator 
SpTIGR4-0726 (2L19) 0.02 5.39+ phosphomethylpyrimidine kinase 
SpTIGR4-0730 (2P19) 0.01 3.36+ pyruvate oxidase 
SpTIGR4-0731 (2I20) 0.01 2.87+ hypothetical protein 
SpTIGR4-0766 (2L24) 0.02 4.17+ superoxide dismutase, 
manganasedependent 
SpTIGR4-0783 (3E2) 0.04 2.23- hypothetical protein 
SpTIGR4-0784 (3F2) 0 3.27+ glutathione reductase 
SpTIGR4-0789 (3C3) 0.03 1.96+ hypothetical protein 
SpTIGR4-0790 (3D3) 0 2.07+ hypothetical protein 
SpTIGR4-0798 (3D4) 0.03 1.56+ DNA-binding response regulator CiaR 
SpTIGR4-0799 (3E4) 0.02 1.60+ sensor hitidine kinase CiaH 
SpTIGR4-0818 (3H6) 0.04 1.53+ IS630-Spn1 transposase 
SpTIGR4-0820 (3B7) 0.03 2.08+ ATP-dependent Clp protease ATP-binding subunit 
SpTIGR4-0823 (3E7) 0.05 1.52- amino acid ABC transporter permease 
SpTIGR4-0867 (3I1) 0.01 3.87+ ABC transporter ATP-binding protein 
SpTIGR4-0868 (3J1) 0.02 5.92+ hypothetical protein 
SpTIGR4-0869 (3K1) 0 7.16+ aminotransferase, class-v 
SpTIGR4-0870 (3L1) 0.03 4.38+ NifU family protein 
SpTIGR4-0875 (3I2) 0.03 1.77- lactose phosphotransferase system 
repressor 
SpTIGR4-0916 (3J7) 0 2.40- lysine decarboxylase 
SpTIGR4-0918 (3L7) 0.01 2.08- spermidine synthase 
SpTIGR4-0919 (3M7) 0.02 2.05- hypothetical protein 
SpTIGR4-0920 (3N7) 0 1.97- carboxynorspermidine 
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decarboxylase 
SpTIGR4-0921 (3O7) 0.01 2.24- agmatine deiminase 
SpTIGR4-0922 (3P7) 0.02 2.18- carbon-nitrogen hydrolase family protein 
SpTIGR4-0959 (3M12) 0.04 1.60- translation initiation factor factor IF-3 
SpTIGR4-0960 (3N12) 0.05 1.78- 50S ribosomal protein L35 
SpTIGR4-0961 (3O12) 0.01 1.65- 50S ribosomal protein L20 
SpTIGR4-0962 (3P12) 0.02 1.60- lactoylglutathione lyase 
SpTIGR4-0963 (3A13) 0.03 1.95- dihydroorotate dihydrogenase 
electron tranfer subunit 
SpTIGR4-0964 (3B13) 0.02 1.97- dihydroorotate dihydrogenase 1B 
SpTIGR4-0999 (3E17) 0.01 2.26+ cytochrome c-type biogenesis protein CcdA 
SpTIGR4-1000 (3F17) 0.01 2.37+ thioredoxin family protein 
SpTIGR4-1041 (3G22) 0.04 1.52- hypothetical protein 
SpTIGR4-1064 (3N13) 0.01 1.87- IS200 family transposase 
SpTIGR4-1117 (3K20) 0.02 1.53- NAD-dependent DNA ligase ligA 
SpTIGR4-1118 (3L20) 0.04 1.55- pullulanase 
SpTIGR4-1125 (3K21) 0.04 1.62- phosphoserine phosphatase SerB 
SpTIGR4-1149 (3K24) 0.01 1.6+ IS630-Spn1, transposase Orf1 
SpTIGR4-1160 (4F1) 0 2.60+ lipoate-protein ligase 
SpTIGR4-1161 (4G1) 0.04 2.66+ acetoin dehydrogenase complex, E3 component 
SpTIGR4-1162 (4H1) 0.01 2.64+ dihydrolipoamide acetyltransferase 
SpTIGR4-1163 (4A2) 0 2.29+ acetoin dehyrogenase, E1 
component beta subunit 
SpTIGR4-1164 (4B2) 0 2.23+ acetoin dehyrogenase, E1 
component alpha subunit 
SpTIGR4-1180 (4B4) 0.01 1.63- ribonucleotide-diphsphate 
reductase subunit deta 
SpTIGR4-1208 (4F7) 0.01 1.52- uridine kinase 
SpTIGR4-1225 (4G9) 0.02 1.97+ vicX protein 
SpTIGR4-1226 (4H9) 0.01 2.12+ sensory box sensor histidine kinase 
SpTIGR4-1227 (4A10) 0 2.21+ DNA-binding response regulator 
SpTIGR4-1228 (4B10) 0.02 3.60+ A/G-specific adenine glycosylase 
SpTIGR4-1248 (4E12) 0.04 1.71- ribonuclease 
SpTIGR4-1276 (4I4) 0.03 1.98- carbamoyl phosphate synthase 
small subunit 
SpTIGR4-1277 (4J4) 0.01 2.03- aspartate carbamoyltransferase 
catalytic subunit pyrB 
SpTIGR4-1278 (4K4) 0.02 2.09- 
bifunctional pyrimidine regulatory 
protein PyrR uracil 
phosphoribosyltransferase 
SpTIGR4-1286 (4K5) 0.03 2.13- uracil permease 
SpTIGR4-1353 (4F13) 0.02 1.94- hypothetical protein 
SpTIGR4-1354 (4G13) 0.05 1.62- 50S ribosomal protein L7/L12 
SpTIGR4-1357 (4B14) 0.01 1.72+ ABC transpoter ATP-binding protein/permease 
SpTIGR4-1358 (4C14) 0.03 1.63+ ABC transpoter ATP-binding protein/permease 
SpTIGR4-1361 (4F14) 0.04 1.53+ homoserine dehydrogenase 
SpTIGR4-1415 (4D21) 0.03 2.41+ glucosamine-6-phosphate isomerase 
SpTIGR4-1427 (4H22) 0.01 3.37- U32 family peptidase 
SpTIGR4-1428 (4A23) 0.02 3.41- hypothetical protein 
SpTIGR4-1429 (4B23) 0.02 2.73- U32 family peptidase 
SpTIGR4-1438 (4C24) 0.04 2.24+ ABC transpoter ATP-binding protein 
SpTIGR4-1458 (4O14) 0.02 1.63+ thioredoxin reductase 
SpTIGR4-1462 (4K15) 0.03 1.55+ hypothetical protein 
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SpTIGR4-1464 (4M15) 0.03 1.75+ acetyltransferase 
SpTIGR4-1471 (4L16) 0.03 3.63- oxidoreductase 
SpTIGR4-1472 (4M16) 0.01 4.14- oxidoreductase 
SpTIGR4-1499 (4P19) 0 2.52+ bacteriocin transport accessory protein 
SpTIGR4-1532 (4I24) 0.03 1.50- conserved domain protein 
SpTIGR4-1539 (4P24) 0.03 1.52- 30S ribosomal protein S18 
SpTIGR4-1546 (5G1) 0.01 4.41+ hypothetical protein 
SpTIGR4-1587 (5H6) 0.02 24+ oxalate:formate antiporter 
SpTIGR4-1592 (5E7) 0.03 1.61- hypothetical protein 
SpTIGR4-1622 (5C11) 0.02 2.01- IS200 family transposase 
SpTIGR4-1651 (5P2) 0.01 6.96+ thiol peroxidase 
SpTIGR4-1690 (5O7) 0.03 2.20+ ABC-transporter supstrate-binding protein 
SpTIGR4-1695 (5L8) 0.02 1.53+ acetyl xylan esterase 
SpTIGR4-1708 (5I10) 0.05 1.65+ hypothetical protein 
SpTIGR4-1716 (5I11) 0.05 1.51+ hypothetical protein 
SpTIGR4-1717 (5J11) 0.01 1.71+ ABC transpoter ATP-binding protein 
SpTIGR4-1721 (5N11) 0.03 1.86- fructokinase 
SpTIGR4-1724 (5I12) 0.01 1.52- sucrose-6-phosphate hydrolase 
SpTIGR4-1725 (5J12) 0.04 1.64- sucrose operon repressor 
SpTIGR4-1775 (5D18) 0.01 2.26+ hypothetical protein 
SpTIGR4-1776 (5E18) 0.04 2.17+ thioredoxin 
SpTIGR4-1778 (5G18) 0.01 3.87+ aquaporin 
SpTIGR4-1793 (5F20) 0.02 2.03+ hypothetical protein 
SpTIGR4-1794 (5G20) 0.02 2.33+ hypothetical protein 
SpTIGR4-1807 (5D22) 0 1.57+ acetyltransferase 
SpTIGR4-1809 (5F22) 0.02 1.87+ transcriptional regulator 
SpTIGR4-1845 (5J15) 0.01 2.03+ exodeoxyribonuclease 
SpTIGR4-1846 (5K15) 0.05 1.65+ conserved hypothetical protein 
SpTIGR4-1852 (5I16) 0.01 2.47+ galactose-1-phosphate 
uridylytransferase 
SpTIGR4-1860 (5I17) 0.04 2.6+ choline transporter 
SpTIGR4-1861 (5J17) 0.02 2.82+ choline transporter 
SpTIGR4-1862 (5K17) 0.03 2.89+ hypothetical protein 
SpTIGR4-1863 (5L17) 0.03 2.46+ MarR family transcriptional 
regulator 
SpTIGR4-1869 (5J18) 0.01 2.60+ iron-compound ABC transporter permease 
SpTIGR4-1871 (5L18) 0.03 2.43+ iron-compound ABC transporter ATP-binding protein 
SpTIGR4-1872 (5M18) 0.04 2.29+ iron-compound ABC transporter iron-compound-binding protein 
SpTIGR4-1884 (5I20) 0.03 2.25+ trehalose PTS system, IIABC 
components 
SpTIGR4-1894 (5K21) 0.01 2.28+ sucrose phosphorylase 
SpTIGR4-1895 (5L21) 0.01 2.21+ sugar ABC tranporter permease 
SpTIGR4-1896 (5M21) 0.02 2.54+ sugar ABC tranporter permease 
SpTIGR4-1897 (5N21) 0 2.43+ sugar ABC transporter substrate-binding protein 
SpTIGR4-1898 (5O21) 0.01 2.51+ alpha-glactosidase 
SpTIGR4-1947 (6H3) 0.02 2.23+ hypothetical protein 
SpTIGR4-1972 (6A7) 0.02 1.66+ hypothetical protein 
SpTIGR4-1988 (6A9) 0.02 1.74+ immunity protein 
SpTIGR4-2016 (6E12) 0 2.90+ nicotinate-nucleotide pyrophosphorylase 
SpTIGR4-2017 (6F12) 0 4.34+ hypothetical protein 
SpTIGR4-2026 (6O1) 0.03 3.30- bifunctional acetaldehyde-CoA/alcohol dehydrogenase 
SpTIGR4-2054 (6K5) 0.02 3.90+ hypothetical protein 
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SpTIGR4-2056 (6M5) 0.02 2.39+ N-acetylglucosamine-6-phosphate deacetylase 
SpTIGR4-2057 (6N5) 0.02 1.61+ hypothetical protein 
SpTIGR4-2063 (6L6) 0.02 2.60+ LysM domain-containing protein 
SpTIGR4-2073 (6N7) 0.03 1.58+ ABC transpoter ATP-binding protein/permease 
SpTIGR4-2075 (6P7) 0.01 1.76+ ABC transpoter ATP-binding protein/permease 
SpTIGR4-2084 (6I9) 0.01 1.88+ phosphate ABC transporter phosphate-binding protein 
SpTIGR4-2085 (6J9) 0.04 2.08+ phosphate ABC transporter permease 
SpTIGR4-2086 (6K9) 0.02 2.09+ phosphate ABC transporter permease 
SpTIGR4-2088 (6M9) 0.04 2.10+ phosphate transporter system 
regulator protein PhoU 
SpTIGR4-2096 (6M10) 0.04 1.53+ M20/M25/M40 family peptidase 
SpTIGR4-2106 (6O11) 0.01 3.42+ glycogen phosphrylase family protein 
SpTIGR4-2107 (6P11) 0.02 3.50+ 4-alpha-glucanotransferase 
SpTIGR4-2135 (6D15) 0.05 1.51- 3-keto-L-gulonate-phosphate decarboxylase 
SpTIGR4-2146 (6G16) 0.03 1.74+ hypothetical protein 
SpTIGR4-2181 (6A21) 0.01 2.63+ identified by similarity to EGAD:135254 
SpTIGR4-2186 (6F21) 0.01 2.60+ glycerol kinase glpK 
SpTIGR4-2188 (6H21) 0.02 2.08+ Hsp 33-like chaperonin 
SpTIGR4-2189 (6A22) 0.04 1.96+ NifR3 family TIM-barrel protein 
SpTIGR4-2190 (6B22) 0.02 1.50+ choline binding protein A 
SpTIGR4-2192 (6D22) 0.01 1.65+ sensor hesitidine kinase 
SpTIGR4-2194 (6F22) 0.02 1.91+ ATP-dependent Clp protease ATP-binding subunit 
SpTIGR4-2195 (6G22) 0.03 1.82+ transcriptional regulator CtsR 
SpTIGR4-2202 (6F23) 0.03 1.61+ hypothetical protein 
SpTIGR4-2203 (6G23) 0.04 1.63+ replicative DNA helicase 
SpTIGR4-2204 (6H23) 0 1.59+ 50S ribosomal protein L9 
SpTIGR4-2205 (6A24) 0.02 1.68+ DHH subfamily 1 protein 
SpTIGR4-2239 (6K16) 0.01 2.50+ serine protease 
SpTIGR4-2240 (6L16) 0.01 2.51+ spspoJ protein 
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Table A - 2 List of genes expressed significantly (p<0.05) during pneumomococcal TIGR4 
growth in oxygenated as compared to aerobic environmental conditions. P<0.05 with 
Benjamini and Hochberg correction applied for multiple testing using 1 way ANOVA test. 
Gene expression above 1.5-fold cut-off is used in the table. 
 
Gene number P<0.05 Fold change in O2 Biological function 
SpTIGR4-0148 (1L7) 0.0954 1.50+ ABC transporter substrate-binding protein 
SpTIGR4-0409 (2A4) 0.0877 2.65+ hypothetical protein 
SpTIGR4-0459 (2C10) 0.0871 2.21- formate acetyletransferase 
SpTIGR4-0626 (2H18) 0.0954 1.53+ branched-chain amino acid transport system II carrier protein 
SpTIGR4-0701 (2K16) 0.0877 2.03- orotidine 5-phosphate decarboxylase 
SpTIGR4-0702 (2L16) 0.0877 2.61- orotate phosphoribosyltransferase 
SpTIGR4-0703 (2M16) 0.0969 1.57- hypothetical protein 
SpTIGR4-0730 (2P19) 0.0994 1.70+ pyruvate oxidase 
SpTIGR4-0869 (3K1) 0.0925 1.79+ aminotransferase, class-v 
SpTIGR4-0916 (3J7) 0.0871 1.57- lysine decarboxylase 
SpTIGR4-0963 (3A13) 0.0877 2.28- dihydroorotate dihydrogenase 
electron tranfer subunit 
SpTIGR4-0964 (3B13) 0.0969 2.12- dihydroorotate dihydrogenase 1B 
SpTIGR4-0999 (3E17) 0.0871 2.14+ cytochrome c-type biogenesis protein CcdA 
SpTIGR4-1000 (3F17) 0.0925 2.35+ thioredoxin family protein 
SpTIGR4-1064 (3N13) 0.0877 1.62- IS200 family transposase 
SpTIGR4-1154 (3P24) 0.0877 1.73+ immunoglobulin A1 protease 
SpTIGR4-1175 (4E3) 0.0969 1.55+ hypothetical protein 
SpTIGR4-1277 (4J4) 0.0871 1.94- aspartate carbamoyltransferase 
catalytic subunit pyrB 
SpTIGR4-1278 (4K4) 0.0954 1.85- 
bifunctional pyrimidine regulatory 
protein PyrR uracil 
phosphoribosyltransferase 
SpTIGR4-1286 (4K5) 0.0871 2.35- uracil permease 
SpTIGR4-1499 (4P19) 0.0796 2.52+ bacteriocin transport accessory protein 
SpTIGR4-1572 (5A5) 0.0994 2.19- non-heme iron containing ferritin 
SpTIGR4-1622 (5C11) 0.0871 1.88- IS200 family transposase 
SpTIGR4-1651 (5P2) 0.0871 2.45+ thiol peroxidase 
SpTIGR4-1721 (5N11) 0.0871 1.71- fructokinase 
SpTIGR4-1775 (5D18) 0.0871 1.64+ hypothetical protein 
SpTIGR4-1811 (5H22) 0.0954 1.75+ tryptophan synthase subunit alpha 
SpTIGR4-1884 (5I20) 0.0871 2.94- trehalose PTS system, IIABC 
components 
SpTIGR4-2005 (6B11) 0.0877 1.57+ hypothetical protein 
SpTIGR4-2072 (6M7) 0.0994 1.94+ glutamine amidotransferase class I 
SpTIGR4-2084 (6I9) 0.0877 2.42- phosphate ABC transporter phosphate-binding protein 
SpTIGR4-2085 (6J9) 0.0877 2.58- phosphate ABC transporter permease 
SpTIGR4-2086 (6K9) 0.0877 2.63- phosphate ABC transporter permease 
SpTIGR4-2088 (6M9) 0.0969 2.88- phosphate transporter system 
regulator protein PhoU 
SpTIGR4-2187 (6G21) 0.0877 1.56+ hypothetical protein 
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Table A - 3 List of genes expressed during pneumomococcal TIGR4 growth in anoxygenated as 
compared to aerobic environmental conditions. P<0.05 with Benjamini and Hochberg 
correction applied for multiple testing using 1 way ANOVA test. Gene expression above 1.5-
fold cut-off is used in the table. 
 
Gene number P<0.05 Fold change in AnO2 Biological function 
SpTIGR4-0095 (1G12) 0.0397 28.66- hypothetical protein 
SpTIGR4-2054 (6K5) 0.0281 4.61- hypothetical protein 
SpTIGR4-2187 (6G21) 0.0177 6.60- hypothetical protein 
SpTIGR4-0012 (1D2) 0.0477 1.56- hypoxanthine-guanine phosphoribosyltransferase 
SpTIGR4-0013 (1E2) 0.0207 1.52- cell division protein FtsH 
SpTIGR4-0045 (1E6) 0.0119 2.67- phosphoribosylformylglycinamidine 
synthase 
SpTIGR4-0046 (1F6) 0.0493 3.15- amidophosphorobosyltransferase 
SpTIGR4-0047 (1G6) 0.0494 2.82- phosphoribosylaminoimidazole 
synthetase 
SpTIGR4-0050 (1B7) 0.0202 2.73- bifunctional 
SpTIGR4-0051 (1C7) 0.0202 1.65- phosphoribosylamine-glycine ligase 
SpTIGR4-0075 (1C10) 0.0427 1.84- phosphorylase Pnp/Udp family protein 
SpTIGR4-0079 (1G10) 0.0494 1.56- Trk family potassium uptake protein 
SpTIGR4-0083 (1C11) 0.0473 1.60- DNA-binding response regulator 
SpTIGR4-0088 (1H11) 0.0269 2.51- hypothetical protein 
SpTIGR4-0089 (1A12) 0.0428 1.56- hypothetical protein 
SpTIGR4-0095 (1G12) 0.00975 28.66- hypothetical protein 
SpTIGR4-0107 (1K2) 0.013 3.62- LysM domain-containing protein 
SpTIGR4-0118 (1N3) 0.0421 1.53- tRNA-specific MnmA 
SpTIGR4-0119 (1O3) 0.0282 1.92- MutT/nudix family protein 
SpTIGR4-0145 (1I7) 0.0322 1.64- hypothetical protein 
SpTIGR4-0191 (1O12) 0.0433 1.86- hypothetical protein 
SpTIGR4-0193 (1A13) 0.0449 1.64- match to protein family HMM TIGR00250 
SpTIGR4-0198 (1F13) 0.00975 2.20- hypothetical protein 
SpTIGR4-0199 (1G13) 0.0213 1.80- cardiolipin synthetase 
SpTIGR4-0220 (1D16) 0.0399 1.543+ 50 S ribosomal protein L24 
SpTIGR4-0259 (1C21) 0.049 1.52- holliday junction DNA helicase RuvB 
SpTIGR4-0267 (1C22) 0.0277 1.85- hypothetical protein 
SpTIGR4-0299 (1K14) 0.0473 1.52- IS630-Spn1, transposase Orf1, 
authentic frameshift 
SpTIGR4-0324 (1L17) 0.0391 5.74- PTS system, IIC component 
SpTIGR4-0325 (1M17) 0.0391 8.91- PTS system, IID component 
SpTIGR4-0338 (1J19) 0.00975 28.58- ATP-dependent Clp protease ATP-binding subunit 
SpTIGR4-0385 (2A1) 0.0399 1.59- hypothetical protein 
SpTIGR4-0409 (2A4) 0.0262 2.13+ hypothetical protein 
SpTIGR4-0488 (2O1) 0.0202 2.96- hypothetical protein 
SpTIGR4-0489 (2P1) 0.0269 2.22- PAP2 family protein 
SpTIGR4-0490 (2I2) 0.0202 2.09- hypothetical protein 
SpTIGR4-0492 (2K2) 0.0477 2.10- hypothetical protein 
SpTIGR4-0499 (2J3) 0.0477 2.09+ phosphoglycerate kinase 
SpTIGR4-0710 (2L17) 0.0289 2.90- amino acid ABC transporter permease 
SpTIGR4-0711 (2M17) 0.0322 2.93- amino acid ABC transporter permease 
SpTIGR4-0716 (2J18) 0.0494 3.07- transcriptional regulator 
SpTIGR4-0717 (2K18) 0.0494 3.45- hydroxyethylthiazole kinase 
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SpTIGR4-0726 (2L19) 0.025 3.26- phosphomethylpyrimidine kinase 
SpTIGR4-0730 (2P19) 0.0433 1.97- pyruvate oxidase 
SpTIGR4-0731 (2I20) 0.0213 2.07- hypothetical protein 
SpTIGR4-0789 (3C3) 0.0449 1.85- hypothetical protein 
SpTIGR4-0790 (3D3) 0.00975 2.00- hypothetical protein 
SpTIGR4-0799 (3E4) 0.0473 2.56- sensor histidine kinase CiaH 
SpTIGR4-0820 (3B7) 0.031 2.02- ATP-dependent Clp protease ATP-binding subunit 
SpTIGR4-0868 (3J1) 0.0207 3.28- hypothetical protein 
SpTIGR4-0869 (3K1) 0.0119 4.00- aminotransferase, class-V 
SpTIGR4-0916 (3J7) 0.0289 1.52+ lysine decarboxylase 
SpTIGR4-0918 (3L7) 0.0493 1.64+ spermidine synthase 
SpTIGR4-0921 (3O7) 0.0466 1.52+ agmatine deiminase 
SpTIGR4-1090 (3P16) 0.0405 2.00+ redox-sensing transcriptional 
repressor Rex 
SpTIGR4-1148 (3J24) 0.0268 1.56- IS630-Spn1, transposase Orf2 
SpTIGR4-1149 (3K24) 0.0399 1.63- IS630-Spn1, transposase Orf1 
SpTIGR4-1152 (3N24) 0.0473 1.50+ exonuclease RexA 
SpTIGR4-1153 (3O24) 0.0443 1.57+ hypothetical protein 
SpTIGR4-1163 (4A2) 0.0174 2.34- acetoin dehyrogenase, E1 
component beta subunit 
SpTIGR4-1164 (4B2) 0.0322 2.26- acetoin dehyrogenase, E1 
component alpha subunit 
SpTIGR4-1180 (4B4) 0.0174 1.86+ ribonucleotide-diphsphate 
reductase subunit deta 
SpTIGR4-1190 (4D5) 0.0213 2.33+ tagatose 1,6-diphosphate aldolase 
SpTIGR4-1192 (4F5) 0.0202 2.04+ glactose-6-phosphate isomerase 
subunit LacB 
SpTIGR4-1227 (4A10) 0.0402 1.50- DNA-binding response regulator 
SpTIGR4-1228 (4B10) 0.00975 2.39- A/G-specific adenine glycosylase 
SpTIGR4-1415 (4D21) 0.0266 2.06- glucosamine-6-phosphate isomerase 
SpTIGR4-1419 (4H21) 0.0174 1.96+ acetyltransferase 
SpTIGR4-1420 (4A22) 0.0494 1.73+ NAD synthetase 
SpTIGR4-1428 (4A23) 0.0267 1.70+ hypothetical protein 
SpTIGR4-1438 (4C24) 0.0399 2.84- ABC transpoter ATP-binding protein 
SpTIGR4-1450 (4O13) 0.0289 1.60+ platelet activation factor 
SpTIGR4-1451 (4P13) 0.0414 1.72+ Cof family protein 
SpTIGR4-1452 (4I14) 0.0202 1.58+ hypothetical protein 
SpTIGR4-1470 (4K16) 0.013 3.03+ thiamine biosynthesis protein ApbE 
SpTIGR4-1471 (4L16) 0.0202 4.00+ oxidoreductase 
SpTIGR4-1472 (4M16) 0.0372 3.42+ oxidoreductase 
SpTIGR4-1546 (5G1) 0.0269 2.69- hypothetical protein 
SpTIGR4-1587 (5H6) 0.0202 9.00- oxalate: formate antiporter 
SpTIGR4-1651 (5P2) 0.0266 2.84- thiol peroxidase 
SpTIGR4-1778 (5G18) 0.0258 3.45- aquaporin 
SpTIGR4-1793 (5F20) 0.0211 4.11- hypothetical protein 
SpTIGR4-1794 (5G20) 0.013 4.07- hypothetical protein 
SpTIGR4-1809 (5F22) 0.0119 1.90- transcriptional regulator 
SpTIGR4-1852 (5I16) 0.0433 2.80- glactose-1-phosphate 
uridylyltransferase 
SpTIGR4-1860 (5I17) 0.0277 2.00- choline transporter 
SpTIGR4-1861 (5J17) 0.013 2.33- choline transporter 
SpTIGR4-1862 (5K17) 0.00975 2.35- hypothetical protein 
SpTIGR4-1883 (5P19) 0.0174 4.16- dextran glucosidase DexS 
SpTIGR4-1884 (5I20) 0.013 6.62- trehalose PTS system, IIABC 
components 
SpTIGR4-1894 (5K21) 0.0282 1.95- sucrose phosphorylase 
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SpTIGR4-1896 (5M21) 0.0322 2.35- sugar ABC transporter permease 
SpTIGR4-1897 (5N21) 0.0322 2.22- sugar ABC transporter substrate-binding protein 
SpTIGR4-1898 (5O21) 0.00975 2.20- alpha-glactosidase 
SpTIGR4-1988 (6A9) 0.0449 1.71- immunity protein 
SpTIGR4-2010 (6G11) 0.0494 1.58- penicillen-binding protein 2A 
SpTIGR4-2013 (6B12) 0.0289 2.01- hypothetical protein 
SpTIGR4-2016 (6E12) 0.0266 3.40- nicotinate-nucleotide pyrophosphorylase 
SpTIGR4-2054 (6K5) 0.00975 4.52- hypothetical protein 
SpTIGR4-2056 (6M5) 0.0372 2.65- N-acetylglucosamine-6-phosphate deacetylase 
SpTIGR4-2058 (6O5) 0.0146 2.00- queuine tRNA-ribosyltranferase 
SpTIGR4-2063 (6L6) 0.0266 2.78- LysM domain-containing protein 
SpTIGR4-2073 (6N7) 0.0289 1.68- ABC transpoter ATP-binding protein/permease 
SpTIGR4-2076 (6I8) 0.0333 1.58- DNA mismatch repair protein protein HexA 
SpTIGR4-2084 (6I9) 0.0207 4.56- phosphate ABC transporter phosphate-binding protein 
SpTIGR4-2085 (6J9) 0.0289 5.39- phosphate ABC transporter permease 
SpTIGR4-2086 (6K9) 0.0311 5.52- phosphate ABC transporter permease 
SpTIGR4-2088 (6M9) 0.0399 6.05- phosphate transporter system 
regulator protein PhoU 
SpTIGR4-2106 (6O11) 0.0108 5.19- glycogen phosphrylase family protein 
SpTIGR4-2146 (6G16) 0.0202 2.16- hypothetical protein 
SpTIGR4-2148 (6A17) 0.0399 1.79- arginine deiminase 
SpTIGR4-2150 (6B17) 0.0473 1.72- ornithine carbamoyltransferase 
SpTIGR4-2180 (6H20) 0.0449 1.89- conserved hypothetical protein 
SpTIGR4-2181 (6A21) 0.0262 3.07- identified by similarity to EGAD:135254 
SpTIGR4-2186 (6F21) 0.0267 2.17- glycerol kinase glpK 
SpTIGR4-2187 (6G21) 0.00975 6.60- hypothetical protein 
SpTIGR4-2193 (6E22) 0.0494 1.61- DNA-binding response regulator 
SpTIGR4-2194 (6F22) 0.0289 1.82- ATP-dependent Clp protease ATP-binding subunit 
SpTIGR4-2195 (6G22) 0.0289 2.10- transcriptional regulator CtsR 
SpTIGR4-2210 (6F24) 0.0428 1.56- hypothetical protein 
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Table A - 4 List of genes expressed (p<0.1) during pneumomococcal TIGR4 growth in 
different levels of oxygen. Oxy = oxygenated, Anoxy = anoxygenated, Anaero = anaerobic 
and Aero = aerobic. P<0.1 with Benjamini and Hochberg correction applied for multiple 
testing using 1 way ANOVA test. 
 
Oxy. vs Anoxy. Anaero. vs Aero. 
Gene P<0.1 Gene P<0.1 
SpTIGR4-0013 (1E2) 0.00852 SpTIGR4-0004 (1D1) 0.0374 
SpTIGR4-0014 (1F2) 0.0804 SpTIGR4-0011 (1C2) 0.0669 
SpTIGR4-0015 (1G2) 0.071 SpTIGR4-0012 (1D2) 0.0477 
SpTIGR4-0016 (1H2) 0.00664 SpTIGR4-0013 (1E2) 0.0207 
SpTIGR4-0023 (1G3) 0.0495 SpTIGR4-0016 (1H2) 0.0889 
SpTIGR4-0024 (1H3) 0.0265 SpTIGR4-0022 (1F3) 0.0666 
SpTIGR4-0025 (1A4) 0.0611 SpTIGR4-0023 (1G3) 0.0768 
SpTIGR4-0026 (1B4) 0.0605 SpTIGR4-0026 (1B4) 0.0845 
SpTIGR4-0032 (1H4) 0.00451 SpTIGR4-0032 (1H4) 0.0322 
SpTIGR4-0036 (1D5) 0.0414 SpTIGR4-0034 (1B5) 0.0907 
SpTIGR4-0041 (1A6) 0.0218 SpTIGR4-0044 (1D6) 0.0586 
SpTIGR4-0044 (1D6) 0.0486 SpTIGR4-0045 (1E6) 0.0119 
SpTIGR4-0045 (1E6) 0.0582 SpTIGR4-0046 (1F6) 0.0493 
SpTIGR4-0046 (1F6) 0.0414 SpTIGR4-0047 (1G6) 0.0494 
SpTIGR4-0047 (1G6) 0.0618 SpTIGR4-0048 (1H6) 0.0652 
SpTIGR4-0048 (1H6) 0.0711 SpTIGR4-0049 (1A7) 0.0551 
SpTIGR4-0049 (1A7) 0.0733 SpTIGR4-0050 (1B7) 0.0202 
SpTIGR4-0050 (1B7) 0.0556 SpTIGR4-0051 (1C7) 0.0202 
SpTIGR4-0051 (1C7) 0.093 SpTIGR4-0053 (1E7) 0.0701 
SpTIGR4-0053 (1E7) 0.091 SpTIGR4-0060 (1D8) 0.08 
SpTIGR4-0055 (1G7) 0.0702 SpTIGR4-0069 (1E9) 0.0822 
SpTIGR4-0056 (1H7) 0.0787 SpTIGR4-0075 (1C10) 0.0427 
SpTIGR4-0060 (1D8) 0.0431 SpTIGR4-0079 (1G10) 0.0494 
SpTIGR4-0063 (1G8) 0.0733 SpTIGR4-0083 (1C11) 0.0473 
SpTIGR4-0075 (1C10) 0.015 SpTIGR4-0084 (1D11) 0.0275 
SpTIGR4-0079 (1G10) 0.0179 SpTIGR4-0088 (1H11) 0.0269 
SpTIGR4-0083 (1C11) 0.0146 SpTIGR4-0089 (1A12) 0.0428 
SpTIGR4-0084 (1D11) 0.021 SpTIGR4-0095 (1G12) 0.00975 
SpTIGR4-0085 (1E11) 0.0377 SpTIGR4-0096 (1H12) 0.0525 
SpTIGR4-0088 (1H11) 0.032 SpTIGR4-0102 (1N1) 0.0554 
SpTIGR4-0089 (1A12) 0.0741 SpTIGR4-0105 (1I2) 0.0473 
SpTIGR4-0095 (1G12) 0.00688 SpTIGR4-0107 (1K2) 0.013 
SpTIGR4-0096 (1H12) 0.045 SpTIGR4-0118 (1N3) 0.0421 
SpTIGR4-0102 (1N1) 0.0377 SpTIGR4-0119 (1O3) 0.0282 
SpTIGR4-0104 (1P1) 0.0335 SpTIGR4-0120 (1P3) 0.072 
SpTIGR4-0105 (1I2) 0.00722 SpTIGR4-0142 (1N6) 0.0677 
SpTIGR4-0106 (1J2) 0.0255 SpTIGR4-0145 (1I7) 0.0322 
SpTIGR4-0107 (1K2) 0.0182 SpTIGR4-0168 (1P9) 0.0702 
SpTIGR4-0110 (1N2) 0.0162 SpTIGR4-0173 (1M10) 0.0669 
SpTIGR4-0118 (1N3) 0.0367 SpTIGR4-0189 (1M12) 0.0666 
SpTIGR4-0119 (1O3) 0.0994 SpTIGR4-0191 (1O12) 0.0433 
SpTIGR4-0120 (1P3) 0.00976 SpTIGR4-0192 (1P12) 0.0586 
SpTIGR4-0142 (1N6) 0.0549 SpTIGR4-0193 (1A13) 0.0449 
SpTIGR4-0145 (1I7) 0.033 SpTIGR4-0198 (1F13) 0.00975 
SpTIGR4-0148 (1L7) 0.0489 SpTIGR4-0199 (1G13) 0.0213 
SpTIGR4-0149 (1M7) 0.0504 SpTIGR4-0202 (1B14) 0.0919 
SpTIGR4-0153 (1I8) 0.0531 SpTIGR4-0217 (1A16) 0.0702 
SpTIGR4-0163 (1K9) 0.0531 SpTIGR4-0220 (1D16) 0.0399 
SpTIGR4-0165 (1M9) 0.0402 SpTIGR4-0222 (1F16) 0.072 
SpTIGR4-0168 (1P9) 0.0273 SpTIGR4-0223 (1G16) 0.0554 
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SpTIGR4-0173 (1M10) 0.0552 SpTIGR4-0228 (1D17) 0.0592 
SpTIGR4-0187 (1K12) 0.0733 SpTIGR4-0231 (1G17) 0.0845 
SpTIGR4-0189 (1M12) 0.0368 SpTIGR4-0232 (1H17) 0.0954 
SpTIGR4-0191 (1O12) 0.0479 SpTIGR4-0234 (1B18) 0.0768 
SpTIGR4-0192 (1P12) 0.0237 SpTIGR4-0237 (1E18) 0.0372 
SpTIGR4-0193 (1A13) 0.0733 SpTIGR4-0250 (1B20) 0.0673 
SpTIGR4-0198 (1F13) 0.00352 SpTIGR4-0255 (1G20) 0.0666 
SpTIGR4-0199 (1G13) 0.0295 SpTIGR4-0259 (1C21) 0.049 
SpTIGR4-0202 (1B14) 0.0365 SpTIGR4-0261 (1E21) 0.0667 
SpTIGR4-0203 (1C14) 0.091 SpTIGR4-0263 (1G21) 0.0561 
SpTIGR4-0204 (1D14) 0.0237 SpTIGR4-0267 (1C22) 0.0277 
SpTIGR4-0205 (1E14) 0.032 SpTIGR4-0272 (1H22) 0.0202 
SpTIGR4-0206 (1F14) 0.045 SpTIGR4-0284 (1D24) 0.0504 
SpTIGR4-0208 (1H14) 0.0273 SpTIGR4-0287 (1G24) 0.0846 
SpTIGR4-0209 (1A15) 0.0279 SpTIGR4-0290 (1J13) 0.08 
SpTIGR4-0210 (1B15) 0.0556 SpTIGR4-0299 (1K14) 0.0473 
SpTIGR4-0211 (1C15) 0.0268 SpTIGR4-0311 (1O15) 0.0904 
SpTIGR4-0212 (1D15) 0.033 SpTIGR4-0314 (1J16) 0.0859 
SpTIGR4-0213 (1E15) 0.0418 SpTIGR4-0324 (1L17) 0.0391 
SpTIGR4-0214 (1F15) 0.091 SpTIGR4-0325 (1M17) 0.0391 
SpTIGR4-0217 (1A16) 0.0278 SpTIGR4-0330 (1J18) 0.0525 
SpTIGR4-0219 (1C16) 0.063 SpTIGR4-0338 (1J19) 0.00975 
SpTIGR4-0220 (1D16) 0.0367 SpTIGR4-0342 (1N19) 0.0322 
SpTIGR4-0222 (1F16) 0.0497 SpTIGR4-0344 (1P19) 0.0854 
SpTIGR4-0223 (1G16) 0.0479 SpTIGR4-0345 (1I20) 0.0787 
SpTIGR4-0228 (1D17) 0.0582 SpTIGR4-0354 (1J21) 0.0822 
SpTIGR4-0230 (1F17) 0.045 SpTIGR4-0356 (1L21) 0.0666 
SpTIGR4-0232 (1H17) 0.0253 SpTIGR4-0358 (1N21) 0.0473 
SpTIGR4-0233 (1A18) 0.0173 SpTIGR4-0359 (1O21) 0.0884 
SpTIGR4-0234 (1B18) 0.0193 SpTIGR4-0360 (1P21) 0.0845 
SpTIGR4-0237 (1E18) 0.0095 SpTIGR4-0368 (1P22) 0.0697 
SpTIGR4-0239 (1G18) 0.0701 SpTIGR4-0369 (1I23) 0.00975 
SpTIGR4-0240 (1H18) 0.0521 SpTIGR4-0370 (1J23) 0.0473 
SpTIGR4-0246 (1F19) 0.0975 SpTIGR4-0371 (1K23) 0.0774 
SpTIGR4-0250 (1B20) 0.0769 SpTIGR4-0372 (1L23) 0.055 
SpTIGR4-0259 (1C21) 0.095 SpTIGR4-0373 (1M23) 0.0423 
SpTIGR4-0261 (1E21) 0.0527 SpTIGR4-0377 (1I24) 0.0847 
SpTIGR4-0263 (1G21) 0.0339 SpTIGR4-0378 (1J24) 0.0666 
SpTIGR4-0264 (1H21) 0.0554 SpTIGR4-0385 (2A1) 0.0399 
SpTIGR4-0266 (1B22) 0.0701 SpTIGR4-0386 (2B1) 0.0702 
SpTIGR4-0267 (1C22) 0.0167 SpTIGR4-0387 (2C1) 0.0586 
SpTIGR4-0270 (1F22) 0.0618 SpTIGR4-0389 (2E1) 0.0598 
SpTIGR4-0271 (1G22) 0.0861 SpTIGR4-0390 (2F1) 0.0964 
SpTIGR4-0272 (1H22) 0.00451 SpTIGR4-0402 (2B3) 0.0311 
SpTIGR4-0273 (1A23) 0.0108 SpTIGR4-0405 (2E3) 0.0861 
SpTIGR4-0275 (1C23) 0.0742 SpTIGR4-0409 (2A4) 0.0262 
SpTIGR4-0278 (1F23) 0.0748 SpTIGR4-0412 (2D4) 0.0554 
SpTIGR4-0282 (1B24) 0.0974 SpTIGR4-0432 (2H6) 0.0859 
SpTIGR4-0283 (1C24) 0.0605 SpTIGR4-0438 (2F7) 0.0741 
SpTIGR4-0284 (1D24) 0.0387 SpTIGR4-0453 (2E9) 0.0713 
SpTIGR4-0286 (1F24) 0.063 SpTIGR4-0459 (2C10) 0.013 
SpTIGR4-0287 (1G24) 0.0899 SpTIGR4-0481 (2I1) 0.0904 
SpTIGR4-0288 (1H24) 0.0975 SpTIGR4-0482 (2J1) 0.0854 
SpTIGR4-0289 (1I13) 0.0331 SpTIGR4-0483 (2K1) 0.0504 
SpTIGR4-0295 (1O13) 0.0504 SpTIGR4-0487 (2N1) 0.0669 
SpTIGR4-0299 (1K14) 0.0767 SpTIGR4-0488 (2O1) 0.0202 
SpTIGR4-0300 (1L14) 0.0492 SpTIGR4-0489 (2P1) 0.0269 
SpTIGR4-0311 (1O15) 0.0753 SpTIGR4-0490 (2I2) 0.0202 
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SpTIGR4-0324 (1L17) 0.0237 SpTIGR4-0492 (2K2) 0.0477 
SpTIGR4-0325 (1M17) 0.021 SpTIGR4-0496 (2O2) 0.0713 
SpTIGR4-0330 (1J18) 0.00704 SpTIGR4-0499 (2J3) 0.0477 
SpTIGR4-0338 (1J19) 0.00411 SpTIGR4-0500 (2K3) 0.0845 
SpTIGR4-0340 (1L19) 0.0546 SpTIGR4-0506 (2I4) 0.0847 
SpTIGR4-0344 (1P19) 0.032 SpTIGR4-0507 (2J4) 0.076 
SpTIGR4-0345 (1I20) 0.0431 SpTIGR4-0515 (2J5) 0.0693 
SpTIGR4-0349 (1M20) 0.063 SpTIGR4-0516 (2K5) 0.0536 
SpTIGR4-0351 (1O20) 0.0143 SpTIGR4-0526 (2M6) 0.0494 
SpTIGR4-0352 (1P20) 0.0541 SpTIGR4-0527 (2N6) 0.0423 
SpTIGR4-0353 (1I21) 0.0691 SpTIGR4-0529 (2P6) 0.0679 
SpTIGR4-0354 (1J21) 0.0727 SpTIGR4-0530 (2I7) 0.0254 
SpTIGR4-0355 (1K21) 0.0218 SpTIGR4-0532 (2K7) 0.0561 
SpTIGR4-0356 (1L21) 0.0444 SpTIGR4-0547 (2J9) 0.0511 
SpTIGR4-0357 (1M21) 0.0884 SpTIGR4-0565 (2K11) 0.068 
SpTIGR4-0358 (1N21) 0.032 SpTIGR4-0568 (2N11) 0.0473 
SpTIGR4-0359 (1O21) 0.04 SpTIGR4-0605 (2C16) 0.0504 
SpTIGR4-0360 (1P21) 0.0899 SpTIGR4-0626 (2H18) 0.0954 
SpTIGR4-0361 (1I22) 0.0897 SpTIGR4-0645 (2C21) 0.0859 
SpTIGR4-0366 (1N22) 0.0728 SpTIGR4-0648 (2F21) 0.0787 
SpTIGR4-0368 (1P22) 0.0295 SpTIGR4-0663 (2E23) 0.0494 
SpTIGR4-0369 (1I23) 0.0201 SpTIGR4-0666 (2H23) 0.0915 
SpTIGR4-0370 (1J23) 0.0237 SpTIGR4-0667 (2A24) 0.0974 
SpTIGR4-0372 (1L23) 0.00249 SpTIGR4-0674 (2H24) 0.0689 
SpTIGR4-0373 (1M23) 0.00766 SpTIGR4-0675 (2I13) 0.0994 
SpTIGR4-0375 (1O23) 0.0674 SpTIGR4-0688 (2N14) 0.0945 
SpTIGR4-0376 (1P23) 0.0237 SpTIGR4-0695 (2M15) 0.0702 
SpTIGR4-0377 (1I24) 0.066 SpTIGR4-0704 (2N16) 0.0282 
SpTIGR4-0378 (1J24) 0.0193 SpTIGR4-0707 (2I17) 0.0554 
SpTIGR4-0385 (2A1) 0.0339 SpTIGR4-0709 (2K17) 0.0527 
SpTIGR4-0386 (2B1) 0.00411 SpTIGR4-0710 (2L17) 0.0289 
SpTIGR4-0387 (2C1) 0.0479 SpTIGR4-0711 (2M17) 0.0322 
SpTIGR4-0389 (2E1) 0.0193 SpTIGR4-0715 (2I18) 0.0854 
SpTIGR4-0391 (2G1) 0.0367 SpTIGR4-0716 (2J18) 0.0494 
SpTIGR4-0393 (2A2) 0.0598 SpTIGR4-0717 (2K18) 0.0494 
SpTIGR4-0401 (2A3) 0.075 SpTIGR4-0718 (2L18) 0.0702 
SpTIGR4-0412 (2D4) 0.0489 SpTIGR4-0726 (2L19) 0.025 
SpTIGR4-0421 (2E5) 0.0632 SpTIGR4-0728 (2N19) 0.0974 
SpTIGR4-0430 (2F6) 0.0977 SpTIGR4-0729 (2O19) 0.0787 
SpTIGR4-0432 (2H6) 0.0302 SpTIGR4-0730 (2P19) 0.0433 
SpTIGR4-0438 (2F7) 0.0414 SpTIGR4-0731 (2I20) 0.0213 
SpTIGR4-0440 (2H7) 0.0994 SpTIGR4-0736 (2N20) 0.0701 
SpTIGR4-0445 (2E8) 0.071 SpTIGR4-0742 (2L21) 0.0954 
SpTIGR4-0453 (2E9) 0.0343 SpTIGR4-0748 (2J22) 0.0635 
SpTIGR4-0487 (2N1) 0.0492 SpTIGR4-0783 (3E2) 0.0473 
SpTIGR4-0488 (2O1) 0.00704 SpTIGR4-0789 (3C3) 0.0449 
SpTIGR4-0489 (2P1) 0.0223 SpTIGR4-0790 (3D3) 0.00975 
SpTIGR4-0490 (2I2) 0.0131 SpTIGR4-0791 (3E3) 0.0257 
SpTIGR4-0492 (2K2) 0.0508 SpTIGR4-0798 (3D4) 0.0832 
SpTIGR4-0494 (2M2) 0.0834 SpTIGR4-0799 (3E4) 0.0473 
SpTIGR4-0499 (2J3) 0.0673 SpTIGR4-0806 (3D5) 0.0697 
SpTIGR4-0500 (2K3) 0.0302 SpTIGR4-0819 (3A7) 0.0602 
SpTIGR4-0501 (2L3) 0.0639 SpTIGR4-0820 (3B7) 0.031 
SpTIGR4-0504 (2O3) 0.0565 SpTIGR4-0823 (3E7) 0.0423 
SpTIGR4-0506 (2I4) 0.0114 SpTIGR4-0838 (3D9) 0.0726 
SpTIGR4-0507 (2J4) 0.0333 SpTIGR4-0842 (3H9) 0.064 
SpTIGR4-0508 (2K4) 0.0801 SpTIGR4-0844 (3B10) 0.088 
SpTIGR4-0515 (2J5) 0.0477 SpTIGR4-0846 (3D10) 0.0974 
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SpTIGR4-0516 (2K5) 0.0548 SpTIGR4-0851 (3A11) 0.0262 
SpTIGR4-0525 (2L6) 0.0532 SpTIGR4-0857 (3G11) 0.0525 
SpTIGR4-0526 (2M6) 0.04 SpTIGR4-0858 (3H11) 0.0266 
SpTIGR4-0527 (2N6) 0.075 SpTIGR4-0867 (3I1) 0.0601 
SpTIGR4-0529 (2P6) 0.0327 SpTIGR4-0868 (3J1) 0.0207 
SpTIGR4-0530 (2I7) 0.0224 SpTIGR4-0869 (3K1) 0.0119 
SpTIGR4-0532 (2K7) 0.0425 SpTIGR4-0870 (3L1) 0.0701 
SpTIGR4-0533 (2L7) 0.0727 SpTIGR4-0872 (3N1) 0.0854 
SpTIGR4-0545 (2P8) 0.0203 SpTIGR4-0876 (3J2) 0.0768 
SpTIGR4-0547 (2J9) 0.0429 SpTIGR4-0877 (3K2) 0.0904 
SpTIGR4-0548 (2K9) 0.0508 SpTIGR4-0887 (3M3) 0.0736 
SpTIGR4-0549 (2L9) 0.0787 SpTIGR4-0893 (3K4) 0.0652 
SpTIGR4-0550 (2M9) 0.0632 SpTIGR4-0898 (3P4) 0.0405 
SpTIGR4-0564 (2J11) 0.0425 SpTIGR4-0901 (3K5) 0.0449 
SpTIGR4-0567 (2M11) 0.0843 SpTIGR4-0902 (3L5) 0.0698 
SpTIGR4-0568 (2N11) 0.0733 SpTIGR4-0916 (3J7) 0.0289 
SpTIGR4-0579 (2A13) 0.0244 SpTIGR4-0918 (3L7) 0.0493 
SpTIGR4-0580 (2B13) 0.0504 SpTIGR4-0919 (3M7) 0.0798 
SpTIGR4-0581 (2C13) 0.0279 SpTIGR4-0920 (3N7) 0.0399 
SpTIGR4-0601 (2G15) 0.0537 SpTIGR4-0921 (3O7) 0.0466 
SpTIGR4-0605 (2C16) 0.0516 SpTIGR4-0922 (3P7) 0.097 
SpTIGR4-0613 (2C17) 0.0834 SpTIGR4-0931 (3I9) 0.0949 
SpTIGR4-0614 (2D17) 0.0733 SpTIGR4-0938 (3P9) 0.0893 
SpTIGR4-0617 (2G17) 0.0404 SpTIGR4-0947 (3I11) 0.0561 
SpTIGR4-0618 (2H17) 0.0632 SpTIGR4-0950 (3L11) 0.0289 
SpTIGR4-0621 (2C18) 0.0504 SpTIGR4-0961 (3O12) 0.0859 
SpTIGR4-0626 (2H18) 0.0729 SpTIGR4-0962 (3P12) 0.0174 
SpTIGR4-0629 (2C19) 0.0479 SpTIGR4-0968 (3F13) 0.0907 
SpTIGR4-0630 (2D19) 0.0402 SpTIGR4-0995 (3A17) 0.0787 
SpTIGR4-0631 (2E19) 0.0801 SpTIGR4-0996 (3B17) 0.0907 
SpTIGR4-0633 (2G19) 0.0733 SpTIGR4-1003 (3A18) 0.0587 
SpTIGR4-0644 (2B21) 0.0367 SpTIGR4-1004 (3B18) 0.0282 
SpTIGR4-0648 (2F21) 0.0431 SpTIGR4-1014 (3D19) 0.0269 
SpTIGR4-0649 (2G21) 0.00976 SpTIGR4-1020 (3B20) 0.0473 
SpTIGR4-0655 (2E22) 0.0637 SpTIGR4-1027 (3A21) 0.0717 
SpTIGR4-0656 (2F22) 0.0497 SpTIGR4-1029 (3C21) 0.0669 
SpTIGR4-0663 (2E23) 0.01 SpTIGR4-1034 (3H21) 0.0945 
SpTIGR4-0664 (2F23) 0.0295 SpTIGR4-1041 (3G22) 0.0669 
SpTIGR4-0666 (2H23) 0.0917 SpTIGR4-1044 (3B23) 0.0494 
SpTIGR4-0680 (2N13) 0.0701 SpTIGR4-1068 (3J14) 0.0354 
SpTIGR4-0681 (2O13) 0.0504 SpTIGR4-1070 (3L14) 0.0907 
SpTIGR4-0682 (2P13) 0.0237 SpTIGR4-1073 (3O14) 0.0838 
SpTIGR4-0701 (2K16) 0.0217 SpTIGR4-1074 (3P14) 0.088 
SpTIGR4-0702 (2L16) 0.00776 SpTIGR4-1075 (3I15) 0.0752 
SpTIGR4-0703 (2M16) 0.0377 SpTIGR4-1076 (3J15) 0.0267 
SpTIGR4-0709 (2K17) 0.0371 SpTIGR4-1077 (3K15) 0.0545 
SpTIGR4-0710 (2L17) 0.0431 SpTIGR4-1078 (3L15) 0.0859 
SpTIGR4-0711 (2M17) 0.0254 SpTIGR4-1088 (3N16) 0.0907 
SpTIGR4-0712 (2N17) 0.066 SpTIGR4-1089 (3O16) 0.0601 
SpTIGR4-0715 (2I18) 0.0245 SpTIGR4-1090 (3P16) 0.0405 
SpTIGR4-0716 (2J18) 0.0444 SpTIGR4-1092 (3J17) 0.0854 
SpTIGR4-0717 (2K18) 0.0628 SpTIGR4-1094 (3L17) 0.0613 
SpTIGR4-0726 (2L19) 0.0218 SpTIGR4-1095 (3M17) 0.0713 
SpTIGR4-0727 (2M19) 0.0841 SpTIGR4-1096 (3N17) 0.0424 
SpTIGR4-0729 (2O19) 0.0974 SpTIGR4-1097 (3O17) 0.0473 
SpTIGR4-0730 (2P19) 0.00752 SpTIGR4-1100 (3J18) 0.0473 
SpTIGR4-0731 (2I20) 0.00714 SpTIGR4-1105 (3O18) 0.0883 
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SpTIGR4-0743 (2M21) 0.0431 SpTIGR4-1106 (3P18) 0.0473 
SpTIGR4-0744 (2N21) 0.054 SpTIGR4-1112 (3N19) 0.0473 
SpTIGR4-0745 (2O21) 0.0479 SpTIGR4-1114 (3P19) 0.0254 
SpTIGR4-0753 (2O22) 0.0384 SpTIGR4-1118 (3L20) 0.0681 
SpTIGR4-0762 (2P23) 0.0702 SpTIGR4-1119 (3M20) 0.0592 
SpTIGR4-0766 (2L24) 0.0193 SpTIGR4-1121 (3O20) 0.0602 
SpTIGR4-0768 (2N24) 0.0733 SpTIGR4-1122 (3P20) 0.0945 
SpTIGR4-0775 (3E1) 0.0497 SpTIGR4-1125 (3K21) 0.0907 
SpTIGR4-0783 (3E2) 0.0387 SpTIGR4-1129 (3O21) 0.0973 
SpTIGR4-0784 (3F2) 0.00411 SpTIGR4-1130 (3P21) 0.0975 
SpTIGR4-0789 (3C3) 0.0255 SpTIGR4-1139 (3I23) 0.0701 
SpTIGR4-0790 (3D3) 0.00474 SpTIGR4-1140 (3J23) 0.0854 
SpTIGR4-0791 (3E3) 0.0199 SpTIGR4-1142 (3L23) 0.0554 
SpTIGR4-0792 (3F3) 0.0504 SpTIGR4-1148 (3J24) 0.0268 
SpTIGR4-0793 (3G3) 0.0994 SpTIGR4-1149 (3K24) 0.0399 
SpTIGR4-0798 (3D4) 0.0302 SpTIGR4-1151 (3M24) 0.0662 
SpTIGR4-0799 (3E4) 0.0151 SpTIGR4-1152 (3N24) 0.0473 
SpTIGR4-0801 (3G4) 0.0481 SpTIGR4-1153 (3O24) 0.0443 
SpTIGR4-0805 (3C5) 0.0733 SpTIGR4-1154 (3P24) 0.0613 
SpTIGR4-0812 (3B6) 0.0826 SpTIGR4-1156 (4B1) 0.0822 
SpTIGR4-0818 (3H6) 0.0444 SpTIGR4-1160 (4F1) 0.0602 
SpTIGR4-0819 (3A7) 0.0497 SpTIGR4-1161 (4G1) 0.0554 
SpTIGR4-0820 (3B7) 0.0268 SpTIGR4-1162 (4H1) 0.0666 
SpTIGR4-0823 (3E7) 0.0489 SpTIGR4-1163 (4A2) 0.0174 
SpTIGR4-0828 (3B8) 0.0637 SpTIGR4-1164 (4B2) 0.0322 
SpTIGR4-0830 (3D8) 0.0709 SpTIGR4-1166 (4D2) 0.0613 
SpTIGR4-0838 (3D9) 0.0687 SpTIGR4-1167 (4E2) 0.0666 
SpTIGR4-0842 (3H9) 0.0504 SpTIGR4-1168 (4F2) 0.0713 
SpTIGR4-0846 (3D10) 0.0504 SpTIGR4-1169 (4G2) 0.0405 
SpTIGR4-0847 (3E10) 0.093 SpTIGR4-1175 (4E3) 0.0613 
SpTIGR4-0852 (3B11) 0.0504 SpTIGR4-1176 (4F3) 0.0915 
SpTIGR4-0853 (3C11) 0.0192 SpTIGR4-1177 (4G3) 0.0399 
SpTIGR4-0854 (3D11) 0.0974 SpTIGR4-1178 (4H3) 0.0768 
SpTIGR4-0855 (3E11) 0.0218 SpTIGR4-1179 (4A4) 0.0613 
SpTIGR4-0857 (3G11) 0.0245 SpTIGR4-1180 (4B4) 0.0174 
SpTIGR4-0858 (3H11) 0.0281 SpTIGR4-1182 (4D4) 0.0773 
SpTIGR4-0861 (3C12) 0.0867 SpTIGR4-1189 (4C5) 0.0699 
SpTIGR4-0864 (3F12) 0.00411 SpTIGR4-1190 (4D5) 0.0213 
SpTIGR4-0866 (3H12) 0.0785 SpTIGR4-1191 (4E5) 0.088 
SpTIGR4-0867 (3I1) 0.00581 SpTIGR4-1192 (4F5) 0.0202 
SpTIGR4-0868 (3J1) 0.0156 SpTIGR4-1193 (4G5) 0.0549 
SpTIGR4-0869 (3K1) 0.00352 SpTIGR4-1194 (4H5) 0.0441 
SpTIGR4-0870 (3L1) 0.0285 SpTIGR4-1200 (4F6) 0.09 
SpTIGR4-0875 (3I2) 0.026 SpTIGR4-1202 (4H6) 0.0439 
SpTIGR4-0876 (3J2) 0.0632 SpTIGR4-1203 (4A7) 0.0494 
SpTIGR4-0877 (3K2) 0.0508 SpTIGR4-1205 (4C7) 0.0768 
SpTIGR4-0880 (3N2) 0.0421 SpTIGR4-1206 (4D7) 0.045 
SpTIGR4-0896 (3N4) 0.0273 SpTIGR4-1207 (4E7) 0.0847 
SpTIGR4-0904 (3N5) 0.0709 SpTIGR4-1213 (4C8) 0.0504 
SpTIGR4-0905 (3O5) 0.0603 SpTIGR4-1225 (4G9) 0.0489 
SpTIGR4-0916 (3J7) 0.00451 SpTIGR4-1226 (4H9) 0.0289 
SpTIGR4-0918 (3L7) 0.00803 SpTIGR4-1227 (4A10) 0.0402 
SpTIGR4-0919 (3M7) 0.0245 SpTIGR4-1228 (4B10) 0.00975 
SpTIGR4-0920 (3N7) 0.00494 SpTIGR4-1229 (4C10) 0.0613 
SpTIGR4-0921 (3O7) 0.012 SpTIGR4-1233 (4G10) 0.0907 
SpTIGR4-0922 (3P7) 0.0194 SpTIGR4-1242 (4G11) 0.0679 
SpTIGR4-0936 (3N9) 0.0733 SpTIGR4-1244 (4A12) 0.0656 
SpTIGR4-0938 (3P9) 0.0643 SpTIGR4-1245 (4B12) 0.0535 
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SpTIGR4-0943 (3M10) 0.026 SpTIGR4-1246 (4C12) 0.0314 
SpTIGR4-0950 (3L11) 0.0193 SpTIGR4-1247 (4D12) 0.0511 
SpTIGR4-0959 (3M12) 0.0436 SpTIGR4-1248 (4E12) 0.0511 
SpTIGR4-0960 (3N12) 0.0489 SpTIGR4-1251 (4H12) 0.0887 
SpTIGR4-0961 (3O12) 0.00664 SpTIGR4-1255 (4L1) 0.0854 
SpTIGR4-0962 (3P12) 0.0224 SpTIGR4-1257 (4N1) 0.0449 
SpTIGR4-0963 (3A13) 0.033 SpTIGR4-1267 (4P2) 0.0727 
SpTIGR4-0964 (3B13) 0.0151 SpTIGR4-1282 (4O4) 0.0787 
SpTIGR4-0967 (3E13) 0.0377 SpTIGR4-1285 (4J5) 0.0586 
SpTIGR4-0969 (3G13) 0.0925 SpTIGR4-1287 (4L5) 0.068 
SpTIGR4-0970 (3H13) 0.091 SpTIGR4-1291 (4P5) 0.0822 
SpTIGR4-0974 (3D14) 0.0431 SpTIGR4-1294 (4K6) 0.0494 
SpTIGR4-0980 (3B15) 0.0637 SpTIGR4-1296 (4M6) 0.0536 
SpTIGR4-0988 (3B16) 0.0433 SpTIGR4-1306 (4O7) 0.0713 
SpTIGR4-0990 (3D16) 0.0596 SpTIGR4-1313 (4N8) 0.0859 
SpTIGR4-0992 (3F16) 0.0735 SpTIGR4-1353 (4F13) 0.0945 
SpTIGR4-0994 (3H16) 0.0909 SpTIGR4-1356 (4A14) 0.0494 
SpTIGR4-0995 (3A17) 0.0873 SpTIGR4-1366 (4C15) 0.0859 
SpTIGR4-0999 (3E17) 0.0119 SpTIGR4-1367 (4D15) 0.0666 
SpTIGR4-1000 (3F17) 0.00845 SpTIGR4-1382 (4C17) 0.0736 
SpTIGR4-1001 (3G17) 0.0556 SpTIGR4-1383 (4D17) 0.0509 
SpTIGR4-1003 (3A18) 0.0138 SpTIGR4-1387 (4H17) 0.0891 
SpTIGR4-1004 (3B18) 0.0436 SpTIGR4-1388 (4A18) 0.0859 
SpTIGR4-1014 (3D19) 0.0481 SpTIGR4-1398 (4C19) 0.0828 
SpTIGR4-1016 (3F19) 0.0714 SpTIGR4-1402 (4G19) 0.0876 
SpTIGR4-1018 (3H19) 0.0453 SpTIGR4-1403 (4H19) 0.0602 
SpTIGR4-1020 (3B20) 0.0697 SpTIGR4-1408 (4E20) 0.0527 
SpTIGR4-1023 (3E20) 0.0295 SpTIGR4-1410 (4G20) 0.0859 
SpTIGR4-1024 (3F20) 0.032 SpTIGR4-1411 (4H20) 0.0811 
SpTIGR4-1027 (3A21) 0.0767 SpTIGR4-1412 (4A21) 0.0289 
SpTIGR4-1033 (3G21) 0.0618 SpTIGR4-1415 (4D21) 0.0266 
SpTIGR4-1034 (3H21) 0.0556 SpTIGR4-1416 (4E21) 0.0973 
SpTIGR4-1035 (3A22) 0.0673 SpTIGR4-1418 (4G21) 0.072 
SpTIGR4-1038 (3D22) 0.0561 SpTIGR4-1419 (4H21) 0.0174 
SpTIGR4-1041 (3G22) 0.0366 SpTIGR4-1420 (4A22) 0.0494 
SpTIGR4-1044 (3B23) 0.0816 SpTIGR4-1421 (4B22) 0.0526 
SpTIGR4-1062 (3L13) 0.0656 SpTIGR4-1427 (4H22) 0.0732 
SpTIGR4-1064 (3N13) 0.00708 SpTIGR4-1428 (4A23) 0.0267 
SpTIGR4-1068 (3J14) 0.0619 SpTIGR4-1429 (4B23) 0.0916 
SpTIGR4-1072 (3N14) 0.00664 SpTIGR4-1431 (4D23) 0.0854 
SpTIGR4-1073 (3O14) 0.021 SpTIGR4-1435 (4H23) 0.0473 
SpTIGR4-1074 (3P14) 0.0556 SpTIGR4-1438 (4C24) 0.0399 
SpTIGR4-1076 (3J15) 0.0237 SpTIGR4-1450 (4O13) 0.0289 
SpTIGR4-1077 (3K15) 0.0651 SpTIGR4-1451 (4P13) 0.0414 
SpTIGR4-1078 (3L15) 0.0556 SpTIGR4-1452 (4I14) 0.0202 
SpTIGR4-1087 (3M16) 0.0787 SpTIGR4-1453 (4J14) 0.0525 
SpTIGR4-1089 (3O16) 0.054 SpTIGR4-1454 (4K14) 0.054 
SpTIGR4-1090 (3P16) 0.0479 SpTIGR4-1470 (4K16) 0.013 
SpTIGR4-1092 (3J17) 0.0975 SpTIGR4-1471 (4L16) 0.0202 
SpTIGR4-1094 (3L17) 0.0974 SpTIGR4-1472 (4M16) 0.0372 
SpTIGR4-1096 (3N17) 0.0643 SpTIGR4-1473 (4N16) 0.0545 
SpTIGR4-1099 (3I18) 0.0162 SpTIGR4-1474 (4O16) 0.0701 
SpTIGR4-1100 (3J18) 0.0566 SpTIGR4-1475 (4P16) 0.0638 
SpTIGR4-1106 (3P18) 0.0343 SpTIGR4-1476 (4I17) 0.0746 
SpTIGR4-1107 (3I19) 0.0591 SpTIGR4-1489 (4N18) 0.0822 
SpTIGR4-1117 (3K20) 0.0199 SpTIGR4-1498 (4O19) 0.0893 
SpTIGR4-1118 (3L20) 0.0431 SpTIGR4-1506 (4O20) 0.077 
SpTIGR4-1122 (3P20) 0.0602 SpTIGR4-1507 (4P20) 0.0726 
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SpTIGR4-1125 (3K21) 0.0433 SpTIGR4-1514 (4O21) 0.0974 
SpTIGR4-1142 (3L23) 0.0932 SpTIGR4-1523 (4P22) 0.0666 
SpTIGR4-1143 (3M23) 0.0644 SpTIGR4-1529 (4N23) 0.0427 
SpTIGR4-1144 (3N23) 0.0974 SpTIGR4-1531 (4P23) 0.0937 
SpTIGR4-1148 (3J24) 0.0281 SpTIGR4-1532 (4I24) 0.0862 
SpTIGR4-1149 (3K24) 0.0149 SpTIGR4-1533 (4J24) 0.0494 
SpTIGR4-1151 (3M24) 0.0444 SpTIGR4-1534 (4K24) 0.077 
SpTIGR4-1152 (3N24) 0.0259 SpTIGR4-1539 (4P24) 0.0787 
SpTIGR4-1153 (3O24) 0.0497 SpTIGR4-1543 (5D1) 0.0202 
SpTIGR4-1154 (3P24) 0.0857 SpTIGR4-1545 (5F1) 0.0289 
SpTIGR4-1156 (4B1) 0.0727 SpTIGR4-1546 (5G1) 0.0269 
SpTIGR4-1157 (4C1) 0.0733 SpTIGR4-1560 (5E3) 0.0174 
SpTIGR4-1159 (4E1) 0.0849 SpTIGR4-1562 (5G3) 0.0954 
SpTIGR4-1160 (4F1) 0.00411 SpTIGR4-1563 (5H3) 0.0935 
SpTIGR4-1161 (4G1) 0.0434 SpTIGR4-1572 (5A5) 0.0649 
SpTIGR4-1162 (4H1) 0.00663 SpTIGR4-1573 (5B5) 0.0854 
SpTIGR4-1163 (4A2) 0.00263 SpTIGR4-1575 (5D5) 0.0621 
SpTIGR4-1164 (4B2) 0.00418 SpTIGR4-1576 (5E5) 0.0994 
SpTIGR4-1166 (4D2) 0.0779 SpTIGR4-1583 (5D6) 0.0289 
SpTIGR4-1169 (4G2) 0.032 SpTIGR4-1587 (5H6) 0.0202 
SpTIGR4-1176 (4F3) 0.075 SpTIGR4-1588 (5A7) 0.0313 
SpTIGR4-1177 (4G3) 0.0656 SpTIGR4-1589 (5B7) 0.0449 
SpTIGR4-1178 (4H3) 0.087 SpTIGR4-1590 (5C7) 0.0789 
SpTIGR4-1179 (4A4) 0.0793 SpTIGR4-1591 (5D7) 0.0787 
SpTIGR4-1180 (4B4) 0.0102 SpTIGR4-1631 (5D12) 0.0662 
SpTIGR4-1183 (4E4) 0.0852 SpTIGR4-1651 (5P2) 0.0266 
SpTIGR4-1189 (4C5) 0.0592 SpTIGR4-1661 (5J4) 0.0422 
SpTIGR4-1190 (4D5) 0.0673 SpTIGR4-1663 (5L4) 0.0638 
SpTIGR4-1192 (4F5) 0.0508 SpTIGR4-1674 (5O5) 0.0745 
SpTIGR4-1203 (4A7) 0.0596 SpTIGR4-1688 (5M7) 0.055 
SpTIGR4-1208 (4F7) 0.0108 SpTIGR4-1690 (5O7) 0.0586 
SpTIGR4-1212 (4B8) 0.0917 SpTIGR4-1691 (5P7) 0.0831 
SpTIGR4-1213 (4C8) 0.0199 SpTIGR4-1704 (5M9) 0.0956 
SpTIGR4-1215 (4E8) 0.0793 SpTIGR4-1717 (5J11) 0.0207 
SpTIGR4-1225 (4G9) 0.0179 SpTIGR4-1724 (5I12) 0.0794 
SpTIGR4-1226 (4H9) 0.00581 SpTIGR4-1725 (5J12) 0.055 
SpTIGR4-1227 (4A10) 0.0047 SpTIGR4-1734 (5C13) 0.0337 
SpTIGR4-1228 (4B10) 0.0237 SpTIGR4-1774 (5C18) 0.08 
SpTIGR4-1229 (4C10) 0.0984 SpTIGR4-1775 (5D18) 0.0494 
SpTIGR4-1241 (4F11) 0.0537 SpTIGR4-1776 (5E18) 0.0854 
SpTIGR4-1242 (4G11) 0.0882 SpTIGR4-1778 (5G18) 0.0258 
SpTIGR4-1245 (4B12) 0.0047 SpTIGR4-1786 (5G19) 0.0551 
SpTIGR4-1246 (4C12) 0.0199 SpTIGR4-1793 (5F20) 0.0211 
SpTIGR4-1247 (4D12) 0.0254 SpTIGR4-1794 (5G20) 0.013 
SpTIGR4-1248 (4E12) 0.04 SpTIGR4-1802 (5G21) 0.0207 
SpTIGR4-1255 (4L1) 0.091 SpTIGR4-1804 (5A22) 0.0854 
SpTIGR4-1262 (4K2) 0.0608 SpTIGR4-1809 (5F22) 0.0119 
SpTIGR4-1267 (4P2) 0.0152 SpTIGR4-1845 (5J15) 0.0693 
SpTIGR4-1275 (4P3) 0.0637 SpTIGR4-1846 (5K15) 0.0502 
SpTIGR4-1276 (4I4) 0.0299 SpTIGR4-1851 (5P15) 0.0701 
SpTIGR4-1277 (4J4) 0.01 SpTIGR4-1852 (5I16) 0.0433 
SpTIGR4-1278 (4K4) 0.0151 SpTIGR4-1853 (5J16) 0.089 
SpTIGR4-1279 (4L4) 0.0596 SpTIGR4-1860 (5I17) 0.0277 
SpTIGR4-1280 (4M4) 0.0481 SpTIGR4-1861 (5J17) 0.013 
SpTIGR4-1285 (4J5) 0.0415 SpTIGR4-1862 (5K17) 0.00975 
SpTIGR4-1286 (4K5) 0.032 SpTIGR4-1863 (5L17) 0.0768 
SpTIGR4-1296 (4M6) 0.063 SpTIGR4-1874 (5O18) 0.0202 
SpTIGR4-1299 (4P6) 0.0629 SpTIGR4-1875 (5P18) 0.0595 
237 
SpTIGR4-1306 (4O7) 0.0199 SpTIGR4-1877 (5J19) 0.0473 
SpTIGR4-1311 (4L8) 0.0937 SpTIGR4-1878 (5K19) 0.0174 
SpTIGR4-1313 (4N8) 0.0387 SpTIGR4-1879 (5L19) 0.0504 
SpTIGR4-1353 (4F13) 0.021 SpTIGR4-1880 (5M19) 0.0473 
SpTIGR4-1354 (4G13) 0.0479 SpTIGR4-1881 (5N19) 0.0854 
SpTIGR4-1355 (4H13) 0.0477 SpTIGR4-1883 (5P19) 0.0174 
SpTIGR4-1356 (4A14) 0.0739 SpTIGR4-1884 (5I20) 0.013 
SpTIGR4-1357 (4B14) 0.00562 SpTIGR4-1886 (5K20) 0.0961 
SpTIGR4-1358 (4C14) 0.0344 SpTIGR4-1891 (5P20) 0.0954 
SpTIGR4-1359 (4D14) 0.0378 SpTIGR4-1894 (5K21) 0.0282 
SpTIGR4-1360 (4E14) 0.0409 SpTIGR4-1895 (5L21) 0.0527 
SpTIGR4-1361 (4F14) 0.0425 SpTIGR4-1896 (5M21) 0.0322 
SpTIGR4-1363 (4H14) 0.071 SpTIGR4-1897 (5N21) 0.0322 
SpTIGR4-1364 (4A15) 0.0733 SpTIGR4-1898 (5O21) 0.00975 
SpTIGR4-1366 (4C15) 0.0632 SpTIGR4-1940 (6A3) 0.0586 
SpTIGR4-1367 (4D15) 0.04 SpTIGR4-1941 (6B3) 0.0598 
SpTIGR4-1369 (4F15) 0.0182 SpTIGR4-1942 (6C3) 0.0961 
SpTIGR4-1383 (4D17) 0.0254 SpTIGR4-1944 (6E3) 0.054 
SpTIGR4-1385 (4F17) 0.0505 SpTIGR4-1950 (6C4) 0.0892 
SpTIGR4-1386 (4G17) 0.0781 SpTIGR4-1964 (6A6) 0.0391 
SpTIGR4-1387 (4H17) 0.0833 SpTIGR4-1966 (6C6) 0.077 
SpTIGR4-1388 (4A18) 0.0376 SpTIGR4-1968 (6E6) 0.0446 
SpTIGR4-1389 (4B18) 0.0429 SpTIGR4-1969 (6F6) 0.0974 
SpTIGR4-1394 (4G18) 0.0917 SpTIGR4-1972 (6A7) 0.0822 
SpTIGR4-1402 (4G19) 0.0504 SpTIGR4-1973 (6B7) 0.09 
SpTIGR4-1403 (4H19) 0.0255 SpTIGR4-1976 (6E7) 0.0473 
SpTIGR4-1408 (4E20) 0.091 SpTIGR4-1986 (6G8) 0.0433 
SpTIGR4-1414 (4C21) 0.0576 SpTIGR4-1987 (6H8) 0.0702 
SpTIGR4-1415 (4D21) 0.033 SpTIGR4-1988 (6A9) 0.0449 
SpTIGR4-1417 (4F21) 0.0193 SpTIGR4-1989 (6B9) 0.0262 
SpTIGR4-1418 (4G21) 0.0434 SpTIGR4-1990 (6C9) 0.0473 
SpTIGR4-1419 (4H21) 0.0731 SpTIGR4-1991 (6D9) 0.0647 
SpTIGR4-1420 (4A22) 0.091 SpTIGR4-1994 (6G9) 0.0494 
SpTIGR4-1421 (4B22) 0.0674 SpTIGR4-2008 (6E11) 0.096 
SpTIGR4-1426 (4G22) 0.0909 SpTIGR4-2010 (6G11) 0.0494 
SpTIGR4-1427 (4H22) 0.00803 SpTIGR4-2013 (6B12) 0.0289 
SpTIGR4-1428 (4A23) 0.0201 SpTIGR4-2014 (6C12) 0.0266 
SpTIGR4-1429 (4B23) 0.0216 SpTIGR4-2016 (6E12) 0.0266 
SpTIGR4-1431 (4D23) 0.032 SpTIGR4-2017 (6F12) 0.0527 
SpTIGR4-1433 (4F23) 0.0727 SpTIGR4-2020 (6I1) 0.0702 
SpTIGR4-1438 (4C24) 0.0431 SpTIGR4-2021 (6J1) 0.0494 
SpTIGR4-1450 (4O13) 0.0295 SpTIGR4-2032 (6M2) 0.0637 
SpTIGR4-1451 (4P13) 0.0193 SpTIGR4-2041 (6N3) 0.0787 
SpTIGR4-1452 (4I14) 0.0497 SpTIGR4-2045 (6J4) 0.0369 
SpTIGR4-1453 (4J14) 0.0444 SpTIGR4-2054 (6K5) 0.00975 
SpTIGR4-1454 (4K14) 0.0828 SpTIGR4-2055 (6L5) 0.0511 
SpTIGR4-1456 (4M14) 0.0314 SpTIGR4-2056 (6M5) 0.0372 
SpTIGR4-1458 (4O14) 0.0237 SpTIGR4-2057 (6N5) 0.0174 
SpTIGR4-1462 (4K15) 0.032 SpTIGR4-2058 (6O5) 0.0146 
SpTIGR4-1463 (4L15) 0.0828 SpTIGR4-2060 (6I6) 0.0635 
SpTIGR4-1464 (4M15) 0.0275 SpTIGR4-2063 (6L6) 0.0266 
SpTIGR4-1470 (4K16) 0.0738 SpTIGR4-2072 (6M7) 0.0743 
SpTIGR4-1471 (4L16) 0.0343 SpTIGR4-2073 (6N7) 0.0289 
SpTIGR4-1472 (4M16) 0.00581 SpTIGR4-2075 (6P7) 0.088 
SpTIGR4-1473 (4N16) 0.0632 SpTIGR4-2076 (6I8) 0.0333 
SpTIGR4-1474 (4O16) 0.00451 SpTIGR4-2084 (6I9) 0.0207 
SpTIGR4-1475 (4P16) 0.0404 SpTIGR4-2085 (6J9) 0.0289 
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SpTIGR4-1476 (4I17) 0.0548 SpTIGR4-2086 (6K9) 0.0311 
SpTIGR4-1477 (4J17) 0.0505 SpTIGR4-2087 (6L9) 0.0536 
SpTIGR4-1488 (4M18) 0.0427 SpTIGR4-2088 (6M9) 0.0399 
SpTIGR4-1491 (4P18) 0.071 SpTIGR4-2096 (6M10) 0.0446 
SpTIGR4-1498 (4O19) 0.0661 SpTIGR4-2097 (6N10) 0.0504 
SpTIGR4-1499 (4P19) 0.00451 SpTIGR4-2106 (6O11) 0.0108 
SpTIGR4-1504 (4M20) 0.0282 SpTIGR4-2107 (6P11) 0.0554 
SpTIGR4-1507 (4P20) 0.03 SpTIGR4-2113 (6N12) 0.0269 
SpTIGR4-1519 (4L22) 0.0801 SpTIGR4-2114 (6O12) 0.0907 
SpTIGR4-1521 (4N22) 0.0666 SpTIGR4-2134 (6C15) 0.0741 
SpTIGR4-1522 (4O22) 0.0617 SpTIGR4-2136 (6E15) 0.0592 
SpTIGR4-1531 (4P23) 0.0415 SpTIGR4-2143 (6D16) 0.077 
SpTIGR4-1532 (4I24) 0.0265 SpTIGR4-2146 (6G16) 0.0202 
SpTIGR4-1533 (4J24) 0.00597 SpTIGR4-2148 (6A17) 0.0399 
SpTIGR4-1534 (4K24) 0.0828 SpTIGR4-2150 (6B17) 0.0473 
SpTIGR4-1535 (4L24) 0.0733 SpTIGR4-2151 (6C17) 0.0602 
SpTIGR4-1539 (4P24) 0.0339 SpTIGR4-2153 (6E17) 0.0854 
SpTIGR4-1543 (5D1) 0.00704 SpTIGR4-2160 (6D18) 0.0822 
SpTIGR4-1544 (5E1) 0.0994 SpTIGR4-2171 (6G19) 0.0266 
SpTIGR4-1546 (5G1) 0.0119 SpTIGR4-2172 (6H19) 0.0694 
SpTIGR4-1550 (5C2) 0.0793 SpTIGR4-2173 (6A20) 0.0768 
SpTIGR4-1552 (5E2) 0.0244 SpTIGR4-2174 (6B20) 0.0588 
SpTIGR4-1560 (5E3) 0.0548 SpTIGR4-2175 (6C20) 0.0822 
SpTIGR4-1563 (5H3) 0.0429 SpTIGR4-2176 (6D20) 0.0787 
SpTIGR4-1564 (5A4) 0.0404 SpTIGR4-2180 (6H20) 0.0449 
SpTIGR4-1565 (5B4) 0.0568 SpTIGR4-2181 (6A21) 0.0262 
SpTIGR4-1568 (5E4) 0.0898 SpTIGR4-2186 (6F21) 0.0267 
SpTIGR4-1569 (5F4) 0.091 SpTIGR4-2187 (6G21) 0.00975 
SpTIGR4-1573 (5B5) 0.0397 SpTIGR4-2189 (6A22) 0.0586 
SpTIGR4-1575 (5D5) 0.0205 SpTIGR4-2190 (6B22) 0.0961 
SpTIGR4-1578 (5G5) 0.0214 SpTIGR4-2191 (6C22) 0.0859 
SpTIGR4-1582 (5C6) 0.0371 SpTIGR4-2192 (6D22) 0.0961 
SpTIGR4-1583 (5D6) 0.0201 SpTIGR4-2193 (6E22) 0.0494 
SpTIGR4-1584 (5E6) 0.0436 SpTIGR4-2194 (6F22) 0.0289 
SpTIGR4-1587 (5H6) 0.0192 SpTIGR4-2195 (6G22) 0.0289 
SpTIGR4-1588 (5A7) 0.0199 SpTIGR4-2201 (6E23) 0.0213 
SpTIGR4-1589 (5B7) 0.0173 SpTIGR4-2203 (6G23) 0.0697 
SpTIGR4-1590 (5C7) 0.0371 SpTIGR4-2204 (6H23) 0.0752 
SpTIGR4-1591 (5D7) 0.0787 SpTIGR4-2205 (6A24) 0.055 
SpTIGR4-1592 (5E7) 0.028 SpTIGR4-2206 (6B24) 0.0893 
SpTIGR4-1593 (5F7) 0.0384 SpTIGR4-2209 (6E24) 0.0322 
SpTIGR4-1602 (5G8) 0.0216 SpTIGR4-2210 (6F24) 0.0428 
SpTIGR4-1612 (5A10) 0.091 SpTIGR4-2222 (6J14) 0.0213 
SpTIGR4-1622 (5C11) 0.0193 SpTIGR4-2225 (6M14) 0.0561 
SpTIGR4-1624 (5E11) 0.0332 SpTIGR4-2226 (6N14) 0.0907 
SpTIGR4-1625 (5F11) 0.0909 SpTIGR4-2239 (6K16) 0.0511 
SpTIGR4-1630 (5C12) 0.0199 SpTIGR4-2240 (6L16) 0.0702 
SpTIGR4-1631 (5D12) 0.04   
SpTIGR4-1633 (5F12) 0.0863   
SpTIGR4-1646 (5K2) 0.0333   
SpTIGR4-1651 (5P2) 0.00704   
SpTIGR4-1663 (5L4) 0.0689   
SpTIGR4-1670 (5K5) 0.0975   
SpTIGR4-1671 (5L5) 0.0733   
SpTIGR4-1674 (5O5) 0.091   
SpTIGR4-1679 (5L6) 0.0605   
SpTIGR4-1684 (5I7) 0.0582   
SpTIGR4-1686 (5K7) 0.0735   
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SpTIGR4-1689 (5N7) 0.0727   
SpTIGR4-1690 (5O7) 0.0343   
SpTIGR4-1691 (5P7) 0.0787   
SpTIGR4-1695 (5L8) 0.0218   
SpTIGR4-1698 (5O8) 0.0431   
SpTIGR4-1699 (5P8) 0.0804   
SpTIGR4-1704 (5M9) 0.0317   
SpTIGR4-1708 (5I10) 0.0481   
SpTIGR4-1710 (5K10) 0.048   
SpTIGR4-1711 (5L10) 0.0564   
SpTIGR4-1712 (5M10) 0.0804   
SpTIGR4-1716 (5I11) 0.0497   
SpTIGR4-1717 (5J11) 0.0095   
SpTIGR4-1720 (5M11) 0.0527   
SpTIGR4-1721 (5N11) 0.0285   
SpTIGR4-1722 (5O11) 0.0394   
SpTIGR4-1724 (5I12) 0.0121   
SpTIGR4-1725 (5J12) 0.0366   
SpTIGR4-1734 (5C13) 0.0217   
SpTIGR4-1762 (5G16) 0.0698   
SpTIGR4-1774 (5C18) 0.0619   
SpTIGR4-1775 (5D18) 0.00664   
SpTIGR4-1776 (5E18) 0.0365   
SpTIGR4-1777 (5F18) 0.052   
SpTIGR4-1778 (5G18) 0.00664   
SpTIGR4-1786 (5G19) 0.0574   
SpTIGR4-1787 (5H19) 0.0994   
SpTIGR4-1793 (5F20) 0.0237   
SpTIGR4-1794 (5G20) 0.0237   
SpTIGR4-1801 (5F21) 0.0201   
SpTIGR4-1802 (5G21) 0.0605   
SpTIGR4-1803 (5H21) 0.091   
SpTIGR4-1804 (5A22) 0.0237   
SpTIGR4-1805 (5B22) 0.0564   
SpTIGR4-1807 (5D22) 0.00451   
SpTIGR4-1809 (5F22) 0.0223   
SpTIGR4-1811 (5H22) 0.091   
SpTIGR4-1814 (5C23) 0.0207   
SpTIGR4-1837 (5J14) 0.0431   
SpTIGR4-1845 (5J15) 0.0102   
SpTIGR4-1846 (5K15) 0.0474   
SpTIGR4-1851 (5P15) 0.0881   
SpTIGR4-1852 (5I16) 0.00581   
SpTIGR4-1853 (5J16) 0.06   
SpTIGR4-1860 (5I17) 0.0368   
SpTIGR4-1861 (5J17) 0.0245   
SpTIGR4-1862 (5K17) 0.032   
SpTIGR4-1863 (5L17) 0.0301   
SpTIGR4-1869 (5J18) 0.00664   
SpTIGR4-1870 (5K18) 0.0568   
SpTIGR4-1871 (5L18) 0.0254   
SpTIGR4-1872 (5M18) 0.0429   
SpTIGR4-1874 (5O18) 0.0481   
SpTIGR4-1875 (5P18) 0.0221   
SpTIGR4-1877 (5J19) 0.0232   
SpTIGR4-1878 (5K19) 0.00752   
SpTIGR4-1879 (5L19) 0.0716   
SpTIGR4-1880 (5M19) 0.00664   
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SpTIGR4-1883 (5P19) 0.0502   
SpTIGR4-1884 (5I20) 0.0265   
SpTIGR4-1886 (5K20) 0.0492   
SpTIGR4-1894 (5K21) 0.0139   
SpTIGR4-1895 (5L21) 0.0094   
SpTIGR4-1896 (5M21) 0.0201   
SpTIGR4-1897 (5N21) 0.0047   
SpTIGR4-1898 (5O21) 0.00722   
SpTIGR4-1901 (5J22) 0.0791   
SpTIGR4-1903 (5L22) 0.0906   
SpTIGR4-1905 (5N22) 0.0949   
SpTIGR4-1906 (5O22) 0.0102   
SpTIGR4-1911 (5L23) 0.093   
SpTIGR4-1912 (5M23) 0.0733   
SpTIGR4-1913 (5N23) 0.0975   
SpTIGR4-1914 (5O23) 0.0851   
SpTIGR4-1915 (5P23) 0.0295   
SpTIGR4-1923 (5P24) 0.0237   
SpTIGR4-1924 (6A1) 0.0158   
SpTIGR4-1925 (6B1) 0.0898   
SpTIGR4-1939 (6H2) 0.0577   
SpTIGR4-1940 (6A3) 0.0201   
SpTIGR4-1947 (6H3) 0.0164   
SpTIGR4-1953 (6F4) 0.0799   
SpTIGR4-1959 (6D5) 0.0474   
SpTIGR4-1964 (6A6) 0.0444   
SpTIGR4-1966 (6C6) 0.0855   
SpTIGR4-1972 (6A7) 0.0213   
SpTIGR4-1973 (6B7) 0.058   
SpTIGR4-1976 (6E7) 0.00451   
SpTIGR4-1986 (6G8) 0.0751   
SpTIGR4-1987 (6H8) 0.0339   
SpTIGR4-1988 (6A9) 0.0154   
SpTIGR4-1989 (6B9) 0.0531   
SpTIGR4-1990 (6C9) 0.0366   
SpTIGR4-1991 (6D9) 0.00704   
SpTIGR4-1992 (6E9) 0.0218   
SpTIGR4-1993 (6F9) 0.0619   
SpTIGR4-1997 (6B10) 0.033   
SpTIGR4-1998 (6C10) 0.0924   
SpTIGR4-2000 (6E10) 0.00976   
SpTIGR4-2001 (6F10) 0.0576   
SpTIGR4-2002 (6G10) 0.0444   
SpTIGR4-2003 (6H10) 0.031   
SpTIGR4-2005 (6B11) 0.0643   
SpTIGR4-2013 (6B12) 0.00581   
SpTIGR4-2014 (6C12) 0.0367   
SpTIGR4-2015 (6D12) 0.0787   
SpTIGR4-2016 (6E12) 0.00411   
SpTIGR4-2017 (6F12) 0.00411   
SpTIGR4-2021 (6J1) 0.0841   
SpTIGR4-2022 (6K1) 0.0224   
SpTIGR4-2026 (6O1) 0.0265   
SpTIGR4-2032 (6M2) 0.075   
SpTIGR4-2040 (6M3) 0.0889   
SpTIGR4-2047 (6L4) 0.0849   
SpTIGR4-2052 (6I5) 0.0841   
SpTIGR4-2053 (6J5) 0.0681   
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SpTIGR4-2054 (6K5) 0.0214   
SpTIGR4-2056 (6M5) 0.0237   
SpTIGR4-2057 (6N5) 0.0201   
SpTIGR4-2058 (6O5) 0.0656   
SpTIGR4-2060 (6I6) 0.0729   
SpTIGR4-2063 (6L6) 0.0182   
SpTIGR4-2072 (6M7) 0.0899   
SpTIGR4-2073 (6N7) 0.0293   
SpTIGR4-2074 (6O7) 0.0484   
SpTIGR4-2075 (6P7) 0.00562   
SpTIGR4-2076 (6I8) 0.0566   
SpTIGR4-2082 (6O8) 0.009   
SpTIGR4-2083 (6P8) 0.0728   
SpTIGR4-2084 (6I9) 0.014   
SpTIGR4-2085 (6J9) 0.0398   
SpTIGR4-2086 (6K9) 0.0236   
SpTIGR4-2087 (6L9) 0.0504   
SpTIGR4-2088 (6M9) 0.0357   
SpTIGR4-2094 (6K10) 0.0543   
SpTIGR4-2095 (6L10) 0.0582   
SpTIGR4-2096 (6M10) 0.0414   
SpTIGR4-2097 (6N10) 0.0735   
SpTIGR4-2099 (6P10) 0.0591   
SpTIGR4-2106 (6O11) 0.00562   
SpTIGR4-2107 (6P11) 0.0154   
SpTIGR4-2113 (6N12) 0.0512   
SpTIGR4-2114 (6O12) 0.0596   
SpTIGR4-2117 (6B13) 0.0889   
SpTIGR4-2120 (6E13) 0.0582   
SpTIGR4-2124 (6A14) 0.0783   
SpTIGR4-2126 (6C14) 0.0701   
SpTIGR4-2134 (6C15) 0.0757   
SpTIGR4-2135 (6D15) 0.0471   
SpTIGR4-2136 (6E15) 0.0429   
SpTIGR4-2141 (6B16) 0.0725   
SpTIGR4-2142 (6C16) 0.0914   
SpTIGR4-2143 (6D16) 0.0733   
SpTIGR4-2146 (6G16) 0.033   
SpTIGR4-2150 (6B17) 0.0574   
SpTIGR4-2151 (6C17) 0.0589   
SpTIGR4-2153 (6E17) 0.0834   
SpTIGR4-2168 (6D19) 0.0281   
SpTIGR4-2170 (6F19) 0.0787   
SpTIGR4-2171 (6G19) 0.0497   
SpTIGR4-2172 (6H19) 0.0546   
SpTIGR4-2173 (6A20) 0.0257   
SpTIGR4-2174 (6B20) 0.0367   
SpTIGR4-2175 (6C20) 0.0874   
SpTIGR4-2176 (6D20) 0.0897   
SpTIGR4-2179 (6G20) 0.0224   
SpTIGR4-2181 (6A21) 0.0117   
SpTIGR4-2184 (6D21) 0.0224   
SpTIGR4-2185 (6E21) 0.0661   
SpTIGR4-2186 (6F21) 0.00913   
SpTIGR4-2187 (6G21) 0.00411   
SpTIGR4-2188 (6H21) 0.0158   
SpTIGR4-2189 (6A22) 0.0415   
SpTIGR4-2190 (6B22) 0.022   
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SpTIGR4-2191 (6C22) 0.0729   
SpTIGR4-2192 (6D22) 0.0119   
SpTIGR4-2193 (6E22) 0.0119   
SpTIGR4-2194 (6F22) 0.0193   
SpTIGR4-2195 (6G22) 0.0293   
SpTIGR4-2201 (6E23) 0.0339   
SpTIGR4-2202 (6F23) 0.0268   
SpTIGR4-2203 (6G23) 0.0365   
SpTIGR4-2204 (6H23) 0.0049   
SpTIGR4-2205 (6A24) 0.0199   
SpTIGR4-2209 (6E24) 0.0217   
SpTIGR4-2210 (6F24) 0.00803   
SpTIGR4-2214 (6J13) 0.0367   
SpTIGR4-2215 (6K13) 0.031   
SpTIGR4-2218 (6N13) 0.0634   
SpTIGR4-2219 (6O13) 0.0994   
SpTIGR4-2220 (6P13) 0.033   
SpTIGR4-2221 (6I14) 0.03   
SpTIGR4-2222 (6J14) 0.00742   
SpTIGR4-2224 (6L14) 0.0941   
SpTIGR4-2228 (6P14) 0.0899   
SpTIGR4-2235 (6O15) 0.0273   
SpTIGR4-2239 (6K16) 0.00704   
SpTIGR4-2240 (6L16) 0.0146   
 
